#investorupdate: Jan van de Winkel, President and CEO, Anthony Pagano, Executive Vice President, Chief Financial Officer, and Judith Klimovsky, Executive Vice President, Chief Development Officer, will be participating in a fireside chat at the Jefferies 2026 Conference.
The webcast will be available here: ir.genmab.com/events-presentations.
#jefferies2026 #biotech #investorrelations
Genmab
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab (Suzhou) Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. More on Wikipedia
-
Genmab
@Genmab
-
Genmab
@Genmab
#investorupdate: Genmab reported financial results for the first nine months of 2026.
Watch our Q3 webcast for updates on our pipeline, strategic priorities and continued progress as an integrated biotech: edge.media-server.com/mmc/p/au5j2bbj/lan/en/.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#newsupdate: We’re looking forward to #ash26, where new and exciting clinical data will be shared. Our research will feature multiple abstracts highlighting our latest advances across various types of #bloodcancer.
Learn more: www.genmab.com/news-insights -
Genmab
@Genmab
#investorupdate | Mark your calendar for November 5: Genmab will release our interim report for the first nine months of 2026.
Join us to learn about our strategic priorities, growth as an integrated biotech and progress in advancing innovative antibody medicines for patients.
Register here: register-conf.media-server.com/register/BId05659f072f84d9…. -
Genmab
@Genmab
Today, we announced positive Phase 3 topline results for our investigational therapy in head and neck cancer. The findings reinforce the potential of our differentiated antibody science and reflect our continued commitment to developing transformative medicines for people living with cancer.
Learn more: gmab.ly/2eLa5100ARh. -
Genmab
@Genmab
#investorupdate: Tune in to Genmab’s upcoming investor event on October 28th at 12:00pm EST for a high-level overview of recent data.
View event details and access the webcast: genmab-investor-event-2026.open-exchange.net/registration. -
Genmab
@Genmab
We shared new research in recurrent or metastatic head and neck squamous cell carcinoma (#hnscc), a disease where significant needs remain, at @myESMO.(1) We are grateful to the investigators, study participants, and healthcare professionals who help to advance #antibodyscience research for this patient community.
Learn more: gmab.ly/2eLa5100ARh. #esmo26
1. Ionna, et al. (2021). Recurrent/metastatic squamous cell carcinoma of the head and neck. Cancers, 13(10), Article 2371. doi.org/10.3390/cancers13102371 -
Genmab
@Genmab
At @myESMO, we presented new research in metastatic colorectal cancer, where there remains a need for continued progress.(1) We are proud to stand alongside the oncology community in advancing the development of potential therapeutic options for people affected by cancer.
Learn more: gmab.ly/2eLa5100ARh. #esmo26
1. Ionna, et al. (2021). Recurrent/metastatic squamous cell carcinoma of the head and neck. Cancers, 13(10), Article 2371. doi.org/10.3390/cancers13102371 -
Genmab
@Genmab
We’ve announced a clinical trial collaboration with @Incyte to evaluate a novel combination of investigational therapies with standard-of-care chemotherapy, reflecting our shared commitment to cancer research.
Learn more: gmab.ly/2eLa5100ARh. -
Genmab
@Genmab
Today, we announced the first Phase 3 results for one of our investigational therapies in ovarian cancer. These data mark a milestone for our gynecologic cancer portfolio and build on our hope in its potential for patients living with ovarian cancer.
Learn more: gmab.ly/2eLa5100ARh. -
Genmab
@Genmab
Genmab is supporting @BloodCancerUtd's Light the Night Walk in Mercer County, NJ, once again. This is an amazing opportunity to come together to celebrate survivors, support those living with blood cancer and remember loved ones lost.
Register for an event in your community here: gmab.ly/zGn550TQUUK.
#lightthenight #inspiredbypatients -
Genmab
@Genmab
Welcome to a new edition of #antibodyhour 🕙!
Watch to hear our colleague Marcia Kruidhof, Clinical Trial Manager, share what motivates her, how collaboration helps teams find solutions, and what Genmab’s patient-focused approach to research means to her.
#patientfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
En 2023, le cancer du col de l’utérus figure parmi les cancers les plus fréquents chez les femmes âgées de 15 à 44 ans en France.(3) Nous œuvrons à faire progresser l’innovation avec un objectif : contribuer à améliorer les résultats pour les patientes. #cervicalcancer #womenshealth
-
Genmab
@Genmab
During this edition of #antibodyhour 🕙, we spotlight our colleague Iris Kolder, Director, Translational and Clinical Data Science.
Iris shares what motivates her work to bring medicines to patients, how she sees the people behind the data, and how her experience as a cancer survivor brings personal meaning to what she does each day.
#antibodyscienceThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#newsupdate: Topline results from a phase 3 study in newly diagnosed diffuse large B-cell #lymphoma (#dlbcl) are now available for our therapy in partnership with @abbvie.
Learn more: ir.genmab.com/genmab-news -
Genmab
@Genmab
At #igcs2026, we shared new Phase 1/2 data evaluating one of our investigational therapies in #ovariancancer.
These results add to the growing body of evidence supporting our clinical program in #gynecologiccancers.
Hear from Dr. Elizabeth Lee.
Learn more: gmab.ly/q2O350ZTfmF. -
Genmab
@Genmab
This #worldlymphomaday, we’re sharing how we’re working to change the course of care for patients and the larger #lymphoma community.
-
Genmab
@Genmab
Today, Genmab colleagues participated in Global Volunteer Day: volunteering 3000+ hours for 50+ local charities in the communities where we live and work.
Learn more here: gmab.ly/s93Q50TmnSH.
#communityatgenmabThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re heading to #soho2026!
Connect with Genmab colleagues at the 14th Annual @SocietyofHemOnc Meeting and visit Booth #176 to learn more about our innovative antibody science and investigational therapies.
#hematology -
Genmab
@Genmab
We are excited to announce that Genmab is now on Facebook and Instagram! These channels offer new ways to share our story and connect with our community.
Follow along to explore our science, our people and how we're committed to our goal of improving the lives of people with cancer and other serious diseases.
Facebook: www.facebook.com/profile.php?id=61593899126873.
Instagram: www.instagram.com/genmab.biotech -
Genmab
@Genmab
Cervical cancer was one of the most common cancers affecting women in the United Kingdom aged 15-44 in 2023. (3)
We’re pushing for change and are committed to improving outcomes.
#cervicalcancer #womenshealth -
Genmab
@Genmab
How can antibody science enable more targeted, personalized approaches in oncology?
In this #antibodyhour 🕙, Marije Overdijk, Head of Early Translational Medicine and Research, shares how her team advances promising antibody medicines from the research bench toward clinical proof of concept.
#antibodyhour #antibodyscienceThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#investorupdate: We announced our earnings report for the first half of 2026, highlighting strong execution against our strategic priorities and a strong financial foundation to support long-term growth.
Learn more and tune in to our investor call: ir.genmab.com/news-releases/news-release-details/genmab-a….
#biotech #earnings #antibodymedicines -
Genmab
@Genmab
Happy #nationalinternday to our incredible Genmab summer interns!
This summer, our interns brought fresh perspectives, curiosity, and enthusiasm to teams across Genmab. From R&D and Commercialization to Data, Digital & AI, Corporate Functions, and other teams across the organization, they collaborated, learned, and made meaningful contributions alongside colleagues.
Thank you to our interns, managers, mentors, and colleagues for making this a rewarding and successful summer! -
Genmab
@Genmab
At the heart of every scientific advancement is a team united by a shared commitment to innovation and collaboration.
In this week's #antibodyhour 🕙, hear from our colleague Neda Dukanovic Misic, Director, Quality Management & Lab Compliance, Global Lab Management, on how a personal connection to cancer inspires her work supporting the consistency and integrity of our labs—and the science behind potential new medicines.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
At Genmab, curiosity and courage drive us to explore bold ideas—always grounded in strong science and teamwork.
During this edition of #antibodyhour 🕙, our colleague Esil shares how she leads oncology programs from discovery toward the clinic with one goal in mind: bringing potential new medicines to patients.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#news: The EU Commission has granted marketing authorization for one of our therapies, developed with @abbvie, as a combination regimen for adults with relapsed/refractory (R/R) follicular #lymphoma (FL).
Learn more: gmab.ly/yonP50ZaGuQ -
Genmab
@Genmab
#newsupdate: Today, topline results are available from a Phase 3 study in relapsed/refractory diffuse large B-cell #lymphoma (#dlbcl), in partnership with @abbvie.
Learn more: gmab.ly/yzJk50ZiuxS -
Genmab
@Genmab
This Cancer Immunotherapy Month, we’re spotlighting our colleague Erik Voets, Associate Director, Product Discovery Lead at Genmab. Erik works on developing innovative immune-based therapies designed to help the body better recognize and target harmful cells
At Genmab, we aspire to advance innovative antibody therapies to positively impact patients.
Learn more: www.genmab.com/antibody-science.
#cancerimmunotherapymonth -
Genmab
@Genmab
During this edition of #antibodyhour 🕙, Farshid Alemdehy, Senior Scientist in Translational Medicine and Research at Genmab, shares how his team works to bridge preclinical and early clinical development to ensure the science behind our medicines translates into meaningful benefits for patients.
This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We want to hear from you! Answer the poll below to let us know what topic interests you and what you would like to learn more about?
Please answer below! ⬇️
What makes you feel most connected to a company’s vision? -
Genmab
@Genmab
We’re headed to #bio2026 and ready to connect and collaborate with the ambition to transform patients' lives.
For more information, please contact licensing@genmab.com
#biointernationalconvention #biotech -
Genmab
@Genmab
Leaving #eha2026 inspired! Grateful to the @EHA_Hematology community for an energizing few days of science, collaboration, and innovation in hematology. A fantastic opportunity to connect, learn, and reframe our focus on helping shape the future of patient care through science and partnership.
#innovation #hematology -
Genmab
@Genmab
#newsupdate: We shared results on one of our assets from two studies developed with @abbvie, in patients with newly diagnosed diffuse large B-cell #lymphoma at #eha2026
Learn more: gmab.ly/iXO850Z7jy0 -
Genmab
@Genmab
Today, we shared data evaluating one of our medicines used in a combination regimen for patients with relapsed/refractory follicular #lymphoma, developed with @abbvie.
Learn more: gmab.ly/rMjn50Z7jIU
#eha2026 -
Genmab
@Genmab
During this edition of #antibodyhour 🕙, hear from Vilmarie Rodriguez, VP of Patient Assistance & Community Engagement at @CancerCare who shares about Cancer Care’s work in developing programs for patients through counseling, support groups and patient advocacy. She shares how she has found purpose in helping others.
Her mission inspires us at Genmab as we move with the ambition to transform the lives of people living with cancer through innovative antibody medicines.
#patientfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re excited to share the latest from our #hematology research at #eha26! Join us at the European Hematology Association’s Congress to explore how we’re advancing antibody science with the ambition to transform patients’ lives.
Visit us at location B3.03 and learn more here: www.genmab.com/antibody-science/pipeline.
#oncology #biotech -
Genmab
@Genmab
At #asco2026, we continued our tradition of bringing together our patient advocacy organizations and professional societies to kick off ASCO with connection, dialogue, and shared purpose.
Thank you to the leaders who spent time with us. Your perspectives and continued advocacy help guide how we think, collaborate, and work toward more patient-centered approaches.
#patientadvocacy -
Genmab
@Genmab
During this edition of #antibodyhour 🕙, patient advisor Linda Emery shares her experience and encourages others to see clinical trials differently; not as a final option but as an opportunity worth exploring.
Her story is a reminder during Clinical Trial Awareness month of the importance of awareness and understanding the potential of clinical research.
Learn more about our impact: www.genmab.com/patients-care-partners
#innovation #patientfirst #clinicaltrialawarenessmonthThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#newsupdate: We’re looking forward to presenting new data in #bloodcancer at #asco2026 and #eha2026, with 20 abstracts showcasing our latest investigational treatment innovations across a range of B-cell malignancies.
Learn more: gmab.ly/Qq7G50Z1MsW -
Genmab
@Genmab
By 2050, #ovariancancer diagnoses are projected to rise by more than 55%, impacting over half a million women globally (1).
On #worldovariancancerday, we stand with the global community to drive awareness, earlier diagnosis, and improved care.
1 Global Cancer Observatory (GCO). International Agency for Research on Cancer, World Health Organization. Estimated numbers from 2022 to 2050, females aged 0–85+. -
Genmab
@Genmab
#investorupdate: Genmab has published its first-quarter interim report. Hear from our executive leaders about the progress we have made in our late-stage pipeline of innovative antibody products and key business milestones achieved this quarter.
Learn More: ir.genmab.com/news-releases/news-release-details/genmab-a….
#innovation #biotechThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Genmab is proud to support the next generation of life-science innovators by sponsoring the Life Science Award at the Danish Entrepreneurship Championship.
Congrats to this year’s winners SundtGear, who created supportive tights with built-in elastic assist to help elderly users stand up safely.
Learn more about how we support our community here: www.genmab.com/our-impact/corporate-responsibility-sustai….
#lifescience #entrepreneurship -
Genmab
@Genmab
Recently, we celebrated our colleagues Amy Whited, Mande Ye, and Laura Højland Larsen who were recognized by @HBAnet as Luminaries and Rising Star at the Woman of the Year event! We congratulate you and thank you for your leadership and impact.
#hbawoty2025 -
Genmab
@Genmab
Our U.S. based colleagues celebrated #takeyourchildtoworkday by welcoming very special guests to Genmab for a day of discovery and learning about finance through a bake sale, making picture frames for children coping with the loss of a parent, building bee boxes to support sustainability, as well as participating in engaging sessions on brand marketing, AI and pathology.
We loved sharing what we do, and why it matters with the next generation. -
Genmab
@Genmab
Head and neck squamous cell carcinoma (HNSCC) can be challenging to treat and can profoundly affect everyday activities, including speaking, swallowing, and interacting with others (1). That’s why awareness, education, and collaboration matter for people living with the disease. Genmab stands with the community and partners working to close gaps in awareness and care. #headandneckcancerawareness
1 McCartney J. Rising incidence of head and neck cancer drives treatment advances. Bull Am Coll Surg. October 2025;110(9). www.facs.org/for-medical-professionals/news-publications/… -
Genmab
@Genmab
For many, the fight against head and neck cancer begins with uncertainty and can have profound impacts on daily life. Clear information, compassionate care, and strong support can make a real difference.
Genmab is proud to stand with patients, care partners, and advocates to develop innovative antibody-based medicines in areas of critical need.
#headandneckcancerawareness #hnscc -
Genmab
@Genmab
What does it mean to lead with vision, drive innovation, and move faster for patients who can’t wait?
Real innovation means challenging convention, embracing new ideas, and collaborating with the ambition to deliver meaningful progress for patients.
Learn what our colleagues have to say about turning these ideas into action.
Thanks to @BioNJ for the original footage produced by @KenBlando at Pulse Productions Inc.
#leadership #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
At #sgo2026, we shared new safety data supporting the combination potential of one of our investigational agents in recurrent #ovariancancer. Results add to the growing body of clinical evidence for this program and its potential to expand treatment options for patients.
Visit: ir.genmab.com/genmab-news. -
Genmab
@Genmab
From bold antibody discovery to breakthrough innovation — this is Genmab.
Learn how we’ve evolved from designing next-generation antibodies to taking greater ownership of their journey from discovery, through development, and all the way to the patients who need them most.
Watch the full video to see how we’re leading antibody science for better futures here: www.genmab.com/about.
#antibodyscienceThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Inside Antibody Innovation: What’s Next?
In this #antibodyhour 🕙, we spotlight the people driving our innovation. Hear from Patrick Engelberts, Associate Director, Product Discovery at Genmab, on how we’re advancing the natural precision of antibodies.
From target specificity to binding strength, every detail shapes next-gen therapeutics. As the science advances, so does our ambition to continuously improve and apply the latest innovations with the goal of benefitting patients.
Learn more about our science: www.genmab.com/antibody-science.
#biotech #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Genmab has been awarded Finansforeningen’s Special Prize 2025, selected unanimously by the Accounting Committee for our open, timely, and consistent investor communication.
Finansforeningen (CFA Society Denmark) is a Danish professional association for finance and investment professionals.
Thank you to our investors and stakeholders for the continued trust, and to our teams who work with the goal of making a difference for patients through antibody medicines.
Learn more: cfa.dk.
#investorrelations -
Genmab
@Genmab
#investorupdate: Today, Genmab held its 2026 Annual General Meeting.
Our CEO Jan van de Winkel and CFO Anthony Pagano presented Genmab’s 2025 Annual Report.
For more information, visit: ir.genmab.com/news-releases/news-release-details/passing-…. -
Genmab
@Genmab
"I believe breakthrough science can be a miracle for a patient and her family.” - Robin Cohen
Tune in to this edition of #antibodyhour 🕙 to hear from Robin Cohen, BSN, CEO of the Sandy Rollman Ovarian Cancer Foundation, as she shares how a patient’s final words shaped her mission.
Robin reminds us that “a win” looks different for every patient. Some ask, “How long will I live?” Others ask, “How will I live?” Those questions challenge all of us as scientists, clinicians, and colleagues to focus on what truly matters to each individual patient and their family. At Genmab, stories like these are grounding. They remind us why breakthrough science and urgency matter, and why every antibody we work on carries our aspiration to transform the lives of patients.
#patientfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
In honor of International Women’s Day, we were pleased to welcome Courtney Clark for a special keynote on building resilience and navigating change, through what she refers to as revisionary thinking. The session includes reflection facilitated by Amy Whited and Leslie Amendola.
Genmab is also making a donation to @WomanspaceInc, a secure space for women, as part of our commitment to making a positive impact in the communities where we live and work.
#communityatgenmab #internationalwomensday -
Genmab
@Genmab
During this episode of #antibodyhour 🕙, Patient Advisor Linda Emery reflects on her personal experience with cancer and the moments that defined it.
She shares that while she never felt misunderstood during treatment, she found purpose by turning her experience into action and continues to find meaning in helping others.
Thank you, Linda, for sharing your story. We’re grateful for your perspective as we continue working to bring innovative antibody medicines to patients.
#patientfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re at @ESGO_society 2026, joining experts shaping the future of gynecologic oncology. Our work in antibody science starts with patients and is strengthened by connection across the scientific community.
Visit booth #4 and www.genmab.com/news-insights/stories/redefining-what-is-p….
#gynecologiconcology -
Genmab
@Genmab
#investorupdate: Genmab has published its 2025 Annual Report.
We have evolved into a fully integrated biotech with a wholly owned, diversified pipeline. Our focus remains unchanged: translating our antibody science into meaningful outcomes for patients.
Learn more: ir.genmab.com/news-releases/news-release-details/genmab-p…. -
Genmab
@Genmab
#icymi: Our 2025 Annual Report is now live.
We highlight how strategic investments and progress across our late-stage pipeline are advancing our evolution into a fully integrated biotech — focused on delivering meaningful innovation for patients and sustainable growth.
Visit: www.genmab.com/news-insights/stories/delivering-genmabs-n…. -
Genmab
@Genmab
On #internationaldayofwomenandgirlsinscience, we spotlight our inspiring colleagues who are dedicated to overcoming challenges, advancing science, and turning complexity into progress for patients.
Tune in to this week’s #antibodyhour 🕙 to hear from our team as they share how our can-do, proactive mindset keeps Genmab innovative, with the goal of impacting patients.
#innovation #womeninstem #womeninscienceThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Congratulations to Genmab CEO Jan van de Winkel, Ph.D., on receiving the @BioNJ 2026 Dr. Sol J. Barer Award for Vision, Innovation and Leadership.
This honor recognizes his patient-first leadership, commitment to breakthrough antibody science, and lasting impact on the biotech and pharma community in New Jersey and beyond.
Under Jan’s leadership, Genmab continues to evolve into an integrated biotech with a clear purpose to improve patients’ lives.
#biotech #leadership #genmab #bionj -
Genmab
@Genmab
On this #worldcancerday, we are spotlighting a powerful conversation between Patient Advisor Jennifer Thompson, and EVP, CPO, Christopher Cozic.
Follow along with us as we bring back our #antibodyhour🕙 series highlighting our people and purpose as we aspire to impact patient lives with innovative antibody medicines.
#inspiredbypatients #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
This #worldcancerday, we’re united by what makes each cancer journey unique.
Our colleague Iris’ words remind us why it is vital to put patients at the center of innovation at Genmab.
Learn how we aspire to empower patients and care partners: www.genmab.com/patients-care-partners.
#unitedbyunique -
Genmab
@Genmab
Growing Together for a Greener Future!
Our colleagues teamed up with Trees for All to plant trees in the beautiful Het Groene Woud, another meaningful step in our ongoing commitment to sustainability and positive impact.
#sustainability #csr -
Genmab
@Genmab
This week, Genmab hosted a Career Exploration Day at our Utrecht site, welcoming nearly 80 students.
Students listened in to several scientific presentations, worked on a data analysis assignment, and took a tour of the site, giving future scientists a firsthand look at what a career in biotech looks like.
#stem #careerexploration -
Genmab
@Genmab
#investorupdate for Genmab Shareholders: Stay informed by registering your email to receive electronic shareholder communications from Genmab, including notices for our Annual General Meetings.
Simply log in to the Investor Portal and add your email under “My Profile.”
Click here: investor.vp.dk/ip/ctrl/portal/Frontpage.do?command=&aside…. -
Genmab
@Genmab
#icymi: President & CEO Jan van de Winkel shared an update on our transformation into a fully integrated biotech with a growing portfolio of proprietary medicines and a promising late-stage pipeline at #jpm2026, hosted by @jpmorgan.
Watch the replay here: ir.genmab.com/events-presentations. -
Genmab
@Genmab
As Genmab presents at #jpm2026, we’re continuing to build the foundation of a more scalable, digitally enabled R&D engine to advance the company’s vision of bringing transformative antibody-based medicines to patients.
Read more: gmab.ly/J6kq50XSV0P. -
Genmab
@Genmab
#newsupdate: Genmab has partnered with @Anthropic to accelerate research and development processes through agentic artificial intelligence.
@claudeai
Read more: gmab.ly/J6kq50XSV0P. -
Genmab
@Genmab
Happy New Year from Genmab!
As we enter 2026, our purpose to improve patients’ lives through innovative antibody therapeutics continues to inspire us.
We’ll be presenting at the 44th @jpmorgan Healthcare Conference.
Read more: gmab.ly/MyRA50XSbXE.
#jpm2026 -
Genmab
@Genmab
As 2025 ends, we’re reflecting on a year of scientific progress toward our vision: improving the lives of patients with innovative antibody medicines.
Thank you to the patients, caregivers, partners & colleagues who inspire us.
Follow along on our journey as we enter 2026: www.genmab.com/our-impact/patient-engagement.
#inspiredbypatients #patientsfirst -
Genmab
@Genmab
As we wrap up our final #antibodyhour 🕙 episode of the year, we’re closing with the voices that matter most.
Before we return in 2026, we’re proud to share reflections from members of our Patient Advisory Council on what meaningful partnership truly looks like. Hear from Portia, Stephanie and Keith as they share their message to Genmab colleagues.
We can’t wait to keep sharing more stories, breakthroughs, and perspectives in 2026.
Follow along as the next chapter of Antibody Hour begins: gmab.ly/qLNJ50XKuU6.
#inspiredbypatients #patientsfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#news: Genmab has closed the Merus acquisition, an important step in our evolution as a global biotechnology leader.
This milestone strengthens our late-stage portfolio and advances our long-term #strategy. We’re excited to welcome our Merus colleagues.
Learn more at: gmab.ly/SrTV50XHXQN
#biotech #oncology -
Genmab
@Genmab
At Genmab, our 25+ years of #antibodyexpertise fuels our vision to advance next generation #oncology therapies. Through proprietary technologies, agile R&D and AI-powered insights, we're breaking barriers in treatment #innovation – with patients at the center of everything we do.
The latest video in our R&D series showcases the science behind our discoveries: youtu.be/9CfHl7sddFg.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
At Genmab, our purpose comes to life when we listen to patients.
In this edition of #antibodyhour 🕙, we’re spotlighting Keith, a member of our Patient Advisory Council. Keith shared that serving as a patient advisor has been really gratifying to be able to take his experience and share it in a constructive way.
We’re grateful for Keith, who inspires us and strengthens our commitment to meaningful innovation in cancer.
#patientfirst #innovation #patientadvocacyThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
At the @ASH_hematology Annual Meeting, we shared new data investigating one of our assets, in collaboration with @abbvie, for patients with Richter transformation (RT). Read more: gmab.ly/fyTz50XFYly
#ash2025 -
Genmab
@Genmab
At the @ASH_hematology Annual Meeting, we presented new data on our medicine for relapsed/refractory follicular #lymphoma, in partnership with @abbvie. These findings were also published in @TheLancet. Read more: gmab.ly/evju50XELIw
#ash2025 -
Genmab
@Genmab
We shared new data at the @ASH_hematology Annual Meeting evaluating one of our medicines as a monotherapy and in combination for diffuse large B-cell #lymphoma (#dlbcl), in collaboration with @abbvie. Read more: gmab.ly/N2Qs50XExFh
#ash2025 -
Genmab
@Genmab
#investorupdate: Join us virtually on December 11 for our 2025 R&D Update and #ash25 Data Review where we’ll be offering insights into our antibody innovations and #hematology #pipeline.
Register today: gmab.ly/GMxf50XBvrM.
Please note that this event is not part of the official ASH Annual Meeting. -
Genmab
@Genmab
We’re excited to attend this year’s @ASH_hematology annual meeting (#ash25) and look forward to presenting new data from our hematology portfolio to further our goal in bringing innovative antibody medicines to patients.
To learn more, stop by our booth #701 and visit: www.genmab.com/antibody-science/pipeline. -
Genmab
@Genmab
#icymi: We’re focused on our commitment to our vision and strategic roadmap as we aim to innovate for the benefit of patients. At the heart of this journey are the patients. Their perspectives guide all we do at Genmab. We always want them to feel seen and heard.
Hear from Daan Meester in this edition of #antibodyhour 🕙 on how we keep patient perspectives at the forefront of drug development.
#patientfirst #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
What sets Genmab apart is our deep connection between groundbreaking science and the patients we serve.
During this edition of #antibodyhour 🕙, our colleague Shawn Keogan, Director of Patient Advocacy, shares how Genmab’s people and purpose inspire her.
#patientfirst #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#newsupdate: The @US_FDA has approved a new indication for one of our antibody-based products, developed with @AbbVie, as a treatment option for adults with relapsed or refractory follicular #lymphoma.
Read more: gmab.ly/NTCY50XtAZW -
Genmab
@Genmab
Investor Update: Genmab President & CEO Jan van de Winkel will be participating in a fireside chat alongside EVP & CFO Anthony Pagano at the @Jefferies 2025 Conference, where they will share Genmab’s strategic direction, innovation priorities, and growth roadmap.
The webcast will be available here: ir.genmab.com/events-presentations.
#jefferies2025 #biotech #investorrelations -
Genmab
@Genmab
This #nationalfamilycaregiversmonth, Genmab honors the dedication of care partners.
In this edition of #antibodyhour 🕙, Leslie Amendola, Senior Vice President and US General Manager reflects on her experience caring for her mother and how understanding those experiences deepen Genmab’s commitment to supporting patients and those who care for them.
#patientfirst #carepartnerThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#investorupdate: Genmab presented an update on our financial performance for the first nine months of 2025.
This quarter, we advanced our late-stage pipeline, brought innovative antibody medicines to patients in new geographies on our own, and continued our transformation into an integrated biotech.
Check out our Q3 highlights: www.genmab.com/investor-relations. -
Genmab
@Genmab
Innovation means reshaping how we think and work.
During this episode of #antibodyhour 🕙 hear from Ewan Robson, Senior Director, EU Medical Affairs, as he explains how controlled disruption fuels progress at Genmab.
#innovation #2030vision -
Genmab
@Genmab
#investorupdate | Mark your calendar for November 6: Genmab will release our interim report for the first nine months of 2025.
Join us to learn how we’re advancing our strategic priorities and delivering on our vision to become an integrated biotech company, bringing innovative antibody medicines to patients.
Register here: gmab.ly/of2v50X8svC.
#biotech #antibodyscience #innovation -
Genmab
@Genmab
We’re looking forward to #ash2025, where we will feature more than 20 abstracts, including 7 oral presentations highlighting our latest research across various types of #bloodcancer, as we seek to address critical patient needs. Learn more: gmab.ly/E6ao50Xm1j0
-
Genmab
@Genmab
This weekend our NJ team joined @BloodCancerUtd Light The Night in Mercer County, honoring survivors, remembering loved ones & supporting families impacted by blood cancer. ❤️💛🤍💡
#lightthenight -
Genmab
@Genmab
#icymi: Welcome to a new edition of #antibodyhour 🕙!
Hear from our colleague Brian Elliott, VP and Clinical Lead, a former hematologist-oncologist, as he shares why he joined Genmab – to help develop antibody medicines that are not only innovative but aspire to be truly meaningful in the lives of patients.
#innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Congrats to our colleagues Allison Jurgens, Chera Jarrett and Liz Violin—honored in Ragan’s Top Women in Marketing 2025 for their leadership in Tech/Digital Marketers, Disrupters and Product Marketer categories respectively.
#ragantopwomeninmarketing2025 #ragan2025 -
Genmab
@Genmab
This year we are walking with @BloodCancerUtd at Mercer County’s Light the Night, honoring survivors, remembering loved ones, and standing united against blood cancer.
Register for an event here: gmab.ly/zGn550TQUUK.
#lightthenight #inspiredbypatients -
Genmab
@Genmab
We believe that innovation is guided by understanding patient insights.
This week on #antibodyhour 🕙, Portia Badham, Patient Advisor, highlights the importance of listening to patients. At Genmab, their perspectives inspire our purpose, as we believe that every breakthrough in antibody medicine should begin with understanding the people that our science is designed to help.
#patientfirst -
Genmab
@Genmab
We presented new data evaluating our investigational therapy in #gynecologiconcology at the @myESMO #esmo25 Congress.
Our latest data underscore our commitment to deliver on our vision and accelerate our late-stage pipeline of #antibodymedicines for patients seeking potential new options.
Read more: gmab.ly/aNZi50X1Qho. -
Genmab
@Genmab
#icymi: During this edition of Antibody Hour 🕙, hear from @stephanielieber of @ImermanAngels as she shares why peer-to-peer support is vital in cancer care.
At Genmab, we’re inspired by voices like hers, reminding us that advancing science must go hand in hand with advancing patient support.
#antibodyhour #patientadvocacyThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
As a leader in antibody research committed to improving lives through innovative and differentiated antibody therapeutics, Genmab aims to create novel therapies that have the potential to transform the treatment of cancer and other serious diseases.
To learn more, visit our new webpage at: gmab.ly/fr9N50X1aMt. -
Genmab
@Genmab
Honored to receive the 2025 Nancy & Marty Dowd Spirit of Hope Award from @Cr4Hope, supporting people with cancer and their loved ones.
Proud to stand with fellow honorees Gov. Phil Murphy and Dr. Eshaan Patel as we continue advancing public health in Mercer County, NJ.
#impact #communityatgenmab -
Genmab
@Genmab
At Genmab, we’re driven by the impact innovation can have on people living with cancer.
During this #antibodyhour 🕙, our colleague Emily Spencer, RN, Senior Manager, Patient Engagement Liaison, shares her hopes for how cancer care will evolve in the next 5 years.
Learn more about our pipeline: gmab.ly/wTPn50X7NqO.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
This week we hosted our 4th annual Science Day, a day dedicated to fostering two-way dialogue between leaders from patient advocacy and professional organizations, as well as our patient advisors.
The day brought together shared perspectives and a strong commitment to continue shaping the future of science with patients at the center of all we do.
Learn more: gmab.ly/eiUt50TKPrz.
#scienceday #patientsfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Breaking #news: Genmab to acquire Merus, a clinical-stage #biotech, expanding our late-stage #oncology pipeline and accelerating sustainable growth.
This proposed acquisition aligns with our long-term strategy and track record in antibody innovation and strengthens our commitment to delivering innovative cancer therapies that can make a meaningful impact for patients.
Learn more at: gmab.ly/M5Gv50X3pwI -
Genmab
@Genmab
This #bloodcancerawarenessmonth, we're inspired by Arlen, who shares his experience living with diffuse large B-cell lymphoma (#dlbcl). We hope his story of resilience empowers others navigating their health journeys. gmab.ly/34iQ50WTpoX
-
Genmab
@Genmab
We’re focused on our commitment to our vision and strategic roadmap as we aim to innovate for the benefit of patients.
At the heart of this journey are the patients. Their perspectives guide all we do at Genmab. We always want them to feel seen and heard.
Hear from Daan Meester in this edition of #antibodyhour 🕙 on how we keep patient perspectives at the forefront of drug development.
#patientfirst #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
During this edition of Antibody Hour 🕙, hear from @stephanielieber of @ImermanAngels as she shares why peer-to-peer support is vital in cancer care. At Genmab, we’re inspired by voices like hers—reminding us that advancing science must go hand in hand with advancing patient support.
#antibodyhour #patientadvocacyThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#icymi: Recently on #antibodyhour 🕙: Our colleague Brian Elliott, VP, Clinical Lead and former oncologist shared his perspective on the innovation behind our antibody medicines and how at Genmab we are driven by a patient-first mindset and collaborative spirit.
Watch below to learn more.
#innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Today, Genmab colleagues participated in Global Volunteer Day: volunteering over 3,000 hours for 43 local charities in the communities where we live and work.
Learn more here: gmab.ly/s93Q50TmnSH.
#communityatgenmab -
Genmab
@Genmab
We’re attending the 13th Annual Meeting of the @SocietyofHemOnc #soho25 covering the latest advancements and innovation in the #hematology space.
To learn more about our innovative antibody science and investigational therapies, visit our booth #176. -
Genmab
@Genmab
It’s #antibodyhour! 🕙At Genmab, our culture is defined by genuine collaboration and a shared commitment to putting patients first.
Hear more from our colleague Leslie Amendola on what drives us.
#innovation #cultureThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Breaking News: We shared new data evaluating one of our assets at the @SocietyofHemOnc Annual Meeting, in partnership with @Abbvie. #soho2025 Read more: gmab.ly/MBTH50WPJb7
-
Genmab
@Genmab
We’re looking forward to presenting 6 abstracts that showcase our latest research in #bloodcancer at the @SocietyofHemOnc Annual Meeting tomorrow. #soho2025
-
Genmab
@Genmab
#newsupdate: The FDA has granted Breakthrough Therapy Designation for our investigational treatment in #gynecologiconcology. This designation underscores our commitment to advancing innovative antibody therapies for people with cancer and other serious diseases.
Read more: gmab.ly/U2It50WLGXQ.
#gynonc -
Genmab
@Genmab
What’s the secret to staying inspired and focused as a leader?
In this #antibodyhour 🕙 episode, our CEO Jan van de Winkel, PhD shares how Genmab’s North Star—our belief in the power of antibodies to transform lives—drives everything we do.
#innovation #biotechThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
As a socially responsible biotech company, we’re excited to launch the Genmab and Mercer County Community College Mentoring Program. Genmab mentors will work with science scholarship recipients for 10 months of growth, learning & connection. Investing in the next generation of scientific talent starts here.
#mentorship #communityatgenmab #stemeducation #nextgenstem -
Genmab
@Genmab
#icymi: At Genmab, transforming patient lives drives our 2030 vision. Hear from Ewan Robson, Senior Director, EU Medical Affairs, on how patient insights fuel our innovation and allow us to push boundaries in bringing medicines to patients.
#patientfirst #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#icymi: What makes a difference in a cancer journey?
Our patient advisors and patient advocates say: self-advocacy. This week on #antibodyhour 🕙, hear from Keith, Portia Badham, and Stephanie Lieber on why it’s not just empowering—it’s essential.
#patientadvocacy #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Genmab is delivering strong H1 2025 results with 19% revenue growth and 56% operating profit increase.
We’re accelerating our late-stage pipeline, maximizing potential of our commercial medicines, and executing disciplined capital allocation to drive continued growth and value for patients, shareholders, and employees.
edge.media-server.com/mmc/p/kwgn27js/.
#biotech #antibodymedicines #earnings -
Genmab
@Genmab
#investorupdate: We announced our earnings report for the first half of 2025, highlighting robust revenue growth and progress in advancing key pipeline assets.
Learn more and tune in to our investor call: ir.genmab.com/news-releases/news-release-details/genmab-a….
#biotech #earnings #antibodymedicines -
Genmab
@Genmab
#icymi: Scientific #innovation powers our progress—from our deep expertise in antibody therapies to how we advance our late-stage pipeline. At Genmab, our approach to disease biology is grounded in purpose, and our R&D teams are fueled by deep curiosity and bold thinking.
Dive deeper and explore how we're working to shape the future of #antibodyscience to potentially deliver targeted treatment for patients: www.youtube.com/watch?v=ya5EhwzHqb8.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
This week on #antibodyhour 🕙:
Our colleague Brian Elliott, VP, Clinical Lead and former oncologist shares his perspective on the innovation behind our antibody medicines and how at Genmab we are driven by a patient-first mindset and collaborative spirit.
Watch below to learn more.
#innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We want to hear from you! Please participate in the below poll:
What type of content would you like to see more from Genmab on X? -
Genmab
@Genmab
It’s #nationalinternday, and we want to thank our passionate summer interns in the Netherlands and the U.S. for their contributions at Genmab in helping advance innovation in antibody medicines, and we also reflect on our own internships and recognize those who came before us and helped shape us as we continue our journey to help patients.
#internship -
Genmab
@Genmab
During this edition of #antibodyhour 🕙:
Our colleague Shawn Keogan PhD, Director of Patient Advocacy, shares why embedding the patient perspective isn’t just good practice; it’s essential.
At Genmab, we’re genuinely listening to patients and absorbing their insights - because patients aren’t just stakeholders, they're experts in their experience.
#patientfirst #innovation -
Genmab
@Genmab
Inspiring Tomorrow's Scientists
Genmab is proud to nurture the next generation of scientific innovators. We partnered with @Students2Science to host aspiring scientists at our Princeton NJ location for a hands-on Exploration Day to inspire a passion for innovation.
Learn more: www.genmab.com/our-impact/corporate-responsibility-sustai…. -
Genmab
@Genmab
#icymi: We believe that transforming the lives of patients starts with empowering our people.
This week on #antibodyhour 🕙, hear from our colleagues Ewan Robson & Francis Blokzijl who share how our open culture drives collaboration to continue advancing innovation in antibody medicines.
#innovation #cultureThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Scientific #innovation powers our progress—from our deep expertise in antibody therapies to how we advance our late-stage pipeline. At Genmab, our approach to disease biology is grounded in purpose, and our R&D teams are fueled by deep curiosity and bold thinking.
Dive deeper and explore how we're working to shape the future of #antibodyscience to potentially deliver targeted treatment for patients: www.youtube.com/watch?v=ya5EhwzHqb8.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
After 23 incredible years, EVP & Chief Legal Officer Birgitte Stephensen will retire. We thank her for her lasting impact on our organization, culture, and people.
We welcome Greg Mueller as our new EVP, General Counsel & Chief Legal Officer. Greg joins from AstraZeneca with 20+ years of global legal experience.
Read more at: ir.genmab.com/news-releases/news-release-details/genmab-a…. -
Genmab
@Genmab
🎉 We’re thrilled to announce the grand opening of our expanded site in New Jersey, a vibrant space built for innovation, collaboration & our #onegenmab spirit.
We’re grateful to mark this moment with patient advisors, community leaders, government officials, academic partners, and our incredible Genmab colleagues.
This expansion deepens our roots in New Jersey’s thriving life sciences ecosystem and moves us closer to our vision: bringing knock-your-socks-off (KYSO) antibody therapies® to patients.
@BioNJ_Org, @NJEDA, @Cr4Hope
#genmab #biotech #growth -
Genmab
@Genmab
This #cancerimmunotherapymonth, meet our colleague Marieke Heineke, Senior Scientist at Genmab who explores novel immune mechanisms and helps translate early research into potential new antibody medicines.
At Genmab, we’re advancing antibody therapies with the goal of transforming the lives of people with cancer.
Learn more: www.genmab.com/antibody-science.
#immunotherapy #oncology -
Genmab
@Genmab
We believe that transforming the lives of patients starts with empowering our people.
This week on #antibodyhour 🕙, hear from our colleagues Ewan Robson & Francis Blokzijl who share how our open culture drives collaboration to continue advancing innovation in antibody medicines.
#innovation #cultureThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re looking forward to #18icml, where we will be presenting 27 abstracts that showcase our latest research in #bloodcancer.
-
Genmab
@Genmab
Leaving #eha2025 inspired! Grateful to the @EHA_Hematology community for a powerful few days of science, collaboration, and innovation in hematology. A fantastic opportunity to connect, learn, and advance care for patients worldwide.
#innovation #hematology -
Genmab
@Genmab
Breaking News: We shared new data evaluating our investigational antibody medicine in patients with relapsed or refractory #dlbcl at #eha2025, in partnership with @AbbVie. Read more: gmab.ly/9zmm50Wa4xn
-
Genmab
@Genmab
At #eha2025, we are excited to present new clinical data for #bloodcancer. Swipe to learn more about the subtypes of non-Hodgkin #lymphoma (NHL) – a diverse group of blood cancers that arise from lymphocytes, a type of white blood cell.
-
Genmab
@Genmab
#investorupdate: We are excited to participate in a fireside chat at the @GoldmanSachs 46th Annual Global Healthcare Conference. Click here to learn more: ir.genmab.com/events-presentations.
-
Genmab
@Genmab
We’re excited to share the latest from our #hematology research at #eha25! Join us at the European Hematology Association’s Congress to explore how we’re turning science into medicine.
Visit us at location G.03 and learn more here: www.genmab.com/antibody-science/pipeline.
#oncology #biotech -
Genmab
@Genmab
Thank you to everyone who connected with us at the @ASCO 2025 meeting! We're energized by the conversations, inspired by the community, and proud to share our purpose in advancing cancer care.
#asco2025 #oncology #innovation -
Genmab
@Genmab
On this #nationalcancersurvivorsday we’re spotlighting the voices that matter most — patients. Hear from Keith & Portia as they share their powerful journeys and survivorship.
#patientfirst #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re headed to #bio2025 and ready to connect, collaborate, and drive antibody innovation forward.
For more information, please contact licensing@genmab.com.
#biointernationalconvention #biotech -
Genmab
@Genmab
Our data presentation at @ASCO #asco2025 Annual Meeting is a testament to our work toward advancing #antibodyscience to address the unmet need in gynecologic oncology. Read more: gmab.ly/UlzU50W2Rt2.
-
Genmab
@Genmab
At Genmab, our purpose is driven by the voices of patients. Thank you to the incredible leaders from patient advocacy organizations and professional societies who met with us at @ASCO 2025. Your perspectives continue to shape how we innovate antibody medicines and support the patient journey.
#patientadvocacy #asco25 -
Genmab
@Genmab
We will be in Chicago for the @ASCO Annual Meeting.
Stop by booth 27115 to connect with our team to learn how we’re advancing antibody science with the purpose of shaping what’s next in oncology.
Learn more at: www.genmab.com/antibody-science/pipeline.
#asco2025 -
Genmab
@Genmab
At Genmab, we recognize that each patient’s journey is unique, and a diagnosis can be life-altering—not just for patients but for families and friends as well.
During this #antibodyhour 🕙 episode, Keith shares his experience with cancer, challenging misconceptions and reflecting on how his family’s unwavering support became a source of strength during his fight.
Listen to his inspiring story.
#supportThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re looking forward to presenting our latest data in gynecologic oncology and hematology at the @ASCO #asco2025 Annual Meeting. At Genmab, we’re committed to advancing #innovative antibody therapies for cancer patients.
Learn more: gmab.ly/1WwI50VXPgX. -
Genmab
@Genmab
This #oncologynursingmonth, Genmab celebrates the impact of oncology nurses everywhere.
During this edition of #antibodyhour 🕙, we spotlight our colleague Emily Spencer, RN, Sr. Manager, Patient Engagement Liaison, as she shares how her experience as a former oncology nurse shapes her work at Genmab, with the goal of improving patients’ lives, inspiring hope, and driving change.
#patientfirst #nursing #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re looking forward to #eha2025, where we will be presenting 14 abstracts that showcase our latest research evaluating our investigational medicine in #bloodcancer, furthering our goal of improving the lives of patients. Learn more: gmab.ly/N5Jh50VTwN9
-
Genmab
@Genmab
What makes a difference in a cancer journey? Our patient advisors and patient advocates say: self-advocacy.
This week on #antibodyhour 🕙, hear from Keith, Portia Badham, and Stephanie Lieber on why it’s not just empowering—it’s essential.
#patientadvocacy #innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Recently, we celebrated Robyn Bilmes & Riemke R. Van Dijkhuizen being recognized as Luminaries, and Shawn Keogan as a Rising Star at @HBAnet's Woman of the Year event! Thank you for your leadership and impact.
#hbawoty2025 -
Genmab
@Genmab
#investorupdate: Genmab has published its first-quarter interim report. Hear from our executive leaders about the progress we have made in our late-stage pipeline of innovative antibody products and key business milestones achieved this quarter.
Learn More: gmab.ly/GC3S50VPq3o.
#innovation #biotechThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Behind every innovation are the people who inspire it.
This week on Antibody Hour 🕙, Monika Jun shares her journey — as a leader, researcher, and cancer survivor — reminding us that behind every data point and discovery are real experiences. We are grateful for Monika and all our colleagues who are pushing antibody innovation forward.
#antibodyhourThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
This week, our colleagues are presenting data at the @AACR Annual Meeting #aacr25. The research, spanning hematologic and solid tumors, underscores our focus on potentially bringing innovative antibody medicines to people living with cancer. #antibodyscience
-
Genmab
@Genmab
Our U.S. teams celebrated #takeyourchildtoworkday with hands-on science experiments, a lemonade stand, cancer education kits, and fun sessions on AI, social media & more.
A day full of learning and laughter—we so enjoyed having them with us!This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We’re heading to the @AACR 2025 Annual Meeting! Discover Genmab’s latest scientific breakthroughs and innovations in antibody medicine.
Visit us at booth #509 and learn more: www.genmab.com/antibody-science.
#aacr2025 -
Genmab
@Genmab
In this edition of #antibodyhour 🕙, Portia Badham shares the mantra that fuels her resilience: “Life is how you change it.” Her story inspires us to innovate faster and deliver next-gen antibody therapies that truly impact patients’ lives.
#patientfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Leading antibody science for better futures – that’s the heart of what we do at Genmab.
In this #antibodyhour episode 🕙, Daan Meester & Alejandra Segura share what it means to work at the forefront of drug development —being able to see their work directly impact patients.
Watch here:
#innovationThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
Recently, Genmab was recognized with the Student Impact Award by @MercerCollege for funding scholarships for students pursuing science degrees which aligns with our goal to empower future innovators.
Learn more: gmab.ly/QIT250VsLbT.
#stem #communityatgenmab -
Genmab
@Genmab
At Genmab, we work with patients to shape the future of biotechnology.
In this #antibodyhour 🕙, Shawn Keogan shares how our 2030 vision is driven by collaboration – with patients, advocates, providers and the broader community – to shape innovation in antibody medicine with a goal to truly make an impact on patients’ lives.
#patientadvocacy #cancerresearch #innovation -
Genmab
@Genmab
Welcome to a new edition of #antibodyhour 🕙! Hear from our colleague Brian Elliott, VP and Clinical Lead, a former hematologist-oncologist, as he shares why he joined Genmab – to help develop antibody medicines that are not only innovative but aspire to be truly meaningful in the lives of patients.
#innovation -
Genmab
@Genmab
Learn how as a socially responsible biotech company, we’re turning our values into action. From supporting patients and our colleagues, to advancing environmental sustainability, we are committed to making a positive impact in the communities where we live and work.
See our 2024 highlights here: gmab.ly/P4X350VshP8.
#communityatgenmab -
Genmab
@Genmab
We are committed to leveraging novel approaches to make an impact on patients' lives through innovative antibody medicines.
Hear from our experts on how we are harnessing the power of precision medicine with the goal of delivering the right treatment to the right patient at the right time.
Learn more here:
#innovation -
Genmab
@Genmab
We are proud to share that three of our colleagues have been recognized by @HBAnet for their leadership and impact!
Learn more about our unstoppable team at: gmab.ly/q96S50VoVhg.
#hbaimpact #hbawoty25 -
Genmab
@Genmab
At Genmab, we believe that real #innovation starts with the voices that matter most—#patients and #caregivers
In this edition of #antibodyhour🕙, Stephanie Lieber of Imerman Angels shares powerful insights on why patient perspectives are essential in every aspect of drug development.
Learn more about Stephanie’s insights. -
Genmab
@Genmab
We’re advancing our oncology pipeline to potentially make a difference for people with gynecologic cancers. Hear from Kathy Amiri, VP, Head of Global Medical Affairs Strategy, on data shared with the scientific community at #sgomtg. gmab.ly/qEQw50VkK9g
-
Genmab
@Genmab
Our work is personal – we hope to help advance cancer treatment and provide better outcomes for patients. In this edition of #antibodyhour 🕙, Leslie Amendola, SVP, US General Manager, shares her experience with losing her mother to cancer and her role as a care partner. #innovation
-
Genmab
@Genmab
Today, we announced the latest data from our investigational asset in #ovariancancer, presented at the @SGO_org's #sgomtg. We’re dedicated to developing potential new treatment options for people living with #gynecologiccancer. Read more: gmab.ly/HEec50Vji8A.
-
Genmab
@Genmab
We’ll be attending the @SGO_org's Annual Meeting in Seattle, Washington! Join us at booth 109 to explore the latest oncology research at Genmab.
Learn more: gmab.ly/RabN50VhE4H.
#antibodyscience #sgomtg -
Genmab
@Genmab
Congratulations to the Genmab colleagues who have recently been elected to our #boardofdirectors, continuing our tradition of employee representation in key decisions.
Learn more at www.genmab.com/about/board-of-directors. -
Genmab
@Genmab
#investorupdate: Today, Genmab held its 2025 Annual General Meeting.
Our CEO Jan van de Winkel and CFO Anthony Pagano presented Genmab’s 2024 Annual Report.
For more information, visit: gmab.ly/25iG50VgAP0. -
Genmab
@Genmab
On #internationalwomensday, we recognize the achievements of women everywhere, especially those driving innovation in science, medicine and beyond.
During this edition of #antibodyhour 🕙, hear from our colleagues on what innovation means to them.
#innovation #impact -
Genmab
@Genmab
Welcome to this week’s edition of #antibodyhour 🕙: Unveiling the stories driving antibody innovation!
At Genmab, transforming patient lives drives our 2030 vision. Hear from Ewan Robson, Senior Director, EU Medical Affairs, on how patient insights fuel our innovation and allow us to push boundaries in bringing medicines to patients.
#patientfirst #innovation -
Genmab
@Genmab
Genmab is proud to share that our colleagues’ research is published in Frontiers in Oncology.
The article discusses a new RNA-sequencing data visualization tool - advancing data-driven drug discovery, which allows for informed decision-making in selecting appropriate indications and supports our goal of improving the lives of patients through innovative antibody therapies.
Read more: gmab.ly/1ecI50USqru.
#datascience #oncology -
Genmab
@Genmab
New on Antibody Hour 🕙: Unveiling the stories driving antibody innovation. At Genmab, we recognize that each patient’s journey is unique, and a diagnosis can be life-altering—not just for patients but for families and friends as well.
Keith shares his experience with cancer, challenging misconceptions and reflecting on how his family’s unwavering support became a source of strength during his fight.
Listen to his inspiring story.
#antibodyhour #support -
Genmab
@Genmab
Genmab Welcomes Future Scientists!
We’re thrilled to have hosted 80 high school students from Amadeus Lyceum at our R&D Center in Utrecht! From hands-on workshops to a behind-the-scenes tour, we loved sharing our passion for biotechnology - highlighting our purpose to improve the lives of patients through innovative antibody therapies, with the next generation of bright minds.
#genmab #futurescientists #biotech -
Genmab
@Genmab
#icymi: We recently published our 2024 #annualreport. EVP and CFO Anthony Pagano shares how our strategic investments and focus on late-stage programs are driving our evolution into a biotech innovation powerhouse.
Visit: gmab.ly/uvbl50UYQ4c. -
Genmab
@Genmab
We are happy to share that our latest research in collaboration with Leiden University Medical Center has been published in @jitcancer. The research article shows how combination therapies can potentially boost CD3 bispecific antibody therapy for more durable anti-tumor immunity.
Learn more: gmab.ly/XtUY50UQrWO.
#cancerresearch #innovation -
Genmab
@Genmab
#investorupdate: Genmab has published its 2024 annual report. 2024 was a year of significant milestones in our evolution as we strengthened our foundation and invested in future success—advancing towards our vision to transform patient lives with antibody medicines.
Learn more: gmab.ly/uvbl50UYQ4c. -
Genmab
@Genmab
Today we celebrate #internationaldayofwomenandgirlsinscience.
In this edition of #antibodyhour 🕙, our colleague Emily Spencer, RN shares advice to young professionals aspiring to enter healthcare professions.
#innovation #womeninstem -
Genmab
@Genmab
Growing Together for a Greener Future!
Our colleagues and Trees for All came together to plant trees in the beautiful Het Groene Woud, showing our commitment to sustainability and a greener world.
#sustainability #csr -
Genmab
@Genmab
This #worldcancerday, we honor progress in cancer care and recognize the challenges that remain. Cancer touches us all – fueling a collective resolve to make a difference.
Learn more about how we’re putting people at the center of innovation: gmab.ly/9Rm150USHvZ. -
Genmab
@Genmab
On this #worldcancerday, we reflect on the many advancements in science and innovation that provide hope to patients.
During this edition of #antibodyhour 🕙, hear from our colleague Mark Peters, Senior Director, Patient Advocacy, as he shares his life-defining moment at age 11, when he lost his mom to cancer and how proud he is to work in the industry alongside so many individuals who push the boundaries every day to advance science for patients.
#innovation #hope -
Genmab
@Genmab
Thank you @CDC_Cancer for sharing and educating others about cervical health and cancer prevention this #cervicalcancerawarenessmonth.
CDC Cancer
@CDC_Cancer
#cervicalcancer is the most common #hpv-associated #cancer among women. Most infections go away on their own, but long-lasting infections can progress to precancer and cancer. www.cdc.gov/united-states-cancer-statistics/publications/… #cervicalcancerawarenessmonth
-
Genmab
@Genmab
Genmab and academia partners are proud to share a review in Seminars in Immunology on optimizing antibody therapies through enhanced complement activation.
Read more: gmab.ly/Ko5k50UBmWI.
#innovation -
Genmab
@Genmab
At Genmab, our commitment to patients drives everything we do.
In this edition of #antibodyhour 🕙, hear from our colleague Daan Meester on how the mindset "Every day counts" inspires our work.
#patientfirst #innovation -
Genmab
@Genmab
For the third consecutive year, we’ve been recognized as a #topemployer in the U.S., Denmark, and the Netherlands by @topemployer. This recognition is a testament to our colleagues’ commitment to making a difference for patients and our #extranotordinary culture.
Learn more: gmab.ly/bNgT50ULlfo. -
Genmab
@Genmab
During this edition of #antibodyhour 🕙, Monika Jun, Senior Director, US CORE, shares more on our data-driven approach which helps us identify how we can make the greatest impact on patients.
#innovation -
Genmab
@Genmab
In our very first edition of Antibody Hour🕙, a video series unveiling the stories driving antibody innovation, we asked our CEO Jan van de Winkel, PhD:
"What drives innovation in antibody science?"
Hear his insights here:
#antibodyhour #innovation -
Genmab
@Genmab
At @jpmorgan’s #jpm2025, President & CEO Jan van de Winkel will share progress on our work toward our 2030 vision of transforming the lives of people with cancer and other serious diseases through innovative antibody medicines.
Tune in: jpmorgan.metameetings.net/events/healthcare25/sessions/58… -
Genmab
@Genmab
Data evaluating our investigational medicine as a combination therapy for patients with relapsed/refractory (R/R) diffuse large B-cell #lymphoma (#dlbcl) is now published in @BloodJournal, in partnership with @abbvie. Read more: gmab.ly/Zo0E50UFonk
-
Genmab
@Genmab
Introducing Antibody Hour! 🕙
A new video series from Genmab highlighting the breakthroughs, stories, and passion driving antibody innovation.
Follow along to learn more about our people, purpose and progress in shaping the future of antibody science.
#antibodyhour #innovation -
Genmab
@Genmab
We’re excited to share a company update at the 43rd annual J.P. Morgan Healthcare Conference.
Read more: gmab.ly/A8ct50UAmg3.
#jpm2025 #pipeline -
Genmab
@Genmab
As 2024 comes to an end, we reflect with immense gratitude on a year of innovation and impact. Together, we’ve worked to advance research in antibody-based medicines, deliver these therapies to patients, and collaborate with incredible patients, advocates, and advocacy groups who inspire us daily.
Here’s to making an even greater impact in 2025!
Happy Holidays from the Genmab team!
Follow along for our journey as we enter 2025: www.genmab.com/our-impact/patient-engagement.
#patientsfirstThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
We are proud to sponsor @BioNJ's "Give Back" initiative, where colleagues and BioNJ members together assembled “Bio Bears,” with super-hero capes to be donated to pediatric patients in New Jersey.
Learn more here: gmab.ly/yZic50UavXv. -
Genmab
@Genmab
To create an innovative and extra[not]ordinary® culture, our colleagues collaborate to achieve a shared vision of transforming the lives of patients.
Frank Beurskens, Director, Antibody Format Translation Lead, shares more about how collaboration with his colleagues truly drives innovation in antibody discovery.
Learn more: www.genmab.com/news-insights/stories. -
Genmab
@Genmab
Genmab recently attended @BioNJ's Tenth Annual Inspiring Women in STEM Conference where colleague Katie Sugarman spoke on a panel among other industry leaders, moderated by colleague Cecilia Fong and discussed leadership and empowerment.
Learn More about Genmab here: gmab.ly/wxgK50UnM45.
#womeninstem -
Genmab
@Genmab
We released new data at the @ASH_hematology Annual Meeting & Exposition evaluating our investigational medicine in patients with diffuse large B-cell #lymphoma (#dlbcl), in partnership with @AbbVie. Read more: gmab.ly/VcFv50UmBXj
-
Genmab
@Genmab
We shared new data at #ash24 evaluating our investigational medicine in relapsed or refractory chronic lymphocytic leukemia (#cll) patients. Learn more: gmab.ly/wSZb50UmBMj
-
Genmab
@Genmab
Breaking News: we shared new data evaluating our investigational medicine in relapsed or refractory follicular #lymphoma patients at #ash24, in partnership with @AbbVie. Read more: gmab.ly/zYWR50UmBvv
-
Genmab
@Genmab
At Genmab, our innovative DuoBody® platform technology generates #bispecific antibodies and is the next step in the future of potentially transforming cancer care research. Watch to learn more about this novel approach. #ash24
This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
#investorupdate: Join us virtually on December 11 for our 2024 R&D Update and #ash24 Data Review where we’ll be offering insights into our antibody innovations and #hematology #pipeline.
Register today: gmab.ly/W1Xl50UfOst. -
Genmab
@Genmab
Inspired by a shared #vision, we harness colleagues' unique perspectives to potentially improve the lives of patients through our KYSO antibody medicines®.
Angelia Lee, Senior Director, Global Compliance Program Lead shares more.
Learn more: www.genmab.com/about. -
Genmab
@Genmab
We’re excited to attend this year’s @ASH_hematology annual meeting (#ash24) and look forward to sharing important new data from our hematology portfolio.
To learn more, stop by booth number 3029, and visit:
gmab.ly/w6Yj50Uj9SQ. -
Genmab
@Genmab
KYSO®, or knock-your-socks-off antibody medicines describes our #innovative #antibodyscience. Our colleagues share more about what this unique term means to us.
Learn more about out antibody science: gmab.ly/UX4Z50UfPuW. -
Genmab
@Genmab
We’re proud to put #patientsfirst: incorporating their perspectives from drug development through approval. Hear from Portia Badham, member of our Patient Advisory Council, on the value of listening to patients’ experiences.
Learn more: www.genmab.com/our-impact/patient-engagement. -
Genmab
@Genmab
One way we foster a culture of caring, is by encouraging a strong work-life balance. Hear from Frank Rebers, Senior Director, Head of Portfolio Analytics and Planning, on his perspective of our extra[not]ordinary® culture.
Learn more: www.genmab.com. -
Genmab
@Genmab
November is #nationalfamilycaregiversmonth in the U.S., and a time to honor the role of care partners.
Learn more from Cecilia Fong, Director, Business Insights & Analytics and Co-Lead of our Community of Caregivers ERG, about our efforts.
Learn more: gmab.ly/OMXy50U9vAe. -
Genmab
@Genmab
Our colleague, Petra Evenäs, Director, Clinical Trial Disclosure & Transparency, recently presented at the Clinical Data Disclosure Europe conference where she shared insights on a framework to secure commercially confidential information.
Learn more: gmab.ly/S3y150U57AC. -
Genmab
@Genmab
At @sitcancer #sitc24, we presented data evaluating one of our investigational bispecific antibodies in #nsclc. We are dedicated to exploring potential treatment options for those living with solid tumors. Learn more: gmab.ly/Yor850U58K2.
-
Genmab
@Genmab
#investorupdate: We’ve released our Interim Report for the first nine months of 2024.
Hear from Anthony Pagano, EVP & Chief Financial Officer on our recent progress toward our goal to impact patients’ lives with antibody medicines.
Learn more: www.genmab.com/investor-relations. -
Genmab
@Genmab
Please join us in congratulating our colleagues Ilana Lanciotti and Jenny Grimm who were presented with awards from Ragan’s Top Women in Marketing, Class of 2024
Learn more: www.genmab.com/about/our-purpose
#leadership -
Genmab
@Genmab
At #ash2024, we look forward to showcasing the strength of our development program for our investigational antibody treatment. Learn more: gmab.ly/j2cJ50U0AwZ
-
Genmab
@Genmab
We’re gearing up for this year’s @sitcancer’s #sit24 Annual Meeting to connect with the oncology community and share our latest advancements in #antibody science.
Visit booth #814 and: gmab.ly/icRI50TQV63. -
Genmab
@Genmab
We take a data-driven approach to accelerate drug discovery & development of antibody medicines with a goal to better serve patients.
Joe Szustakowski recently spoke at a @HBAnet panel sharing our innovative approach to #ai and #innovation.
Learn more: www.genmab.com/antibody-science/artificial-intelligence. -
Genmab
@Genmab
#investorupdate: We’re sharing our interim report for the first nine months of 2024. Tune in to hear more about our progress from President & CEO Jan van de Winkel and EVP & Chief Financial Officer Anthony Pagano.
To register, visit: gmab.ly/O1Ef50TQV38.
#biotech -
Genmab
@Genmab
Our colleagues embrace our passion for innovation, determination, integrity and working as one team.
Hear from Abdullah Almiqasbi and Sayaka Kikuta on how they experience empowerment in their work.
Learn more: gmab.ly/Ihwn50TQUXm.
#extranotordinary -
Genmab
@Genmab
This past weekend, we raised our lanterns at @LLSusa’s #lightthenight walk in Mercer County, NJ to honor and support blood cancer patients and their families. 🤍❤️💛
Learn more: gmab.ly/ZQjA50TQV0j.
#inspiredbypatients #patientsfirst #cancelbloodcancer -
Genmab
@Genmab
Hisham Hamadeh, SVP, Global Head of Data Science & AI and Bryan Hancsin, Senior Director, US Digital Marketing, recently presented at @RE_Pharma’s #recustomerusa sharing insights on #datascience & #ai, and strategies to boost engagement.
Learn more: gmab.ly/YGaC50TQUYH. -
Genmab
@Genmab
Join us and the @LLSusa at the #lightthenight Walk in Mercer County, NJ as we raise awareness of and recognize those who have been impacted by blood cancer.
Register for an event here: gmab.ly/zGn550TQUUK.
#inspiredbypatients #patientsfirst #cancelbloodcancer -
Genmab
@Genmab
Come join us at the 2024 AMWA Medical Writing & Communication Conference on October 23-26 at Table #11 and meet our medical writing team and explore job opportunities at Genmab.
Learn More: gmab.ly/zmW450TgK2k. -
Genmab
@Genmab
Recently, our U.S. colleagues had the unique opportunity to bring their parents to work at Genmab! It was an incredible day where we shared our company’s history, purpose, and our vision to impact patients' lives with antibody therapies.
Learn more here: gmab.ly/rbmn50TPPLP. -
Genmab
@Genmab
Brad Bailey, EVP and Chief Commercial Officer, was a panelist at #statsummit, discussing the role of integrating patient perspectives in driving innovation. Learn more: www.genmab.com/our-impact/patient-engagement.
#inspiredbypatients #patientsfirst -
Genmab
@Genmab
Recently, Hisham Hamadeh, SVP of Data Science & AI, presented at @BioNJ C-Suite Summit and LSX Nordic Congress exploring AI's role in biotech innovation. These events help us share insights, learn and stay inspired.
Learn more: gmab.ly/4VNX50TN6Z3.
#innovation #ai #biotech -
Genmab
@Genmab
We’re committed to enriching our communities! We recently welcomed 30+ students from Mercer County Vocational Schools for our first Career Exploration Day, in partnership with @JAofNJ. We're thrilled to inspire these young people.
Learn More here: gmab.ly/Iuf750TJEyC -
Genmab
@Genmab
We recently hosted leaders from patient advocacy and professional organizations, and our patient advisors to our third annual Science Day – a day dedicated to fostering two-way dialogue.
Learn more about our efforts: gmab.ly/eiUt50TKPrz.
#inspiredbypatients #patientadvocacy -
Genmab
@Genmab
EVP & CSO Martine van Vugt has been named to this year’s @PharmaVoice #pv100. Martine has influenced Genmab’s vision and evolution into a biotech innovation powerhouse, and we are proud to celebrate her dedication to impacting patients’ lives.
Read more: gmab.ly/Hvtg50TGJZp. -
Genmab
@Genmab
Genmab, in partnership with @saintjosephs is recruiting for 2025-2027 Multidisciplinary PharmD Fellowship positions – open to all PharmD graduates nationwide!
Learn more and apply here: www.genmab.com/genmab-fellowship-brochure -
Genmab
@Genmab
We’ve been selected as one of @NJBIZ’s Best Places to Work in New Jersey for 2024! 🎉 A true testament to the hard work of our unstoppable teams.
Learn more about open opportunities today! gmab.ly/xJoe50TxhvI.
#joingenmab -
Genmab
@Genmab
This Hispanic Heritage Month, we are proud to provide scholarship funding for students of Hispanic heritage studying science.
Genmab will welcome Dr. Marcia Cruz-Correa, who will discuss health disparities in the Hispanic community.
Learn more: gmab.ly/M7sS50TtsW1. -
Genmab
@Genmab
At Genmab, we recognize both #bloodcancer and #gynecologiccancer Awareness Months and are dedicated to supporting people living with these conditions through our innovative research, patient resources, and strong community partnerships.
Learn more: gmab.ly/ms9050TtHak -
Genmab
@Genmab
Genmab launches “AI Everywhere” with ChatGPT Enterprise, supported by @OpenAI's commitment to security and privacy.
Click here to learn more: gmab.ly/7WxC50TqTk8. -
Genmab
@Genmab
At Genmab, our vibrant culture makes us extra[not]ordinary®. Colleagues are encouraged to be authentic and feel respected in doing so.
Hear from Jesper Lykkesfeldt, VP, Head of Legal, Global R&D and Corporate Strategy.
#joingenmab: careers.genmab.com/global/en. -
Genmab
@Genmab
Robyn Bilmes, Senior Vice President, Head of Medical Affairs, discusses the strides that Genmab is making to potentially bring new options to people living with ovarian and endometrial cancers. Learn about our oncology pipeline: gmab.ly/WRmE50Tp4K3. #esmo24
-
Genmab
@Genmab
Follicular #lymphoma (FL) is one of several subtypes of non-Hodgkin’s lymphoma (NHL) and the second most common type of NHL worldwide.
What percentage of NHL cases does FL account for worldwide?
#bloodcancerawarenessmonth
Genmab
@Genmab
The correct answer is 22%. FL is a slow-growing type of NHL that accounts for approximately 22% of all NHL cases worldwide.
-
Genmab
@Genmab
Diffuse large B-cell lymphoma & follicular #lymphoma are the two most common types of non-Hodgkin’s lymphoma globally. This #worldlymphomaawarenessday, and every day, we are devoted to our goal of advancing research to transform the lives of people living with blood cancer. #wlad
-
Genmab
@Genmab
Today we announced new data from one of our trials studying our investigational therapy in patients with advanced ovarian and endometrial cancers presented at #esmo24. Read about the data: gmab.ly/gpJX50TnIM2.
-
Genmab
@Genmab
Genmab colleagues recently participated in Global Volunteer Day: volunteering 3,000 hours for 43 local charities in the communities where we live and work.
Learn more here: gmab.ly/s93Q50TmnSH.
#communityatgenmab -
Genmab
@Genmab
Join us at #utrechtscienceweek for networking and to learn more about “Healthcare and Laboratories of the Future.” We’ll explore how automation, digital transformation and #ai are revolutionizing labs and healthcare.
To register, visit: gmab.ly/cq7S50TiVMl. -
Genmab reposted
Nasdaq Exchange
@NasdaqExchange
⭐ Rooted in science. Inspired by patients. 25 years of innovation with impact.
🔬 @Genmab harnesses the power of antibodies to improve the lives of people with cancer and other serious diseases.
🎊 Congrats, $GMAB! Here’s to another 25 years of transforming tomorrow together! -
Genmab reposted
Nasdaq Exchange
@NasdaqExchange
Welcoming @Genmab to the @NasdaqExchange Opening Bell. x.com/i/broadcasts/1mrGmMjENgBGy
-
Genmab
@Genmab
Excited to ring the @Nasdaq opening bell today in NYC for Genmab’s 25-year milestone!
As a dual-listed company, we rang the Nasdaq bell in Copenhagen earlier this year. This symbolizes our evolution into a #biotech #innovation powerhouse.
Read more: gmab.ly/hM9P50TeLVO. -
Genmab
@Genmab
We’re attending the 12th Annual Meeting of the
@SocietyofHemOnc #soho24 – covering the latest advancements and innovation in the #hematology space.
To learn more about our next-gen antibodies visit our booth and click here: gmab.ly/7nPT50TeuUQ. -
Genmab
@Genmab
We are excited to announce that the @EU_Commission has granted marketing authorization for our treatment for adults with relapsed or refractory follicular #lymphoma, in collaboration with @AbbVie.
Read more: gmab.ly/3NVR50T1vsh -
Genmab
@Genmab
Genmab is proud to have hosted our 4th annual Back-to-School Drive. Our colleagues donated school supplies and first day outfits for students in Central New Jersey at @HomeFront.
To learn more about our CSR efforts, visit: gmab.ly/J0pQ50RwbHQ. -
Genmab
@Genmab
At Genmab, our colleagues embody the spirit of extra[not]ordinary®, which is our unique word, meaning we go way beyond what is usual—to be remarkable, proudly unique, and authentic. Hear from Melissa Rizzo on her experience.
To #joingenmab, visit: gmab.ly/QCBu50SWQy2. -
Genmab
@Genmab
Our state-of-the-art headquarters in Valby, Copenhagen is designed to foster innovation and collaboration.
One year after opening, see how our team is growing in the region.
Explore job opportunities at: gmab.ly/2MzC50SW2YG.
#biotech #innovation -
Genmab
@Genmab
Putting #patientsfirst means prioritizing patients’ needs in every aspect of our work. Hear from Keshia Carpenter as she shares how her experience as a cancer patient shapes her work at Genmab.
Learn more about patient engagement: www.genmab.com/our-impact/patient-engagement.
#inspiredbypatients -
Genmab
@Genmab
#investorupdate: We’ve published our Interim Report for the first half of 2024. CFO Anthony Pagano shares how we’re strengthening our mid-to-late pipeline of innovative antibody products to propel towards our vision.
For more, visit: gmab.ly/elgM50SU4Jk. -
Genmab
@Genmab
#investorupdate: Join us for our 2024 Interim Report for the first half of the year.
To register for the event, visit: gmab.ly/cJU450SL2tV.
#biotech #innovation -
Genmab
@Genmab
At Genmab, every individual plays a role in our efforts to make a difference for patients.
To learn more about a career at Genmab, visit our website below where we share employee stories, extra[not]ordinary® testimonials and open positions.
gmab.ly/a9y950SLgsY -
Genmab
@Genmab
It’s #nationalinternday, and we want to thank our bright summer interns for their insights and contributions at Genmab in helping to advance innovation and bring antibody medicines to patients in need.
#internship -
Genmab
@Genmab
Genmab aims to keep patients first and ensure their voices are heard. Kimberly Williams, Chief Diversity, Equity, and Inclusion Officer at @Cervivor serves as a beacon of hope. Click the link to learn about her courageous battle with cervical cancer: gmab.ly/y1HE50SIlkS.
-
Genmab
@Genmab
Discover Genmab’s culture of innovation. Our 5th annual #innovation Tournament shows our commitment to advancing #antibodyscience. Colleagues showcased the incorporation of AI and digitalization into their work. Congrats to this year's winners!
Learn more: www.genmab.com/antibody-science -
Genmab
@Genmab
We have a “people first” mentality, meaning we foster an extra[not]ordinary™ culture, where colleagues truly care about one another.
Hear from Alexander Man, Director, Strategy & Corporate Development here:
To #joingenmab, visit: genmab.wd3.myworkdayjobs.com/Genmab_Careers_Site.
#extranotordinary -
Genmab
@Genmab
We’re thrilled that for the fourth consecutive year, Genmab has been named a #bestplacetowork in New Jersey by @NJBIZ! This recognition is a testament to our extra[not]ordinary™ people and culture.
Learn more: gmab.ly/ZYxW50StT7M -
Genmab
@Genmab
Today, we are thrilled to share that our investigational treatment for relapsed/refractory (R/R) follicular lymphoma (FL) has received a positive opinion from @EMA_News’ #chmp. Read more: gmab.ly/mnME50Srgwf @AbbVie
-
Genmab
@Genmab
In recognition of #cancerimmunotherapymonth, Genmab is spotlighting our colleague Pauline de Goeje, who works on our Immune-Oncology Product Discovery team.
Learn more about what working on immunological therapies means to her: gmab.ly/F0t150Sqhyo. -
Genmab
@Genmab
At Genmab, our extra[not]ordinary™ colleagues are empowered to innovate, build solutions, and execute.
Vibeke Leth, Medical Portfolio Operations Manager, shares her perspective on how she emulates these values within her teams.
To #joingenmab, visit: www.genmab.com. -
Genmab
@Genmab
Genmab is proud to support @OUTinSTEM, which is celebrating #pridemonth by awarding scholarships to LGBTQIA+ students studying the sciences at a New Jersey university or college.
Learn more: gmab.ly/oPv650Sj8lb.
#communityatgenmab -
Genmab
@Genmab
In honor of #juneteenth, we continue to support the important work of the @SSAAMuseum in promoting diversity and inclusion and fostering a sense of community and cultural pride in New Jersey.
To learn more about our DE&I efforts, click here: gmab.ly/uFnR50Sk4ta
#juneteenth -
Genmab
@Genmab
#dyk that antibodies have the ability to distinguish among countless foreign invaders? Antibodies play a crucial role in immunological memory, enabling a swift and potent response to previously encountered pathogens.
Learn more about our science: gmab.ly/J5BI50Skm9V -
Genmab
@Genmab
Data from a study evaluating our investigational treatment option for relapsed/refractory follicular #lymphoma were presented at #eha2024 and now are published in @TheLancetHaem, in partnership with @AbbVie.
Read more: gmab.ly/6GC250SjtmK -
Genmab
@Genmab
Did you hear? Genmab’s website has a new stories page showcasing our Extra[Not]Ordinary™ people. Our website highlights how our unstoppable teams are dedicated to making a difference for patients.
Check out our new site: gmab.ly/aIUf50Sj80W -
Genmab
@Genmab
Diffuse large B-cell #lymphoma (DLBCL) is a fast-growing type of #bloodcancer. For some patients with DLBCL, their cancer relapses or becomes refractory after treatment. Learn more about our research at #asco24: gmab.ly/i90y50SinPN
-
Genmab
@Genmab
Genmab is happy to bring back our Summer Fridays program this summer. Our US colleagues are encouraged to wrap up work early on Fridays to allow a little extra time to enjoy their summer.
Learn more: gmab.ly/6mnv50P0Bvg
#summerfridays -
Genmab
@Genmab
This year, we’re recognizing our 25-year milestone and evolution as a scientific leader in #antibodyresearch, dedicated to the goal of transforming the treatment of cancer. We celebrated today with the ringing of the @Nasdaq Copenhagen bell.
Learn more: www.genmab.com -
Genmab
@Genmab
As we completed our 25-year milestone this year, we want to honor and recognize the team members who have been with us since the very beginning of our remarkable journey.
It is your dedication and passion that make us extra[not]ordinary™.
#genmab25 #communityatgenmab -
Genmab
@Genmab
We’re committed to our goal of deploying our expertise in "knock-your-socks-off” (KYSO®) antibodies to turn science into medicine. We'll be sharing the latest data in our #oncology research at @EHA_Hematology’s Congress.
Learn more: www.genmab.com/antibody-science/pipeline. -
Genmab
@Genmab
Honoring #nationalcancersurvivor Day in the U.S., we sat down with our colleague Keshia Carpenter to learn about her cancer journey, where she shared her survivorship experience and what it means to her to be a “thriver.”
#inspiredbypatients #patientsfirst -
Genmab
@Genmab
Today we announced new data from one of our trials studying our investigational therapy in patients with head and neck squamous cell carcinoma (HNSCC), presented at #asco24 with our partner, @Pfizer.
Read More About the Data:
gmab.ly/Vnne50S67Mh -
Genmab
@Genmab
Today, we presented the latest scientific updates for our investigational medicine in previously untreated and relapsed/refractory follicular #lymphoma at #asco24 in partnership with @abbvie. Read more here:
gmab.ly/f4eZ50S2vbe -
Genmab
@Genmab
Today we announced new data from our investigational medicine in metastatic non-small cell lung cancer at #asco2024. Read more here: gmab.ly/L4Wk50S4V6G
-
Genmab
@Genmab
We’re advancing our DuoBody® platform technology with the goal to unlock the potential of #bispecific antibody research, as we work to transform how cancer is treated. Watch the video below to learn more about our technology. #asco24
-
Genmab
@Genmab
Join us at #bio2024 for a panel discussion with influential voices in the biotech industry and patient advocacy on collaboration between biotech and patients to accelerate innovation for patients.
Learn more: gmab.ly/a2tc50RwbMx.
#patientsfirst #inspiredbypatients -
Genmab
@Genmab
We are happy to share that our research teams, together in collaboration with @LUMC_Leiden have been published in Cancer Cell for their research on how certain immune cells activated by immunotherapy are key to eliminating tumors.
Read more here: www.cell.com/cancer-cell/fulltext/S1535-6108(24)00135-1 -
Genmab
@Genmab
Our colleague, Saskia van Asten, participated in the 7th Annual @glyconet_nce symposium which aims to showcase the latest innovations in glycomics.
#innovation -
Genmab
@Genmab
We recently welcomed @TeamRynkeby to our headquarters in Copenhagen, Denmark! We are proud to sponsor Team Rynkeby and support their mission to raise money for critically ill children.
Learn more about our CSR efforts here: gmab.ly/J0pQ50RwbHQ.
#communityatgenmab -
Genmab
@Genmab
We’re excited to attend this year’s @ASCO Annual meeting and look forward to sharing our latest data with our oncology peers.
To learn more, stop by booth #16130 and visit: gmab.ly/gL1q50RwbL0.
#asco2024 -
Genmab
@Genmab
At #asco24, we will be presenting our latest #oncology research across blood cancers and solid tumors as we work toward our goal of improving the lives of cancer patients. Learn more about the presentations: gmab.ly/QV4G50RRKps
-
Genmab
@Genmab
To learn how our first acquisition empowers our vision to transform patients’ lives, read the latest article by our President and CEO, Jan van de Winkel, on our evolution into a biotech innovation powerhouse.
gmab.ly/2f0n50RPqTc -
Genmab
@Genmab
#newsupdate: We are excited to announce our acquisition of ProfoundBio, which strengthens our oncology portfolio and our commitment to cancer patients.
We welcome our new colleagues!
Learn more: gmab.ly/647O50RPeqj. -
Genmab
@Genmab
#inspiredbypatients, Genmab’s Patient Advisory Council partners with patients to better integrate their voice to ensure that we always keep #patientsfirst. Clinical Trial Manager Keshia Carpenter shares more on the Council.
Learn more: gmab.ly/wECB50Rwbze. -
Genmab
@Genmab
Yesterday at Genmab, our U.S. colleagues came together to honor #mentalhealthawarenessmonth by prioritizing our mental well-being by participating in a guided yoga and meditation session and enjoying cold pressed juices and smoothies.
-
Genmab
@Genmab
At #eha2024, we look forward to sharing our latest research across a variety of hematologic malignancies, with the ultimate goal of advancing innovative therapies for #bloodcancer patients. Learn more about the presentations: gmab.ly/Ww6w50RH7oi
-
Genmab
@Genmab
Anne Vroon, VP of Business Development, recently spoke at #bioequityeurope2024 in Spain on the future of antibody drug-conjugates. Discover more about our KYSO® (knock-your-socks-off) #antibodyscience. Learn more: gmab.ly/Ca2K50RyOJM.
#innovation -
Genmab
@Genmab
This #aanhpiheritagemonth, we are proud to support @AAAJ_AAJC and their mission of fighting for civil rights and empowering Asian Americans.
Hear from guest speaker Jessica Cho Kim, LCSW on the topic of Hope in the Aftermath of Racialized Trauma. -
Genmab
@Genmab
Recently, Esther Breij and Jessica McDaniel were recognized as Luminary and Rising Star by @HBANet for their dedication to making an impact for patients. We are very proud of their efforts.
#extranotordinary #hbaimpact #hbawoty24 -
Genmab
@Genmab
Recently Robyn Bilmes, SVP, Global Head of Medical Affairs spoke at the @LifeSciEvents Medical Affairs Strategic Summit on a panel, Revolutionizing Launch Success: Redefining Metrics and Strategies.
To learn more about our medical affairs team, visit: gmab.ly/zz3f50RwbsT. -
Genmab
@Genmab
Recently President & CEO Jan van de Winkel presented at the LSX World Congress on building a global biotech and innovation beyond boundaries with a goal to transform the lives of patients with innovative antibody medicines.
Follow Jan on LinkedIn here: gmab.ly/W4VV50RvM18. -
Genmab
@Genmab
#investorupdate: We have published our financial results for Q1 2024. Learn more about our progress and financial performance from Executive Vice President & Chief Financial Officer Anthony Pagano.
gmab.ly/zm9b50RuWkV.
#biotech #innovation -
Genmab
@Genmab
We’re pleased to announce that we received full @US_FDA approval for our therapy for the treatment of people with recurrent or metastatic #cervicalcancer, developed with our partner, @Pfizer.
-
Genmab
@Genmab
As a biotech company #inspiredbypatients, we prioritize keeping the patient perspective front and center and sharing their stories. Hear from Michael Minnemann, patient advisor, on the importance of having a support system you can rely on while undergoing treatment.
-
Genmab
@Genmab
Our U.S. colleagues recently participated in #bringyourchildtoworkday. Children enjoyed a day packed with fun, educational activities – spanning science, advocacy, AI, and more. It was so fun to have our extended Genmab family join us! Learn more: gmab.ly/PgoT50RpyBw.
-
Genmab
@Genmab
Meijian Guan, Associate Director, Translational Data Science, presented his research at the Translational Digital Pathology & AI Summit on AI-powered medical imaging analysis. Learn more about Meijian’s presentation here: gmab.ly/FCOp50RokRS.
#innovation #biotech -
Genmab
@Genmab
We believe in making a positive impact by actively contributing to our communities & the planet. On #earthday, global colleagues rolled up their sleeves to support local charitable organizations. To learn more about our efforts, visit: gmab.ly/VkHG50Rnnoq. #communityatgenmab
-
Genmab
@Genmab
We’re excited to attend the @oncologynursing's #onscongress this year and share more about the latest in our innovative #oncology research and patient services.
To learn more, stop by booth #8057 and visit: gmab.ly/7Ykf50RmGrx. -
Genmab
@Genmab
At Genmab, we strive to be extra[not]ordinary™ and our people make us unique. Melissa Rizzo, Manager, Finance OTC, shares what being part of the Genmab community means to her. To #joingenmab, visit: gmab.ly/RKNo50RgCHr.
#extranotordinary -
Genmab
@Genmab
SVP, Global Head of Data Science and AI Hisham Hamadeh spoke at the New Jersey AI Summit on “AI for Health.” Hosted by @Princeton, in partnership with @GovMurphy and @NewJerseyEDA, NJ leaders from various sectors came together to discuss leveraging #ai to #innovate. #njaisummit
-
Genmab
@Genmab
Please join us in congratulating Becky Fahrenbruch, Senior Medical Science Liaison, US Medical Affairs, for being selected as a recipient of the 2024 @HOPArx #mentorship Award for her efforts in demonstrating outstanding mentorship throughout her career.
#hopa2024 -
Genmab
@Genmab
Breaking #news: Genmab to broaden and strengthen its #oncology portfolio with the proposed acquisition of ProfoundBio, a biotechnology company focused on the development of novel #antibodydrugconjugate therapies.
Learn more at: gmab.ly/HIsX50R7akt -
Genmab
@Genmab
Our colleagues act with care for one another and for the patients that we serve. Hear from Alexander Man on how he lives the extra[not]ordinary™ every day.
To join Genmab, visit: gmab.ly/bb9550R39ZT.
#extranotordinary #biotech #innovation -
Genmab
@Genmab
Recently, Diane Wuest, VP, AI & Analytics Products, and Leslie Amendola, VP, US Marketing & Sales, presented at @RE_Pharma on defining the future of #ai and launch effectiveness respectively.
Learn more: gmab.ly/o8oa50R4w25.
#repharmausa -
Genmab
@Genmab
Congratulations to our colleagues recognized this week for their work on our patient support program and brand launch, which received the 2024 @reutersevents Pharma USA Award for Most Valuable Digital Patient Engagement and Best Launch Campaign, respectively. #repharmausa
-
Genmab
@Genmab
We recently had the pleasure of hosting high school students at our Princeton office for a STEM-filled day of lab tours, hands-on experiments and a discussion about STEM careers. Learn more about CSR at Genmab: gmab.ly/qUh550R18M1.
@BGCMercer @S2S_Org
#communityatgenmab -
Genmab
@Genmab
Thrilled to share that Esther Breij and Jessica McDaniel are @HBAnet awardees for their exceptional leadership.
Learn more about our unstoppable team at: gmab.ly/vFVN50QXRzE.
#extranotordinary #hbawoty24 #hbaimpact -
Genmab
@Genmab
#investorupdate: Genmab held its 2024 Annual General Meeting earlier today. For more information, visit: gmab.ly/ovUt50QSGHM.
#biotech #innovation -
Genmab
@Genmab
At Genmab, our core purpose is to improve the lives of patients. At @SXSW, Marisol Mendez Peron, SVP Communications & Corporate Affairs, shared insights on partnering with patients and their communities to shape the future of cancer treatment. #sxsw2024 #inspiredbypatients
-
Genmab
@Genmab
Genmab's Leslie Amendola, VP, US Marketing and Sales, and Gigi Atalla, VP, Head of Global Drug Safety and Pharmacovigilance, have been recognized as @ROINJNews #womeninbusiness Influencers. Congratulations and thank you for your commitment to keeping patients first!
-
Genmab
@Genmab
To recognize #internationalwomensday2024, we’re proud to support @GirlsWhoCode, an organization dedicated to reducing the gender gap in the workplace.
Hear from Melanie Hashmi on how we strive to create and maintain an inclusive culture at Genmab. -
Genmab
@Genmab
We're committed to sustainable business practices and value giving back to our communities. Recently, our Netherlands team planted trees in the Leersum Forest alongside Trees for All, a global tree-planting organization. Learn more about our #csr efforts: gmab.ly/z2yS50QLJ0i.
-
Genmab
@Genmab
Senior Vice President, Communications & Corporate Affairs Marisol Mendez Peron was recognized as a Visionary leader by @RaganComms. Thank you for your dedication to our extra[not]ordinary™ colleagues and #community, and impact on patients.
-
Genmab
@Genmab
The Genmab team is proud to support #fodboldtrøjefredag, Football Jersey Friday, a nationwide initiative in Denmark aimed at standing in solidarity with children battling cancer to boost awareness and gather funds for the Children's Cancer Foundation. #børnecancerfonden
-
Genmab
@Genmab
The @US_FDA accepted the supplemental Biologics License Application (sBLA) for our investigational medicine in relapsed/refractory follicular #lymphoma, developed in partnership with @AbbVie. Read more about the exciting news here: gmab.ly/jPJu50QIcC8 Genmab A/S
-
Genmab
@Genmab
🎉 Celebrating 25 Years of #innovation! On our 25-year milestone, hear from President & CEO Jan van de Winkel about our evolution into a leader in antibody research and our work toward the goal of making an #impact on patients’ lives with innovative antibody medicines. #genmab25
-
Genmab
@Genmab
We encourage our colleagues to serve in leadership positions at local charitable organizations to become engaged citizens. Kim Bialiy is a board member of the West Windsor Farmers Market in the Princeton area. Learn more: gmab.ly/Ejy750QHgMU.
#communityatgenmab -
Genmab reposted
National Cancer Institute
@theNCI
#cervicalcancer tends to occur in people of reproductive age. Because of where it forms in the body, certain aspects of diagnosis and treatment are of special concern. Check out NCI's information on coping with cervical cancer. www.cancer.gov/types/cervical/coping
-
Genmab reposted
IamCervivor
@IamCervivor
Check out the Today Show's featured story on cervical cancer with Cervivors Anna Ogo and Morgan Newman, MSW. They share their experiences to raise awareness. Link available in bio #cervivor #cervicalcancer #ccam #nomorein2024 #todayshow #hpv #vaccination #cancerprevention
-
Genmab
@Genmab
#investorupdate: We published our 2023 Annual Report recently. Our CFO Anthony Pagano shares how Genmab made key strides toward its vision to transform patients’ lives through the power of antibody medicines. Learn more: gmab.ly/iEBj50QBiQy.
#vision #innovation -
Genmab
@Genmab
This #blackhistorymonth, our US-based team heard from Dr. Leonard Egede on the social determinants of health and social risk – and their impact on access to care. We are also supporting @MercerCollege by providing scholarships for African American students studying science.
-
Genmab
@Genmab
EVP and Chief Legal Officer Birgitte Stephensen recently spoke with @NordicLifeSci about our growth and becoming a biotech innovation powerhouse. To see how Genmab is shaping the #biotech landscape, visit: gmab.ly/U7Px50QBX0b.
-
Genmab
@Genmab
When you join Genmab, you’ll be part of a community of people who care deeply about each other and the patients we serve. Ida Kallehauge Nielsen shares what being part of the extra[not]ordinary™ means to her.
Join Genmab: gmab.ly/rO5750QzFm2.
#extranotordinary #biotech -
Genmab
@Genmab
#investorupdate: Genmab’s Annual General Meeting will be held on Wednesday, March 13. Learn more here: gmab.ly/XMb350QBWAC.
#biotech #innovation -
Genmab
@Genmab
Excited to announce that our 2023 Corporate Responsibility Report is now available. Hear from Amy Dupuis, Senior Director, CSR, on our efforts to be a socially responsible biotechnology company. Download the report: gmab.ly/b6AX50QBmYr.
#csr #communityatgenmab -
Genmab
@Genmab
#investorupdate: Our 2023 Annual Report is out. Learn more about our growth & efforts toward our vision that by 2030, our knock-your-socks-off (KYSO®) antibody medicines are transforming lives of people with cancer and other serious diseases: gmab.ly/iEBj50QBiQy. #innovation
-
Genmab
@Genmab
Congratulations to Mark Peters, Senior Director of Patient Advocacy, on the Heart of BioNJ Award for his dedication to patients. We're proud to receive @BioNJ_Org's Innovator Award, recognizing our efforts in bringing innovative treatments to patients. gmab.ly/WIzk50QzFbv.
-
Genmab
@Genmab
This #internationaldayofwomenandgirlsinscience, we’re proud to honor the #womeninstem who are driving innovations in #biotech and in the scientific community. Let’s continue to empower, care, stay authentic, and strive to make an impact! Learn more: gmab.ly/xOFX50QzBpN.
-
Genmab
@Genmab
On #worldcancerday, we honor the courageous individuals impacted by cancer and their loved ones. The courage of patients and survivors inspires us to continue creating innovative antibody medicines to transform cancer care.
#inspiredbypatients #patientsfirst -
Genmab
@Genmab
Breaking: The European Medicines Agency (@EMA_News) has accepted for review the marketing authorization application for our investigational antibody treatment for patients with recurrent or metastatic #cervicalcancer, developed in partnership with @Pfizer. Learn more:
-
Genmab
@Genmab
Our colleague Christina Arnskov volunteers her time to serve the families at Copenhagen's Ronald McDonald House. Her dedication to community service embodies the spirit of #communityatgenmab. Learn more about our CSR initiatives: gmab.ly/5He850Qinxq.
-
Genmab
@Genmab
#icymi, we’ve been recognized as a 2024 Top Employer in Denmark, the United States and the Netherlands for our culture and focus on our people.
Learn more about how we’re #extranotordinary: gmab.ly/rEoh50QvrU4.
#joingenmab #topemployer2024 #forabetterworldofwork -
Genmab reposted
Dia de la Mujer Latina
@DMLCHWS
Harris County Public Health #GetVaxxed
@hcphtx
January is #cervicalcancerawarenessmonth! Did you know most cervical cancers are caused by HPV? Our Humble and Southeast Clinics offer affordable cervical screenings and wellness services. Seeking care? Call 832-927-7350 or visit publichealth.harriscountytx.gov/Find-Care/Services/HWC.
-
Genmab
@Genmab
Thank you, @IamCervivor for your crucial work to spotlight #cervicalcancer voices and connect the community with resources. To get involved, visit cervivor.org!
IamCervivor
@IamCervivor
Are you passionate about ending cervical cancer?
Start a fundraiser for Cervivor! 🎯
Raise awareness, funds, sponsor a Cervivor to attend the Summit and make an impact 💪
Use our Fundraiser Toolkit 📚 bit.ly/48KfCi6Sponsor!
Questions? Email us at info@cervivor.org 📩 -
Genmab reposted
World Health Organization (WHO)
@WHO
Every year, more than 300 000 women die from #cervicalcancer. 90% of cervical #cancer cases and deaths occur in low and middle-income countries.
We can end this with better access to vaccination, screening and treatment.
More information: www.who.int/news-room/fact-sheets/detail/cervical-cancer -
Genmab
@Genmab
At Genmab, we are empowered to innovate, build solutions and envision a bold future. Tatsuya Kitagawa, Associate Director, FP&A, shares how he feels empowered in his day-to-day work.
Be part of the extra[not]ordinary™: gmab.ly/VO3z50Qu9wQ. -
Genmab
@Genmab
When you #joingenmab, you are part of a digital and data-driven community rooted in science, pioneering antibody medicines.
Scott Cenci, SVP, Information Technology and Digital, shares what it means to be part of the extra[not]ordinary™.
Learn more: gmab.ly/oHtT50Qu9nx. -
Genmab
@Genmab
We’re thrilled to announce that we’ve been recognized by @topemployer as a #topemployer2024 for the second consecutive year. Learn more about our #extranotordinary company culture: gmab.ly/RbKP50Qs9bQ.
-
Genmab
@Genmab
Please join us in congratulating Genmab’s researchers and collaborators on their exciting research on bispecific (dual-targeting) #antibodies recently published in @nature! Learn more: go.nature.com/48TaOqF.
#antibodyscience #publication -
Genmab
@Genmab
On this #mlkday, we celebrate the legacy of a visionary leader.
Dr. King’s commitment to equality inspires and motivates us to continue to make diversity, equity and inclusion a pillar of our company.
Learn more: gmab.ly/LtHV50QqngJ. -
Genmab
@Genmab
Join us in extending a warm welcome to Christoffer Dahl as the new President and Representative Director for Genmab K.K. Under his leadership, our Japan team will continue to work toward the goal of making an impact on the lives of patients with innovative antibody medicines.
-
Genmab
@Genmab
#icymi: President & CEO Jan van de Winkel shared progress on our company’s evolution and #pipeline of innovative antibody medicines at #jpm2024, hosted by @jpmorgan. Watch the replay here: gmab.ly/TA0O50QpK0F.
#investorupdate -
Genmab
@Genmab
We’re pleased to announce the FDA’s acceptance and priority review of a supplemental biologics license application (sBLA) for our investigational treatment for recurrent or metastatic #cervicalcancer, developed in partnership with Pfizer. Learn more: gmab.ly/tsQw50Qp78K
-
Genmab
@Genmab
At @jpmorgan’s #jpm2024, President & CEO Jan van de Winkel will share progress on our work toward our 2030 vision of transforming the lives of people with cancer and other serious diseases through innovative antibody medicines. Read more: gmab.ly/xSSm50QokzR. #investorupdate
-
Genmab
@Genmab
Reflecting on 2023, we’re excited by the potential of antibody medicines to impact the lives of patients. Hear from Jan van de Winkel, President & CEO, on our goal to nurture antibody science, innovation and improving the lives of patients. #happyholidays
gmab.ly/uVQ650QlABR -
Genmab
@Genmab
This year, we’re honored to partner with so many patient advocacy and professional organizations who share our goal of making an impact on patients' lives.
Watch the 2023 highlights and visit: gmab.ly/gfSC50Qlufj.
#inspiredbypatients #patientsfirst -
Genmab
@Genmab
Please join us in congratulating Mark Peters for being selected as the 2024 Heart of @BioNJ_Org award honoree for his dedication and work to serve the #patient community. Learn more: gmab.ly/KAjM50Qlu7p.
-
Genmab
@Genmab
In 2023, we continued to make an impact in the communities where our employees live and work and strengthened our commitment to being a sustainable and socially responsible biotechnology company. See below for highlights and visit: gmab.ly/4syf50QkQ1y.
#communityatgenmab -
Genmab
@Genmab
Our colleague Bas Bosma participates in a foundation providing Malawians with education, agriculture and entrepreneurship opportunities. Learn more about the volunteering efforts of our colleagues and CSR initiatives: gmab.ly/5He850Qinxq.
#communityatgenmab -
Genmab
@Genmab
Become part of the extra[not]ordinary™ – our remarkable and authentically unique culture. We deeply care for our colleagues and the impact of our work on patients. Learn more from Jonak Biswas, Senior Business Applications Manager.
Join Genmab: gmab.ly/CQn250Qinh1 -
Genmab
@Genmab
Our #patientsfirst commitment drives us. We prioritize clinical trial transparency, adhering to good clinical practice & sharing clinical trial information so that patients & healthcare providers can make informed decisions. Learn more below, and visit: gmab.ly/ca9T50QiwpP.
-
Genmab
@Genmab
Genmab has joined the Pharmaceutical Research and Manufacturers of America (@PhRMA) and our Chief Operating Officer Anthony Mancini will serve on PhRMA’s Board of Directors. Read more: gmab.ly/CuPE50QiXoq.
#innovation #collaboration #phrma -
Genmab
@Genmab
Headquartered in Copenhagen, Denmark, Genmab colleagues are empowered to learn and grow personally and professionally. Learn more about our culture from Jesper Valbjørn and visit: gmab.ly/GsT550QimRE.
#joingenmab #extranotordinary -
Genmab
@Genmab
We’re feeling inspired after yet another insightful year of scientific exchange at #ash23. We appreciate the commitment of clinicians and the entire scientific community to advance #bloodcancer research to transform the future of patients.
-
Genmab
@Genmab
We are delighted to be honored with Spar Nord and BDO’s 2023 Successful Business award! This recognition reflects our unwavering commitment to patients, contributions to the local region, and the hard work of our extra[not]ordinary™ team.
Join us: gmab.ly/GsT550QimRE. -
Genmab
@Genmab
We are excited to be recognized as a 2023 Top Employer in the US, Denmark & Netherlands by @topemplyer. This award underscores our commitment to be extra[not]ordinary™ and make an impact on patients’ lives. Join us: gmab.ly/ZU2a50QgPWC.
#joingenmab #extranotordinary -
Genmab
@Genmab
We shared new data evaluating our investigational bispecific antibody therapy in patients with relapsed/refractory follicular #lymphoma at #ash23, in partnership with @AbbVie. Read more: gmab.ly/zTJy50Qh3Pz
-
Genmab
@Genmab
As #ash23 kicks off, we’re thrilled to share updates across our portfolio of approved and investigational antibody therapies as the scientific community comes together to discuss unmet needs in #bloodcancer. Learn about our goals in cancer research. gmab.ly/6aOi50QgOa7
-
Genmab
@Genmab
#investorupdate: Join us virtually on December 12 for our 2023 R&D Update and #ash23 Data Review where we’ll be offering insights into our antibody innovations and #pipeline. Register today: gmab.ly/apRj50QgyYI.
#hematology -
Genmab
@Genmab
Our innovative DuoBody® platform technology is inspired by the power of the immune system. Learn more about this novel approach, which is the basis of many #bispecific antibodies in our pipeline. gmab.ly/saVC50QfN8X
-
Genmab
@Genmab
This holiday season, we’re sharing our gratitude with the care givers, healthcare professionals, researchers, and patient advocacy community that support patients in their cancer treatment journey.
#patientsfirst #inspiredbypatients #patientadvocacy -
Genmab
@Genmab
We’re proud to offer colleagues volunteer time off. Ida Kallehauge Nielsen, Senior CMC Project Manager, arranges events each summer for the Danish Youth Red Cross (Ungdommens Røde Kors) children’s camp. Learn more: gmab.ly/76Kk50QanyA. #communityatgenmab
-
Genmab
@Genmab
We work as One Genmab team towards our goal of improving the lives of patients through innovative antibody therapies. Hear from Frank Beurskens, for his perspective on our extra[not]ordinary™ culture. To learn more, visit: gmab.ly/YiB950QanLO.
#joingenmab #extranotordinary -
Genmab
@Genmab
This #pegseurope, Genmab #antibody experts Rob N. de Jong, Esther Breij and Dennis Verzijl shared their insights on our innovations in #antibodyscience targeting cancer and other serious diseases.
To learn more, visit: gmab.ly/Y7L850Qao0A. -
Genmab
@Genmab
We’re proud to encourage acts of generosity on #givingtuesday. In honor of this global movement of kindness, our team members are participating in holiday gift giving drives benefitting five local charities serving the communities where where we live and work.
#communityatgenmab -
Genmab
@Genmab
In recognition of #nationalfamilycaregiversmonth, Iris Kolder and Eva Anderson share their views on the important role of caregivers and advice on how best to support those undergoing the cancer treatment journey. #inspiredbypatients #patientadvocacy
-
Genmab
@Genmab
Our US colleagues came together to honor veterans by embarking on a supply drive to support @CommunityHopeNJ and @osotamerica. #communityatgenmab
-
Genmab
@Genmab
Recently, Hisham Hamadeh, SVP, Global Head of Data Science and AI, spoke at the @medicon_valley Annual Meeting with other industry leaders on our approach of embedding #ai in the discovery, development and delivery of antibody medicines. Learn more: gmab.ly/hisj50QamwB.
-
Genmab
@Genmab
National Family Caregivers Month is an opportunity to reaffirm our commitment and appreciation for care partners and the critical role they play – especially when caring for someone with cancer, a key community we serve. Learn more: gmab.ly/5a7n50Q86wO #nfcmonth
-
Genmab
@Genmab
According to a survey, there were ~2.8 million care partners in the U.S. providing support to family or friends with cancer over the previous 12 months. This #nfcmonth, we’re showing our support of the care partner community. gmab.ly/Pm3e50Q86hX
-
Genmab
@Genmab
Clinical trials are the cornerstone of medical innovation. Participating in clinical trials can help advance medical science and gather evidence for the future of medical treatments. Learn more from Kelly Ragins and visit: gmab.ly/khrG50Q4HNL.
-
Genmab
@Genmab
We are pleased to announce that data from a study evaluating a treatment option for Japanese adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (#dlbcl) has been published in Cancer Science. Learn more: gmab.ly/CO7m50Q5E9g @abbvie
-
Genmab
@Genmab
#investorupdate: We have released our interim report for the first nine months of the year. Learn about the report from EVP & Chief Financial Officer, Anthony Pagano. Read the full report here: gmab.ly/Xzkq50Q5e3W.
-
Genmab
@Genmab
Excited to share that President & CEO Jan van de Winkel will be at @ftlive Global Pharma & Biotech Summit for the CEO panel on Embracing Disruptions as Leaders in Life Sciences sharing insights and strategies that have shaped Genmab today. Register here: gmab.ly/RtGB50Q4P9o.
-
Genmab
@Genmab
#investorupdate: We’re releasing our interim report for the first nine months of 2023. Tune in to hear more about our recent progress from our CEO & President Jan van de Winkel and EVP & Chief Financial Officer Anthony Pagano. To register, visit: gmab.ly/jTMp50Q4KhE. #biotech
-
Genmab
@Genmab
At #ash23, we will showcase our latest #oncology research that underscores our goal to transform the future of #bloodcancer treatment and bring differentiated antibody therapies to patients. Learn more about our oral and poster presentations: gmab.ly/jUa750Q3sIJ
-
Genmab
@Genmab
We’re looking forward to being at this year’s @sitcancer’s #sit23 Annual Meeting to connect with the immunology community and share our latest advancements in #antibody science and #oncology research.
Visit booth #823 and: gmab.ly/JILQ50Q38Yz. -
Genmab
@Genmab
#icymi Anthony Pagano, EVP & CFO, spoke alongside various industry leaders at @BioNJ_ORG’s C-Suite Summit and shared his perspectives on navigating recent trends impacting the industry. Learn more: gmab.ly/cPQe50Q1z8U.
#biotech #innovation -
Genmab
@Genmab
At Genmab, we cultivate a warm, fun, dynamic community that empowers our colleagues to develop innovative solutions. Hear from Abdullah Almiqasbi on how this translates to his day-to-day.
Be part of the extra[not]ordinary™: gmab.ly/Onk850Q1cEj. -
Genmab
@Genmab
This past weekend, Genmab sponsored @LLSusa's #lightthenight walk in Mercer County Park, NJ to honor and support blood cancer patients and their families. 🤍❤️💛
#cancelbloodcancer -
Genmab
@Genmab
We’re proud to support the 12th annual Danish Cancer Society’s and Danish TV2’s fundraising campaign, Knæk Cancer.
Meaning crack, break or beat cancer, the campaign raises money to facilitate research, prevention and patient support. Learn more: gmab.ly/Nbo850Q1cPh. -
Genmab
@Genmab
🤍❤️💛 Together w/ @LLSusa, we are proud to sponsor this year's #lightthenight walk in Mercer County, NJ! Join us as we lift our lanterns to honor survivors, support friends & family, and remember those we've lost to blood cancer.
Register here: gmab.ly/ew2F50Q1yM3. -
Genmab
@Genmab
A study investigating a combination treatment option for people with recurrent or metastatic #cervicalcancer, in partnership with @SeagenGlobal, was recently featured in @JCO_ASCO. Read the full results: gmab.ly/vUWv50Q1cWb
-
Genmab
@Genmab
We recently hosted #patient advisers and leaders of #patientadvocacy and professional societies for our annual Science Day. Thank you for your valuable insights as we continue our efforts to integrate the patient voice throughout our work. Learn more: gmab.ly/YEFH50Q1crI.
-
Genmab
@Genmab
MaryAnne McCarthy, Vice President, Head of Alliance Management, recently spoke on a Pharma Partnering Summit panel discussing deal-making in the #biotech and pharma industry. Learn more about Genmab’s partnerships: gmab.ly/9IJL50Q1ckG.
-
Genmab
@Genmab
We’re leveraging the power of digital and data to innovate antibody therapies with a goal to make an impact on the lives of patients. Hear more from Chris Klijn, VP and Head of Discovery Data Science & Target Discovery. Learn about career opportunities: gmab.ly/HoIP50PZc3A.
-
Genmab
@Genmab
As we continue to share the perspective of cancer survivors, hear from @IrisKolder, Associate Director, Translational & Clinical Data Science, on the importance of advocating for your health and taking control of your well-being.
-
Genmab
@Genmab
Excited to hear innovaTV 301 lead investigator Dr. Ignace B. Vergote present promising data results during the #esmo2023 Presidential Symposium from a global Phase 3 trial in patients with recurrent or metastatic #cervicalcancer. #seagen gmab.ly/RO2z50PZqUG
-
Genmab
@Genmab
Recently, we celebrated the official inauguration of our new headquarters in Copenhagen. We hosted colleagues, local leaders and community members at the new site for a ribbon-cutting to celebrate this milestone.
Be part of the extra[not]ordinary™: gmab.ly/VcV950PVzH8.This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
In celebration of #hispanicheritagemonth, we hosted a panel featuring Chair of the Genmab Board of Directors, Deirdre Connelly, where she shared insights on leadership, career development and embracing different cultures in the workplace.
-
Genmab
@Genmab
In our “Meet the Antibody Experts” series, we’re highlighting our experts who presented at the #utrechtscienceweek on Immuno-Innovation: Changing the Game in Health to raise awareness about the potential of #immunology and #antibody therapies.
-
Genmab
@Genmab
We’re excited to announce that, with our partner @abbvie, we were named a finalist for the 2023 @Citeline Scrip Awards in the Best New Drug category. We’re proud of this accomplishment as we work toward our goal of improving the lives of cancer patients. #scripawards
-
Genmab
@Genmab
Our new HQ in Copenhagen is a space to bring our team together and support Genmab’s unique culture of innovation. Hear from Birgitte Stephensen on what the new space means for Genmab. To be part of the extra[not]ordinary™, visit: gmab.ly/2UEA50PVavG.
-
Genmab
@Genmab
In partnership with the Philadelphia College of Pharmacy – Industry & Education Fellowship Program at Saint Joseph's University, we’re recruiting for 2 Multidisciplinary PharmD Fellowship positions open to all PharmD graduates nationwide! Learn more at: gmab.ly/AM5u50PU3Pc.
-
Genmab
@Genmab
EVP & CSO Martine van Vugt spoke at the 17th Annual International Partnering in Lifescience Society event on how #partnership has shaped our evolution into an integrated #biotech and powered innovative antibody therapies. For more: gmab.ly/bzv150PRULU.
-
Genmab
@Genmab
Recently, Chris Leggett, presented at @thINc360company's Digital Engagement and Experience Summit. Our team is using data science, AI and predictive analytics with a goal to inform our decisions and get innovative antibody therapies to patients. gmab.ly/EF3C50PSUq1
-
Genmab
@Genmab
Later this week, Anthony Pagano, EVP and Chief Financial Officer, is presenting alongside other industry leaders at @BioNJ_ORG’s C-suite summit on the topic of the state of the biotechnology industry. Learn more: gmab.ly/4MQ850PSU47.
#biotech #innovation -
Genmab
@Genmab
Though #bloodcancerawarenessmonth (#bcam) has come to an end, Genmab remains committed to advancing research and uncovering new solutions to improve the lives of cancer patients.
-
Genmab
@Genmab
Today marked the official inauguration of our new headquarters in Valby, Copenhagen. As a celebration of this great milestone for our growth in becoming an integrated biotech, we hosted colleagues and guests for a ribbon cutting. Thank you to everyone who attended!
-
Genmab
@Genmab
We’ve been selected as one of @NJBIZ's Best Places to Work in New Jersey for 2023! 🎉 A true testament to the hard work of our unstoppable teams.
Learn more about open opportunities today!
gmab.ly/lBIQ50PQH3o
#joingenmab -
Genmab reposted
Blood Cancer United
@BloodCancerUtd
RT if you agree: #bloodcancerawarenessmonth is EVERY month until we #cancelbloodcancer once and for all.
-
Genmab
@Genmab
Genmab received the @Lymphoma Research Foundation Leadership Award for our work in antibody therapeutics and continued support of LRF’s research initiatives and educational programs. Thank you for this recognition, LRF!
#lymphoma #risewithus #inspiredbypatients #patientadvocacy -
Genmab
@Genmab
This #hispanicheritagemonth, we are proud to share the perspective of Genmab leaders from the community on their experiences and how these have inspired their journey. Hear from Marisol Mendez Peron, SVP, Global Communications & Corporate Affairs.
-
Genmab
@Genmab
Today, Esther Breij, Vice President Translational Research, R&D, participated in a Topx Network Panel, Rise to the Top: From Comfort Zone to Power Zone. Thanks, Esther, for inspiring other #womeninstem. Learn more about Genmab’s purpose: gmab.ly/3SNN50POECl.
-
Genmab
@Genmab
We are excited to announce that the @EU_Commission approved a treatment option for adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (#dlbcl) after 2 or more lines of systemic therapy. Read more: gmab.ly/GCmn50PP9vc @abbvie
-
Genmab
@Genmab
The Japan Ministry of Health, Labour and Welfare approved a treatment option for patients with certain types of relapsed/refractory (R/R) large B-cell #lymphoma (#lbcl) after 2 or more lines of systemic therapy. Learn more: gmab.ly/T4gm50PP9mm @abbvie
-
Genmab
@Genmab
Join us and the @LLSusa on October 14th in Verona, NJ for the #lightthenight walk as we work together to raise awareness of cancer. Learn more: gmab.ly/yMIq50PGVbW
#cancelbloodcancer -
Genmab reposted
Cancer Research Foundation
@CancerRF
September is #bloodcancerawarenessmonth. You may be more familiar with the term #leukemia, which is a more general term for cancers of the blood.
-
Genmab
@Genmab
Yesterday, we wore red, the color used to promote awareness of #bloodcancer, for #bloodcancerawarenessmonth (#bcam). We came together as a company to celebrate the work being done to target a better future for the #bloodcancer community.
#cancelbloodcancer -
Genmab
@Genmab
Visit us at booth 415 at the @nbmbaahq's 45th Annual Conference & Expo to learn about our extra[not]ordinary™ culture and purpose to improve the lives of patients through differentiated antibody therapeutics. Learn more here: gmab.ly/roYx50PLcwu. #nbmbaa #hiring #biotechjobs
-
Genmab
@Genmab
Thank you, Leukemia and Lymphoma Society (@LLSusa) for your commitment to #cancelbloodcancer.
Blood Cancer United
@BloodCancerUtd
Blood cancer patients and their loved ones need our help when it counts! ❤️ During #bloodcancerawarenessmonth let’s join forces and shout our commitment to #cancelbloodcancer from the rooftops! 📣 ❌🩸 (1/3)
-
Genmab
@Genmab
#investorupdate: CEO Jan van de Winkel and Chief Financial Officer Anthony Pagano will be participating in a fireside chat at the upcoming @MorganStanley 21st Annual Global Healthcare Conference.
To join the webcast, visit: gmab.ly/PqqI50PKGcx. -
Genmab
@Genmab
Genmab is proud to support the @umu_museum, a research museum for curious people in Utrecht, NL dedicated to connecting research and science to society and inspiring scientists of the future. Learn about our CSR efforts: gmab.ly/wEcg50PKAlm.
-
Genmab
@Genmab
Our innovative culture is powered by colleagues who are growth driven and looking to learn and grow in their role and help build the organization. Sayaka Kikuta shares what drew her to Genmab. Be part of the extra[not]ordinary™: gmab.ly/1eHW50PK5N4.
-
Genmab
@Genmab
In the U.S., over 700K people are living with #nonhodgkinslymphoma or in remission, meaning the signs and symptoms have disappeared. Learn more about blood cancers during #bloodcancerawarenessmonth (#bcam) by visiting: gmab.ly/S54050PGUHJ
-
Genmab
@Genmab
Genmab will attend the 11th Annual Meeting of the @SocietyofHemOnc – covering the latest advancements and innovation in the #hematology space.
Visit our booths to learn more about our antibody technologies and investigational therapies.
#soho2023 -
Genmab
@Genmab
Together with our partner, @SeagenGlobal, we are pleased to share positive topline results from a Phase 3 trial in patients with recurrent or metastatic #cervicalcancer.
Link: gmab.ly/ktR450PHQKz -
Genmab
@Genmab
Thank you, @lymphoma for this honor and everything that you do to support the lymphoma community.
Lymphoma Research Foundation
@lymphoma
For @Genmab, hope means possibility & life-transforming potential. Their pioneering work in science & commitment to bringing hope to patients is why LRF will honor them with our Corporate Leadership Award at our Annual Gala on 9/28. To learn more, visit www.lymphoma.org/gala.
-
Genmab
@Genmab
It was exciting for @Genmab to represent the biotech industry and speak about how biotech contributes to the fabric of the larger healthcare innovation ecosystem. Thank you to @CapitalAnalytic for hosting a fantastic event.
-
Genmab
@Genmab
Genmab is proud to have reached the milestone of 2,000 colleagues. To celebrate this incredible achievement, Genmab colleagues across all our locations gathered to celebrate—photo booth style! Here are a few highlights.
-
Genmab
@Genmab
At Genmab, we care for our teams and recognize that our colleagues need to maintain a healthy work-life balance to be effective in all aspects of their lives.
Be part of the extra[not]ordinary™: gmab.ly/8zIL50PlR72. -
Genmab
@Genmab
At Genmab, we are empowered to innovate, build solutions and execute. This feeling is a critical part of working towards our goal of changing the lives of patients around the world.
Be part of the extra[not]ordinary™: gmab.ly/Yhnf50PEmkt. -
Genmab
@Genmab
Undergoing a cancer diagnosis can be scary. Eva Anderson, Senior Director, Clinical Project Lead at Genmab, shares her perspective on early diagnosis and the importance of advocating for your health.
#inspiredbypatients #patientadvocacy -
Genmab
@Genmab
Our new state-of-the-art Quality Control (QC) Laboratory in Denmark serves as a critical step toward our 2030 vision to deliver KYSO (knock-your-socks-off) antibodies to patients and continue our growth as a biotech innovation powerhouse. Join our team: gmab.ly/sl7850PAvSu.
-
Genmab
@Genmab
Our colleagues share their perspectives on what Genmab’s 2030 vision means to them as well as our passion for creating KYSO (knock-your-socks-off) #antibodies and their potential to impact the lives of patients. Learn more at: gmab.ly/on4650PyNnZ.
This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
At Genmab’s annual Innovation Tournament, our unstoppable teams submitted numerous brilliant ideas around the use of algorithms that can help drive the future of Genmab.
Congratulations to our five winning colleagues! Be part of the extra[not]ordinary™: gmab.ly/PU7l50Ps7yp -
Genmab
@Genmab
For us at Genmab, being authentic is a key ingredient to being extra[not]ordinary™. We respect all our colleagues for their opinions and strive to create a welcoming and inclusive environment where everyone can be themselves.
Learn about open roles: gmab.ly/wEry50PlR1K. -
Genmab
@Genmab
Cultivating a caring culture is one of the important ingredients for Genmab to be an extra[not]ordinary™ place to work and belong. Melissa Rizzo, Manager, Financial Accounting & Reporting shares what this means to her. Learn more about our culture: gmab.ly/e4K750PjMcn.
-
Genmab
@Genmab
#investorupdate: Genmab has published its Interim Report for the first half of 2023. EVP and CFO Anthony Pagano shares how we are using our solid financial base to continue our evolution into a fully integrated biotech.
To read the report, visit: gmab.ly/bpMQ50Ps6pb. -
Genmab
@Genmab
This week marks the official opening of our new #headquarters in #copenhagen! This state-of-the-art office will help us continue to thrive as One Genmab and provide space for growth, teamwork and future innovation. Be part of the extra[not]ordinary™: gmab.ly/u9q550PrcJu.
-
Genmab
@Genmab
#investorupdate: Join us for our 2023 Interim Report for the first half of the year.
To register for the event, visit: gmab.ly/tHEI50Pq9Yx
#biotech #innovation -
Genmab
@Genmab
Our colleagues are impact driven. We're deeply rooted in science and committed to changing the lives of patients by pioneering knock-your-socks-off antibodies. For Jenny Grimm, this is a core passion of hers!
Read more: gmab.ly/8gYm50Pg9gB. -
Genmab
@Genmab
Congratulations to Martine van Vugt, EVP and Chief Strategy Officer, for being honored in the @endpts Women in Biopharma R&D Special Report. Learn about her journey & contribution to the evolution of Genmab into a biotech innovation powerhouse: gmab.ly/UoxR50PmFRl.
-
Genmab
@Genmab
Kanako Matsuura shares about the exciting opportunities to learn and grow in our roles and help build the organization by developing and executing ideas, work autonomously as well as with a team, and solve complex challenges. Learn more: gmab.ly/32Pp50Pg7UM
-
Genmab
@Genmab
It’s an honor to be recognized as a @TheStevieAwards winner at the 21st Annual American Business Awards® in multiple categories for our company event celebrating our One Genmab team spirit. Read more here: gmab.ly/HXa550Pg8CV.
#thestevieawards #steviewinner2023 -
Genmab
@Genmab
To promote health and happiness among our colleagues, we launched the GenCare Wellness App. It’s designed as a private space for personal development and growth and guides one’s wellness journey based on individual needs.
Be a part of the team: gmab.ly/ge2G50Pe7wp. -
Genmab
@Genmab
Supporting each other’s ideas and innovations ensures that we all are empowered to act with courage and integrity to envision a bold new future. Alex Man shares how this translates to impact. Be part of the extra[not]ordinary™: gmab.ly/U6oU50Pb2mA.
-
Genmab
@Genmab
We at Genmab are proud of @TeamRynkeby and are cheering them on in support of their mission to raise funds for children with critical illnesses such as cancer. To learn more about our CSR efforts, visit: gmab.ly/Tilz50PayrZ.
#communityatgenmab -
Genmab
@Genmab
Genmab is 2000 people strong! We’re so proud of the dedication and hard work of our unstoppable teams toward the aim of creating and delivering innovative antibody medicines to people living with #cancer and other serious diseases. Join us: gmab.ly/RQ6Y50P46O4.
-
Genmab
@Genmab
Extra[not]ordinary™ is a unique word that captures our aspiration to be remarkable and authentic. We asked Helene Bon, Principal Scientist, Target Discovery what Extra[not]ordinary™ means to her. Learn about joining our extra[not]ordinary™ teams: gmab.ly/rkyi50OZgaV.
-
Genmab
@Genmab
Today, we announced topline results from a Phase 1/2 study in relapsed/refractory follicular #lymphoma, with our partner @abbvie. Learn more: gmab.ly/4uZC50OYNTr
-
Genmab
@Genmab
Introducing our Meet the Antibody experts series:
Meet Principal Scientist Katy Lloyd to learn what motivates her and her work on bispecifics, dual-targeted #antibodies and their potential to help solve complex diseases such as advanced cancer. gmab.ly/OBsQ50OVfIu -
Genmab
@Genmab
Learn from our colleagues on how we aspire to and are given opportunities to make an impact on people’s lives and what keeps us motivated to use our antibody expertise and turn science into medicine.
Be a part of our extra[not]ordinary™ teams: gmab.ly/H7C250OVfvQ. -
Genmab
@Genmab
We're sharing an exciting update that the @NCCN clinical practice guidelines in oncology for B-cell lymphomas have been updated with a new category 2A recommendation. gmab.ly/nNQu50OUJSs @abbvie
-
Genmab
@Genmab
#cancerimmunotherapymonth raises awareness about immunotherapy treatments for cancer patients. We asked Manish Gupta, Vice President, Global Head of Translational & Quantitative Sciences, to explain the importance of immunotherapies. Learn more: gmab.ly/zJSG50OU5XX
-
Genmab
@Genmab
Last week, Genmab colleagues participated in Global Volunteer Day. Our unstoppable teams supported 36 charities in the communities where we live and work. Learn more here: www.genmab.com/our-impact/corporate-responsibility-sustai….
-
Genmab
@Genmab
At Genmab, we’re focused on deploying our KYSO (knock-your-socks-off) antibodies to turn science into medicine. Recently, Mark Fereshteh and David Satijn shared their perspective with @medicine_maker on the future of antibody development.
Read here: gmab.ly/HaeO50OQU3H. -
Genmab
@Genmab
This Juneteenth, Genmab is honored to be a corporate sponsor of the Stoutsburg Sourland African American Museum, whose mission is to tell the unique story, culture, experiences and contributions of the local African American community.
Read more here: gmab.ly/Fifj50OQU0H. -
Genmab
@Genmab
Recently, Vice President, Head of Translational Data Sciences, Brandon Higgs, spoke at @BioNJ_Org’s life sciences Human Resources Conference to discuss how #artificialintelligence will propel the future workforce.
Learn more: gmab.ly/YFn050ON9Ae -
Genmab
@Genmab
We’ll be at this year’s @icmlugano meeting to discuss our latest research in #oncology and how we are working to advance innovation in cancer care. Stay tuned as we present data in blood cancer, including #fl, #dlbcl and #lbcl. #17icml gmab.ly/HxnB50ONasf
-
Genmab
@Genmab
We’re recognizing Pride Month in an extra[not]ordinary™ way by partnering with @OUTinSTEM, the largest, chapter-based, 501(c)(3) non-profit professional association focused on LGBTQ+ people in STEM, through GenPride Scholarships. gmab.ly/9N9y50OHiG4. #communityatgenmab
-
Genmab
@Genmab
#investor Update: We are excited to participate in a fireside chat at the @GoldmanSachs 44th Annual Global Healthcare Conference. Join us on June 13 and check out the webcast at: gmab.ly/fAmq50OJAlM.
-
Genmab
@Genmab
Follicular #lymphoma (#fl) accounts for ~20% of all non-Hodgkin’s lymphoma (NHL) cases globally and is the most common subtype of indolent, or slow growing, NHL. gmab.ly/RzZz50OKA9I
-
Genmab
@Genmab
Today we announced new data from several of our clinical trials at #eha2023. Read more here: gmab.ly/Kbrf50OKzUB
-
Genmab
@Genmab
We’re committed to our goal of deploying our expertise in "knock-your-socks-off" (KYSO) antibodies to turn science into medicine. We'll be sharing the latest data in our #oncology research at @EHA_Hematology’s Congress beginning tomorrow. Learn more: gmab.ly/LtzC50OFZvT.
-
Genmab
@Genmab
Shoutout to our precision medicine team for their poster presentation at @ASCO (#asco2023) this year alongside @DukeU on Head and Neck Cancer. Learn more: gmab.ly/ptA150OGcIM.
#innovation #cancerresearch -
Genmab
@Genmab
At #asco23, it was an honor to host #patientadvocate & professional society representatives. Thank you for all that you do for cancer patients & caregivers. To keep the patient's voice at the forefront of all we do, we look forward to continue our conversation.
-
Genmab
@Genmab
Thank you @CancerAdvocacy for all that you do to support and advocate for quality cancer care for all people touched by cancer. #canceradvocacy #cancersurvivorship #ncsd23 #patientsfirst #inspiredbypatients
Cancer Nation
@CancerAdvocacy
Happy National Cancer Survivors Day!
At NCCS, #cancersurvivors are at the core of all we do. Today, we celebrate the 18.1 million people in the US who are living with, through, and beyond #cancer. Want to join us? Get involved today:canceradvocacy.org/get-involved/ -
Genmab
@Genmab
Diffuse large B-cell #lymphoma (#dlbcl) accounts for ~30% of all non-Hodgkin’s lymphoma (NHL) cases worldwide. Learn more about the scientific data in DLBCL we are presenting at #asco23: gmab.ly/k40250OEvcT
-
Genmab
@Genmab
Our DuoBody® platform technology forms the basis of many of our investigational #bispecific antibodies. Learn more about our scientific approach as we share more on our research at #asco23 and #eha2023. gmab.ly/8pIX50OEv6Y
-
Genmab
@Genmab
Join us as this year’s @ASCO meeting kicks off to discuss the latest research in #oncology. Stay tuned as we share our latest research on types of B-cell #lymphomas across our clinical development programs. #asco23 gmab.ly/kTmg50OEv3L
-
Genmab
@Genmab
Collaborations and partnerships have always been a part of Genmab’s DNA. To learn about our partnership approach to create, develop and deliver innovative antibody therapies, meet our business development team at #bio2023 @IAmBiotech by contacting licensing@genmab.com.
-
Genmab
@Genmab
Our Genmab team is dynamic, impact-driven and rooted in science. We empower our people to be authentically themselves when they come to work each day. To learn more about our #extranotordinary teams, visit our recruitment booth at ASCO.
#innovation #joingenmab -
Genmab
@Genmab
#communityatgenmab means supporting our employees with what matters to them.
This #aanhpiheritagemonth, Genmab has donated to @AAAJ_AAJC to support advancing the civil and human rights of Asian Americans nationwide through education, litigation, and public policy advocacy. -
Genmab
@Genmab
This will be our 15th year at the American Society of Clinical Oncology (ASCO)’s Annual Meeting, #asco23, and we are looking forward to meeting and sharing the latest data with our #oncology peers.
Learn more about our pipeline: gmab.ly/CY4950Op7oW. -
Genmab
@Genmab
This #mentalhealthawarenessmonth, hear from @IrisKolder on the importance of a support system. At Genmab, we are committed to our goal of improving the lives of people with cancer and other serious diseases. Learn more: gmab.ly/pZKn50Ox5um.
#patientsfirst #inspiredbypatients -
Genmab
@Genmab
We recently hosted researchers @MacMillan_Lab, @SCampbellstaton and @bsadamson from @PrincetonChem to share insights and progress on our multiple cancer research collaboration programs as part of the Princeton Catalysis Initiative. Learn more: gmab.ly/6mAB50Os5E7.
-
Genmab
@Genmab
#icymi Genmab’s Karlijn Bastiaansen and Ruta Mockute have been recognized as Rising Stars by @HBAnet for their dedication to making an impact for patients. #extranotordinary #hbaimpact #hbawoty23
-
Genmab
@Genmab
We are excited to announce that the @US_FDA approved our #bispecific antibody for patients with certain types of relapsed/refractory diffuse large B-cell #lymphoma (#dlbcl) who have received at least 2 prior therapies. Read more: gmab.ly/WXqP50Osipz @abbvie
-
Genmab
@Genmab
We center patients’ needs throughout our entire development and discovery process. Aran Labrijn, Director, Antibody Format Discovery Lead at Genmab, shares his perspective on his work in cancer research.
Learn more here: gmab.ly/4R7g50OrZZI. -
Genmab
@Genmab
Headquartered in Copenhagen, Denmark, we’re proud of our roots and the innovations that stem from this thriving community.
Learn more about our extra[not]ordinary™ and unstoppable teams: gmab.ly/JioQ50OkFVw
#joingenmab #extranotordinary -
Genmab
@Genmab
Meet Eva, a #cancer survivor and true inspiration, and hear her thoughts on the importance of living in the moment. Patients’ perspectives are front and center in every decision that we make. Learn more: gmab.ly/yfht50OkFpj.
#patientsfirst #inspiredbypatients -
Genmab
@Genmab
Yesterday, we welcomed the @TeamRynkeby cycling team to our headquarters in Denmark! We are proud to sponsor Team Rynkeby and support their mission to raise money for critically ill children. Learn about our CSR efforts: gmab.ly/aA1550Olz1q.
#communityatgenmab -
Genmab
@Genmab
#investor Update: We have published our financial results for Q1 2023. Learn more about our progress and financial performance from Anthony Pagano, EVP & CFO.
gmab.ly/OPWy50OkGqY -
Genmab
@Genmab
At Genmab, we strive to be extra[not]ordinary™ by embracing empowerment – we act with courage and integrity to envision a bold new future and the opportunity to learn and grow. Learn more: gmab.ly/6Eyy50OgWNv
-
Genmab
@Genmab
Thank you to our young advocates from the Bring Your Kid to Work Day event, and most importantly to the @CancerCare team for all that you do to support people with cancer and their family.
CancerCare
@CancerCare
Thanks to @Genmab for hosting Bring Your Kid to Work Day & decorating gifts for @CancerCare’s Healing Hearts Family Bereavement Camp! Thanks to these young advocates for helping to make this camp special for families who have lost a loved to cancer. www.cancercare.org/community_programs
-
Genmab
@Genmab
Our colleagues in the US brought their children to work this #bringyourchildtoworkday where they had a chance to experience Genmab first-hand! The day included presentations on science, finance, CSR & advocacy, for different age groups. Learn more: gmab.ly/rnw250O0Ynl
-
Genmab
@Genmab
Hear from our #extranotordinary team based out of our Japan location on their experience at Genmab and how they are empowered to innovate, build solutions, and execute with a goal to make an impact on patients' lives.
Join our #unstoppable team at: gmab.ly/lBEE50NRANj -
Genmab
@Genmab
Our Patient Advisory Council consists of experts from diverse backgrounds and experiences. They’ll provide invaluable feedback & insights as we aspire to develop treatments for cancer and other serious diseases. Learn more at: gmab.ly/no3M50NRzQb
-
Genmab
@Genmab
We’re excited to attend the @oncologynursing’s #onscongress this year and share more about the latest in our innovative #oncology research. Visit our booth to learn more about our work.
Read more: gmab.ly/KEfZ50NRzE4 -
Genmab
@Genmab
It is important to recognize the impact of the Scientist↔Survivor program at #aacr23
AACR
@AACR
The AACR Scientist↔Survivor Program® will celebrate its 25th anniversary during #aacr23. Program Chair @AnnaBarker20 reflects on the history of this trailblazing program in AACR Annual Meeting News:
www.aacrmeetingnews.org/scientist-survivor-program-celebr…
#aacrssp -
Genmab
@Genmab
At Genmab, we're committed to being a sustainable, socially responsible biotech company. This #earthday, our colleagues participated in initiatives such as collecting litter, beautifying our campus’ and canals.
Learn more about us: gmab.ly/et9550NOrkM.
#communityatgenmab -
Genmab
@Genmab
Here’s a behind the scenes look at Genmab’s new Headquarter building in Copenhagen, Denmark. It is designed with our #culture and core values of #innovation and teamwork in mind.
Learn more: gmab.ly/1MTS50NOpSnThis media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
For the third consecutive year, our CEO, Jan van de Winkel, has made the @medicine_maker Power List! We’re honored to see him recognized among many distinguished #biopharma leaders.
For more from Jan, follow him on LinkedIn: gmab.ly/otvt50NO57P. -
Genmab
@Genmab
Our DK colleagues recently supported the #fodboldrøjeFredag fundraising campaign for #børnecancerfonden, the Danish Children's Cancer Foundation, which strives to make a difference for children w/ cancer & their families.
Learn more about our CSR efforts: gmab.ly/RxBO50NNoij -
Genmab
@Genmab
#icymi Hear from our team member on why Genmab is an extra[not]ordinary place to work.
To be a part of our unstoppable teams, visit: gmab.ly/oU3J50NM2vj. -
Genmab
@Genmab
We have entered into a multiyear collaboration with @argenxglobal to jointly discover, develop and commercialize novel therapeutic antibodies with applications in immunology and oncology. Learn more: gmab.ly/4AMZ50NKwFj
-
Genmab
@Genmab
#aacr2023 is in full swing and we are excited to present new clinical and preclinical data evaluating several investigational medicines in our pipeline. @AACR @SeagenGlobal
-
Genmab
@Genmab
#icymi: Insights from Tahamtan Ahmadi, our EVP and Chief Medical Officer, Head of Experimental Medicines, were featured in a recent article by @PharmaScrip’s on the advances in the therapeutic areas.
Read more: insights.citeline.com/SC148046/Scrip-AsksWhat-Does-2023-H….
#biotech #research -
Genmab
@Genmab
We’re looking forward to attending the @AACR Annual Meeting this year and share more about the latest in our innovative #oncology research. Visit our booth to learn more about our work. #aacr23
Read more: gmab.ly/Fwx850NIfww -
Genmab
@Genmab
People at Genmab are impact-driven and aspire to make a difference in the lives of patients. Hear from our colleagues on the impact of their work.
Explore the opportunity to be a part of our #extranotordinary team at: gmab.ly/98U450NH8XF -
Genmab
@Genmab
With our global headquarters in Copenhagen, Denmark, we are proud of our Danish roots. We’re excited to see Copenhagen named by @EU_Commission as one of Europe’s most competitive regions in their Regional Competitiveness Index 2022.
Learn more: gmab.ly/rFeB50NCMgY
#rci2022 -
Genmab
@Genmab
In a new series, we’ll share the core tenets of Genmab’s commitment, which is a promise to our current and future team.
Learn more about our #extranotordinary culture at: gmab.ly/2zEW50NxBPt. -
Genmab
@Genmab
This #womenshistorymonth, Genmab is a proud sponsor of @JAofNJ which brings together professionals of diverse backgrounds w/ high school girls in NJ. Genmab female leaders volunteered as mentors to #empower young girls.
Read more about our responsibility: gmab.ly/gTYM50Nx8bj -
Genmab
@Genmab
#investorupdate: Genmab held its 2023 Annual General Meeting earlier today.
Learn more at: gmab.ly/GtTi50NrC4I.
#biotech #innovation -
Genmab
@Genmab
With our R&D center at Utrecht in the Netherlands, we are proud to be a part of an innovation ecosystem. We’re excited that the @EU_Commission has once again named Utrecht as Europe’s most competitive region in their Regional Competitiveness Index 2022.
www.heartofhealth.com/rci -
Genmab
@Genmab
It is our pleasure to announce that Martine van Vugt has been appointed to EVP & Chief Strategy Officer, overseeing Corporate Strategy, Corporate Development, Business Development & Licensing, and Alliance Management. For more information: gmab.ly/EIVP50NtFg4.
-
Genmab
@Genmab
#investorupdate: Join us for our 2023 Annual General Meeting on March 29, 2023.
To join the webcast, visit gmab.ly/8ToJ50NrB8O.
#biotech #innovation -
Genmab
@Genmab
At Genmab, we use #extranotordinary as a unique word to capture what makes this a special place to work.
To learn more about Genmab’s Commitment – our promise to our current and future colleagues, visit: gmab.ly/YrQZ50NregK. -
Genmab
@Genmab
Our core purpose is that our unstoppable team aspires to improve the lives of patients through innovative and differentiated antibody therapeutics. Learn more about our science at our booth at @SGO_org's Annual Meeting: gmab.ly/M6MR50Nqlpp
#innovation #pipeline #gynecology -
Genmab
@Genmab
Many members of our #extranotordinary team are based out of our Denmark headquarters.
We’re proud of our Danish roots and our purpose to improve the lives of patients through innovative and differentiated antibody therapeutics.
To learn more, visit: gmab.ly/NKQa50Nqjw2. -
Genmab
@Genmab
We recently welcomed @RutgersU students to our NJ office for Career Day, to support their pursuit of career opportunities in Oncology to foster #innovation. We’re proud to play a role in the NJ life science ecosystem.
Learn more: gmab.ly/UL4w50NpAeT. -
Genmab
@Genmab
Hear from our team member on why Genmab is an extra[not]ordinary place to work.
To be a part of our unstoppable teams, visit: gmab.ly/ngBW50NpqbT.
#joingenmab #biotechjobs #companyculture #extranotordinary -
Genmab
@Genmab
We’re proud to announce that Karlijn and Ruta have been recognized as an @HBAnet Rising Star for their outstanding performance, leadership, and commitment to excellence.
Learn more about our unstoppable team at: gmab.ly/BRTa50Npg6S.
#extranotordinary #hbawoty23 #hbaimpact -
Genmab
@Genmab
#icymi We’re excited to announce that our 2022 #corporateresponsiblity report is now available.
Download the full report on our #csr efforts here: gmab.ly/SPBR50Nn59W. -
Genmab
@Genmab
#icymi: We published our 2022 annual report. Learn more about our growth and progress towards our #vision that by 2030, our knock-your-socks-off antibody medicines are transforming the lives of people w/ cancer and other serious diseases.
Read more: gmab.ly/yWsh50Nn6o2. -
Genmab
@Genmab
We’re honored to be selected as a finalist for the @PMSociety Awards and @Provoke_News (SABRE) Awards for our #extranotordinary companywide event.
Thank you to everyone who contributed!
Learn more about our #companyculture at: gmab.ly/raFl50Nla8h.
@AshfieldEventEx -
Genmab
@Genmab
At Genmab, we take pride in being rooted in #science and inspired by patients. Explore a recently published article in the Journal of Business Anthropology looking into the story and filmmaking process behind our ‘Pieces of the Puzzle’ video.
Read more:
gmab.ly/zqIa50Njsp3 -
Genmab
@Genmab
We’re thrilled to participate in the 2023 PCI Symposium by @PrincetonChem on May 24. Suzana Couto, VP, Head of Pathology and distinguished researchers, will discuss the role of #collaboration and #innovation in turning science into medicine.
Learn more: gmab.ly/3k0B50NgGOC -
Genmab
@Genmab
We’re excited to participate in this upcoming event with @PrincetonChem and be part of the #innovation ecosystem in New Jersey to help do our part in turning science into medicine!
Princeton Chemistry
@PrincetonChem
It’s only March but we’re already looking forward to the 2023 Princeton Catalysis Initiative Symposium on Wednesday, May 24 at Frick Lab. Eager to see all of our faculty and industry partners! @Genmab @princetonideas @Princeton
-
Genmab
@Genmab
In honor of #womenshistorymonth, we’re proud to announce our continued support of @equalitynow and our scholarship program at @MercerCollege, to support women students in Health & Science studies.
Learn more here about our commitment: gmab.ly/zqR050Nfi0v.
#communityatgenmab -
Genmab
@Genmab
Learn how researchers and clinicians are utilizing a novel approach using bispecifics or dual-targeting antibodies with the goal to bring new treatment options for cancer patients.
#naturesbuildingblocks -
Genmab
@Genmab
What does extra[not]ordinary mean to you?
Learn how the Genmab team came up with a data-driven and collaborative approach to describe their culture as extra[not]ordinary.
Read more here: gmab.ly/XClK50N4Crp. -
Genmab
@Genmab
We’re excited to announce that our 2022 #corporateresponsiblity report is now available.
Download the full report on our #csr efforts here: gmab.ly/u7Au50MZy9a -
Genmab
@Genmab
#investor Update: Genmab has published its 2022 annual report. Executive VP & CFO, Anthony Pagano, shares highlights from 2022.
To read the report, visit: gmab.ly/JTKg50MZxAS -
Genmab
@Genmab
In support of the people affected by the earthquake in Türkiye and Syria, Genmab is donating to @DirectRelief, which is deploying urgently needed medical aid, and doubling and matching employee donations to eligible nonprofits for relief efforts.
-
Genmab
@Genmab
At Genmab, we recognize the importance and support of #womeninstem. This #internationaldayofwomeninscience, Associate Director, GCP Quality & Compliance Kelly Bantle, reflects on her experience in the #oncology field.
Read more here: gmab.ly/38KL50MPBoH. -
Genmab
@Genmab
Congratulations to Chris Cozic, EVP & Chief People Officer, on his appointment to the @BioNJ_Org board. We're proud to be a part of #innovation in NJ and help support #bionj’s mission to improve the lives of patients and their families around the world. gmab.ly/8p2h50MOHLE
-
Genmab
@Genmab
We are proud to support World Cancer Day to help build global awareness and support efforts in creating a cancer-free world.
Find out more on: gmab.ly/IOyy50MJr9k
#worldcancerday -
Genmab
@Genmab
At Genmab, we take pride in being rooted in science and inspired by patients.
On #worldcancerday, Mark Peters, patient advocacy executive and industry veteran shares his thoughts about the impact of innovation in cancer research.
Learn more: gmab.ly/zOLI50MJIq6.
#oncology -
Genmab
@Genmab
#icymi: @PharmaVoice’s 2023 Year in Preview features SVP, General Manager, US Brad Bailey and VP, Global Head of Data Science Hisham Hamadeh who share thoughts on utilizing data & insights w/ a goal to make an impact on the lives of patients.
Read more: www.pharmavoice.com/news/the-2023-pharmavoice-year-in-pre… -
Genmab
@Genmab
#icymi @GYNCancer developed a comprehensive brochure to serve as a resource following diagnosis. Help #movethemessage this #cervicalcancerawarenessmonth by sharing with someone it may benefit.
FdtnForWomensCancer
@GYNCancer
January is Cervical Cancer Awareness Month, and throughout the month, FWC is sharing resources that help you get informed, get screened, and get vaccinated. For more comprehensive information, see our brochure, Cervical Cancer: Your Guide.
Download:
foundationforwomenscancer.org/wp-content/uploads/FWC_Cerv… -
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
ir.genmab.com/news-releases/news-release-details/genmab-a… -
Genmab
@Genmab
Thank you @SpeakerCoughlin, @AswPintorMarin, @ACSCANNJ, @Cr4Hope, @BioNJ_Org, @ACOGAction for bringing awareness to #cervicalcancer.
#cervicalcancerawarenessmonth
Speaker Craig J. Coughlin
@SpeakerCoughlin
This year, about 13,960 new cases of cervical cancer will be diagnosed.
But I have hope.
With the help of the folks below we continue to build out research capabilities, deliver cutting edge treatments, and take steps that save lives and spare families.
#cervicalcancerawareness -
Genmab
@Genmab
We are proud of the many Genmab colleagues who are making a difference in their communities and for causes important to them. Hear what inspired Fiona Glenny to cycle around Egypt for @JoTrust.
Learn more: gmab.ly/x6a950MuW3b
#communityatgenmab -
Genmab
@Genmab
Vice President, Head of Pathology Suzana Couto will discuss how spatial #biology plays a role in drug development at this year’s Spatial Biology Summit for #immunooncology.
Learn more about our pipeline here: www.genmab.com/antibody-science/pipeline -
Genmab
@Genmab
In honor of Dr. Martin Luther King Jr., our US office is closed. This #mlkday, we're proud to announce our Genmab scholarship program w/ @MercerCollege which aims to support African American and black students in Health and Science studies. Learn more: gmab.ly/9jFl50Mp2cm.
-
Genmab
@Genmab
#icymi: President & CEO Jan van de Winkel shared progress on our company’s evolution and #pipeline based on antibody innovations at #jpm2023, hosted by @jpmorgan. Watch the replay here: gmab.ly/oi8R50Mp1GC.
#investorupdate -
Genmab
@Genmab
At @jpmorgan’s #jpm2023, President & CEO Jan van de Winkel will share important updates on our #pipeline based on antibody innovations and priorities for the year. To register, visit: gmab.ly/39QB50MnGHT.
#investorupdate -
Genmab
@Genmab
Check out our latest company update at #jpm2023.
Read more: gmab.ly/QQiV50Mm7Va -
Genmab
@Genmab
Meet Lars Dreioe, Vice President, Head of Quality Assurance, and hear from him about our commitment to keeping patients’ needs at the center of every decision.
-
Genmab
@Genmab
During this week and for the holiday season, our offices at all locations will be closed to provide our colleagues with time off to enjoy themselves with their loved ones!
To learn more about Genmab, visit: gmab.ly/XpcJ50M8T1k
#joingenmab #happyholidays #happynewyear -
Genmab
@Genmab
We’re pleased to share that data from a study evaluating our investigational #bispecific antibody has been published in @JCO_ASCO. Learn more about the findings: gmab.ly/Iwxc50MaYjx @abbvie
-
Genmab
@Genmab
From our Genmab family to yours, #happyholidays and #happynewyear!
-
Genmab
@Genmab
We are pleased to announce the submission of a New Drug Application to Japan’s Ministry of Health, Labor and Welfare (MHLW) for our investigational bispecific antibody for patients with relapsed/refractory large B-cell #lymphoma in partnership with @abbvie gmab.ly/Bt5n50M9i2O
-
Genmab
@Genmab
This year, we were proud to work with impactful global, national and regional organizations that share our goals of sustainability and social responsibility including serving the local communities, together. Thank you!
Learn more: gmab.ly/qAZ550M52RC
#communityatgenmab -
Genmab
@Genmab
In the next installment in our series of conversations with Genmab’s #leaders, hear from Anthony Mancini, our EVP & COO, on what drives our company #culture and what it means to be a part of our extra[not]ordinary community!
Learn more at gmab.ly/zPNc50M4q9q -
Genmab
@Genmab
A recent author of two articles in the @Nature, Simone Oostindie has been a member of our research team since joining us as an intern. She shares her perspective on this extra[not]ordinary journey below.
Join our unstoppable team today! gmab.ly/rbTz50M3vtv -
Genmab
@Genmab
Follicular lymphoma (FL) is a slow-growing type of non-Hodgkin’s lymphoma (NHL), accounting for an estimated 20-30% of NHL cases. As #ash22 ends, learn more about our commitment to improving the lives of patients with FL and other cancers: gmab.ly/SfMl50M0uTh
-
Genmab
@Genmab
Our versatile DuoBody® platform technology is the basis of many of the #bispecific antibodies in our pipeline being investigated to treat various cancers. Learn more about this unique technology: gmab.ly/cwCS50M0uSz #ash22
-
Genmab
@Genmab
A common symptom of Richter's syndrome – a rare complication of chronic lymphocytic leukemia (#cll) and/or small lymphocytic lymphoma (#sll) – is sudden growth in the lymph nodes. During #ash22, learn more about our research in blood cancer: gmab.ly/prk350M0uPb
-
Genmab
@Genmab
At #ash22, we are presenting results evaluating our #bispecific antibody therapy in patients with relapsed/refractory follicular lymphoma (FL) and previously untreated FL with our partner @abbvie. Read more: gmab.ly/KQEf50M0vhe
-
Genmab
@Genmab
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). As #ash22 kicks off, learn about our goal to transform cancer research. gmab.ly/UP8R50M0gvr
-
Genmab
@Genmab
At Genmab, we are committed to advancing innovative research with a goal to bring differentiated antibody therapies to patients. Learn more during our oral and poster presentations at #ash22. gmab.ly/o6jI50M0gqw
-
Genmab
@Genmab
#icymi Genmab is attending the #ash22 Annual Meeting & Exposition beginning tomorrow. Stop by Booth 1242 to learn more about our pipeline of investigational antibodies and meet our team.
For more information, visit: gmab.ly/Cpql50LZzLS
#hematology -
Genmab
@Genmab
#investors Update: Join us on December 12 for our 2022 R&D Update and ASH Data Review where we’ll be offering insights into our antibody innovations and #pipeline.
Register today: gmab.ly/498K50LYQ2y
#ash22 -
Genmab
@Genmab
Thank you to local government members of @MiddlesexCntyNJ, @NewJerseyEDA & @RutgersU for visiting us at our New Jersey offices and allowing us to showcase the innovative work we are doing with a goal to make an impact on the patients.
#biotech #innovation -
Genmab
@Genmab
At Genmab, each of us is motivated by our core purpose to improve the lives of patients with cancer and other serious diseases.
Hear more from our President & CEO, Jan van de Winkel, on what motivates him.
Follow him at: gmab.ly/OeN750LR3Ck
#leadership #vision -
Genmab
@Genmab
Join us at the Annual #ash22 Meeting hosted by @ASH_hematology! Be sure to stop by booth 1242 as we share the recent progress on our #pipeline of investigational #antibodies.
Learn more: gmab.ly/EiXm50LOLMs
#hematology -
Genmab
@Genmab
Our SVP, Communications & Corporate Affairs, Marisol Mendez Peron - @MMPeron, will speak at this year’s @BioNJ_Org Inspiring Women in STEM Conference in a fireside chat about female #leadership!
Register today at: gmab.ly/Vo5J50LJVZw -
Genmab
@Genmab
#innovation is a key part of our culture. During our Annual Innovation Tournament, we encourage our teams to spotlight and pursue their innovative ideas that can support our purpose of improving the lives of patients.
Join our innovative culture! gmab.ly/IHe750LMkHT -
Genmab
@Genmab
We are excited to announce that the @US_FDA has accepted for Priority Review our Biologics License Application for our investigational #bispecific antibody for patients with relapsed/refractory large B-cell #lymphoma (#lbcl), in partnership with @abbvie. gmab.ly/7R5b50LJAh1
-
Genmab
@Genmab
Our EVP & COO, Anthony Mancini, has been appointed to the @IAmBiotech Board of Directors! Congratulations Anthony – we look forward to seeing your leadership continue to make an #impact on the #biotech community.
-
Genmab
@Genmab
We’re excited to attend this year’s @DrugInfoAssn virtual career fair! To be a part of a growing biotech, join us online and connect with our talent acquisition team to learn more about our open roles & company culture.
Visit us today! gmab.ly/agCr50LELSM
#joingenmab -
Genmab
@Genmab
Last week, Genmab was proud to celebrate World Quality Week! This week-long celebration raised the level of quality awareness and recognized the efforts and contributions focused on quality throughout the entire organization.
#worldqualityweek -
Genmab
@Genmab
#investors Update: We’ve released our Q3 earnings report. Hear more about our recent progress from our EVP & Chief Financial Officer, Anthony Pagano.
Read the full report here: gmab.ly/1Tcy50LzaNI -
Genmab
@Genmab
We’re excited to present data at @sitcancer's #sitc22 Annual Meeting!
Be sure to stop by booth 619 to learn more about our pipeline: gmab.ly/sIib50LxMpQ.
#immunotherapy -
Genmab
@Genmab
At #ash22, we will present data evaluating our investigational #bispecific antibody therapy with our partner, @abbvie. Read the latest here: gmab.ly/lpy850Ltq7S
-
Genmab
@Genmab
This past weekend, Genmab sponsored @LLSusa's #lightthenight walk in Mercer County Park, NJ, to show support to those affected by blood cancer. 🤍❤️💛
#cancelbloodcancer -
Genmab
@Genmab
🤍❤️💛 Together w/ @LLSusa, we're proud to sponsor this year's #lightthenight walk in Mercer County, NJ! Join us as we lift our lanterns to honor survivors, support friends & family, and remember those we've lost to blood cancer.
Be sure to stop by our tent! #cancelbloodcancer -
Genmab
@Genmab
Today, Genmab’s Hisham Hamadeh will speak in a panel discussion titled "Applied AI in Life Sciences and Health Care" at @DeloitteUS's 2022 AI Forum presented by #deloitteaiinstitute!
Learn more about our data science expertise: gmab.ly/BkLQ50Lo2y5
#stateofai #lifesciences -
Genmab
@Genmab
Genmab is thrilled to attend #esgo2022, the 23rd Annual Meeting hosted by @ESGO_society! Visit us at Booth 22 to learn more about our pipeline and connect with our colleagues.
Learn more: gmab.ly/jjp550LmPQY
#esgoengage #oncology -
Genmab
@Genmab
At Genmab, our colleagues source key #analytics and develop #businessinsights to drive our efforts in bringing our medicines to patients. Hear from Herb Swanson, Senior Director, Sales & Marketing Operations, on how we’ve found success w/ our evolving capabilities.
-
Genmab
@Genmab
Congratulations to our SVP, Corporate Strategy & Planning, Martine van Vugt, who's been named a winner of the Guiding Star Award at the 2nd Annual @TOPXNetwork Summit in The Netherlands! 🎉
Read more here: gmab.ly/i7u150Lfi1P
#leadership #lifesciences -
Genmab
@Genmab
Genmab is excited to offer two Multidisciplinary PharmD Fellowship positions in collaboration w/ Philadelphia College of Pharmacy - Industry & Education Fellowship Program, and is open to all PharmD graduates nationwide!
Watch the video to learn more. #sju #pharmafellows -
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2022
ir.genmab.com/news-releases/news-release-details/genmab-a… -
Genmab
@Genmab
To commemorate #hispanicheritagemonth, we're proud to continue our scholarship program w/ @MercerCollege, supporting students of Hispanic Heritage in Health & Science studies.
#communityatgenmab -
Genmab
@Genmab
Last month in Copenhagen, over 100 Genmab colleagues participated in the @DHLUS Relay Race, the largest fitness run in the world! Thank you to everyone who participated!
Learn more about our company culture: gmab.ly/XhSt50L8oxW
#dhlrelayrace #companyculture -
Genmab
@Genmab
We’re excited to attend @HireLifeScience’s Career Fair today in Edison, NJ! To be a part of a growing biotech, visit us at booth 3 and connect w/ our talent acquisition team to learn more about our open roles & company culture.
Explore today! gmab.ly/TY5k50KSubK
#hiring -
Genmab
@Genmab
Congratulations to our team on winning 1st Place in the Poster Session at @sbi2_org's Biomolecular Imaging & Informatics 2022! The innovative work showcases utilizing cell paint assay technique to evaluate biological responses when applied to novel antibodies. #sbi2 #innovation
-
Genmab
@Genmab
To help raise awareness about our colleague’s health, safety and environmental footprint, we're recognizing Safe + Sound & #sustainability Week at our NL & US offices!
Learn more about our corporate responsibility here: gmab.ly/gqf450L0Rfc
#safeandsoundweek -
Genmab
@Genmab
Although we’re approaching the end of #bloodcancerawarenessmonth (#bcam) and Gynecologic Cancer Awareness Month (#gcam), Genmab remains committed to driving innovation every day as we work toward our goal of improving the lives of cancer patients.
-
Genmab
@Genmab
We’re excited to attend @IGCSociety's #igcs2022 Global Meeting. Stop by booth 9 to learn more about our pipeline of investigational #antibody therapeutics and connect with leaders in the field!
Learn more: gmab.ly/xAmy50KRmHk
#oncology -
Genmab
@Genmab
Genmab will attend the 10th Annual Meeting of the @SocietyofHemOnc – covering the latest advancements and innovation in the #hematology space!
Join us and visit booth 114 for further information.
#soho2022 -
Genmab
@Genmab
We're excited to attend the @nbmbaahq's 44th Annual Conference & Expo! To be a part of a growing biotech, visit us at booth 2035 and learn more about our open roles and engaging company culture!
Explore today: gmab.ly/TY5k50KSubK
#nbmbaa #hiring #biotechjobs -
Genmab
@Genmab
#icymi we’ve been selected again as one of @NJBIZ’s Best Places to Work in New Jersey for 2022! 🎉 A true testament to the hard work of our unstoppable team.
Learn more about our open opportunities today! gmab.ly/1KVa50KSu5G
#companyculture #hiring #joingenmab -
Genmab
@Genmab
Today, Executive Vice President & Chief People Officer Chris Cozic will speak in the "Future Work Trends in Culture and Well-Being" panel at @BioNJ_Org's New Jersey Life Sciences Human Resource Conference!
Learn more: gmab.ly/bkg850KRqyN
#companyculture #hiring #joingenmab -
Genmab
@Genmab
We’ve defined new aspirations for our future: that by 2030, our knock-your-socks off (KYSO) #antibody medicines will fundamentally transform the lives of people with cancer and other serious diseases.
Learn more about our #vision: www.linkedin.com/pulse/2030-vision-unstoppable-team-two-d…
#biotech -
Genmab
@Genmab
Because the symptoms of #lymphoma may resemble those of less serious illnesses, like the flu, it is often overlooked. Many patients delay visiting the doctor as they don’t suspect cancer. This #worldlymphomaawarenessday, learn more about lymphoma: lymphomacoalition.org/signs-symptoms/
-
Genmab
@Genmab
We aim to give back to our local communities. During our 1st Global Volunteer Day, our colleagues in Denmark, the Netherlands and U.S. collectively volunteered at over 30 organizations!
Learn more about our purpose-driven culture at www.genmab.com
#communityatgenmab -
Genmab
@Genmab
This September, we’re supporting the Danish based foundation @Bornecancerfond, as they work towards raising #childhoodcancerawareness and support children with #cancer and their families.
#ccam -
Genmab
@Genmab
September marks the start of #bloodcancerawarenessmonth (#bcam) and Gynecologic Cancer Awareness Month (#gcam). As @Genmab recognizes the immense unmet need for those living with cancer, read more about our goals in transforming cancer research. www.linkedin.com/pulse/reaffirming-our-purpose-during-blo…
-
Genmab
@Genmab
We are excited to participate in a fireside chat at @MorganStanley’s 20th Annual Global Healthcare Conference. Join us on September 13 and check out the webcast at: event.webcasts.com/starthere.jsp?ei=1566172&tp_key=9e580f….
#healthcare #morganstanley -
Genmab
@Genmab
Approximately 1.28 million #bloodcancer cases were estimated worldwide in 2020. In recognition of #bloodcancerawarenessmonth (#bcam), learn more about the three main blood cancers – lymphoma, leukemia and multiple myeloma. www.lls.org/lymphoma
-
Genmab
@Genmab
Congratulations to Judith Klimovsky, EVP & Chief Development Officer, for being named as one of @PharmaVoice’s 100 Most Inspiring People in the #lifesciences industry! 🎉
Read more here: www.pharmavoice.com/news/judith-klimovsky-pv100-innovator…
#leadership #inspiring -
Genmab
@Genmab
We’ve unveiled our 2030 #vision! This will guide our path forward as we aspire to transform the lives of those living with #cancer and other serious diseases.
Learn more from our President & CEO, Jan van de Winkel: www.linkedin.com/pulse/2030-vision-unstoppable-team-two-d… #investorupdate -
Genmab
@Genmab
#investorupdate: We’ve published our interim report for H1 2022 & unveiled our next chapter – our 2030 #vision – a glimpse at what we hope to accomplish in our future. Read the full report here & view the presentation to learn more about our 2030 Vision: ir.genmab.com/events/event-details/publication-interim-re…
-
Genmab
@Genmab
In a behind-the-scenes clip, hear from VP, Global Head of Diversity, Equity and Inclusion, Vibeke Didriksen, about how we’re working to ensure #equality and #equity are top of mind across all areas of our organization.
#diversity -
Genmab
@Genmab
#icymi We announced our partner, @abbvie plans to submit a Marketing Authorisation Application to the @EMA_News for our investigational #bispecific antibody for the treatment of diffuse large B-cell lymphoma. Learn more about this milestone: ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
Tomorrow, Brad Bailey, SVP, General Manager, U.S., will discuss Genmab’s evolution into a biotech #innovation powerhouse at @CapitalAnalytic’s Invest: North & Central Jersey’s 2022 Conference.
Learn more at capitalanalyticsassociates.com. -
Genmab
@Genmab
Congratulations to Genmab researchers Simone Oostindie, Janine Schuurman and @LavaTx & @genentech colleagues on their publication in @NatRevDrugDisc. Read more on the role of avidity in #antibody biology and biotherapeutic drug design: www.nature.com/articles/s41573-022-00501-8.
#immunotherapy -
Genmab
@Genmab
#newsalert: Genmab to submit Biologics License Application to U.S. FDA for an investigational #bispecific #antibody for the treatment of relapsed/refractory large B-cell #lymphoma. Read the press release: ir.genmab.com/news-releases/news-release-details/genmab-s…
-
Genmab
@Genmab
This #pridemonth, Amy Jeffers of Flourish Training spoke w/ us on the neurological impact of inclusion at work. As we continue to respect & celebrate our differences, we’re proud to support @GSEquality, the largest LGBTQ+ advocacy org in NJ.
Learn more: ir.genmab.com/static-files/3a18c1bc-d3ee-401f-a721-c01704… -
Genmab
@Genmab
Motivated by our mission, Genmab is supporting @prinsesmaximac to benefit Ukrainian children w/ cancer & their families. Based in Utrecht, Netherlands, the center provides extensive care to children w/ cancer and welcomes Ukrainian children w/ cancer & their families. #cancer
-
Genmab
@Genmab
Head of Pathology, Suzana Couto, sat down with @pathologistmag to discuss her #career journey and role as a #pathologist at Genmab. Learn more about her work: thepathologist.com/outside-the-lab/career-snapshots-with-….
-
Genmab
@Genmab
Thank you @JITCancer! We are proud of the work of our brilliant team in #oncologyresearch.
Journal for ImmunoTherapy of Cancer
@jitcancer
New #jitc article: DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity jitc.bmj.com/content/10/6/e004322
-
Genmab
@Genmab
We’re excited to announce that @BioNJ_Org selected Genmab as a recipient of their Innovator Award! It’s an honor to be recognized for our work as part of New Jersey’s extraordinary #lifescience community.
Learn more about this award: bionj.org/2022-annual-dinner-meeting-innovation-celebration. -
Genmab
@Genmab
We are inspired by nature and the power of the immune system to transform #cancer treatment.
Learn more about how we leverage next-generation antibody technologies to do so at @BIOConvention’s #bio2022 and contact our business development team at licensing@genmab.com. -
Genmab
@Genmab
It is an honor to share our late-breaking data during the Presidential Symposium at #eha2022 from our phase 2 study for our investigational #bispecific antibody in relapsed/refractory large B-cell #lymphoma. Hear more during today’s presentation: ir.genmab.com/news-releases/news-release-details/genmab-a… @abbvie
-
Genmab
@Genmab
June is the 10th Annual Cancer Immunotherapy Month hosted by @CancerResearch. Learn more about the lifesaving potential of immunotherapy: www.cancerresearch.org/join-the-cause/cancer-immunotherap….
-
Genmab
@Genmab
We’re excited to be sharing our latest data at @EHA_Hematology’s #eha2022. Each day, our colleagues work tirelessly in hopes that their findings will bring us one step closer to our goal of improving the lives of those living with #cancer. Learn more at library.ehaweb.org/eha/2022/eha2022-congress/357716/ida.h….
-
Genmab
@Genmab
Genmab to Participate in a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference
ir.genmab.com/news-releases/news-release-details/genmab-p… -
Genmab
@Genmab
At Genmab, we’re known for our expertise in next-gen antibodies, and we will be sharing the latest data in our #oncology research at @EHA_Hematology’s #eha2022 Congress beginning tomorrow.
Visit booth #1020 to learn more. -
Genmab
@Genmab
At #asco22, with @SeagenGlobal, we’re presenting interim data from the innovaTV 205 trial, which investigated combinations of antibody-drug conjugate therapy and other cancer agents in patients with high unmet need. ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab reposted
Cancer Nation
@CancerAdvocacy
NCCS's Cancer Survivorship Checklist empowers survivors to be engaged in their care at every step of the survivorship journey, whether they're in treatment, finished treatment, or living with advanced and metastatic cancer. #nationalcancersurvivorsday canceradvocacy.org/resources/survivorship-checklist/
-
Genmab
@Genmab
In honor of #ncsd, @IrisKolder, PhD, Senior Scientist, Discovery Data Science, shared thoughts on her journey as a #cancerssurvivor and advice on how to best support others on their cancer journeys. As explained by Iris, showing any form of support is better than silence.
-
Genmab
@Genmab
In honor of #worldenvironmentalday, Genmab colleagues are volunteering to celebrate our environment with @GreenKayak_ngo’s #paddlefortheoceans in Copenhagen, @TielTipTop’s Trash Bash Litter Pick Up in The Netherlands & @IslesInc’s Urban Gardening in the U.S. #communityatgenmab
-
Genmab
@Genmab
Our core purpose is to improve the lives of those living with #cancer, so #ncsd2022 hits close to home at Genmab. Our colleagues conduct #research each day in the hopes of enabling more people like Gemma to celebrate #nationalcancersurvivorsday.
-
Genmab
@Genmab
Congratulations to Genmab colleagues on their poster presentation at @ASCO’s #asco2022 this morning! Learn about their approach using minimal tissue for simultaneous genomic profiling and tumor pathway analysis: meetings.asco.org/abstracts-presentations/210046.
-
Genmab
@Genmab
Beginning tomorrow, find us at booth 22097 at @ASCO’s #asco22 to learn about our latest data in #antibodytechnology discovery and development, and to help us further support #patients through a fundraiser benefitting @ConquerCancerFd.
-
Genmab
@Genmab
At #asco22, we will be presenting with our partners, @abbvie, @SeagenGlobal and @JanssenGlobal, our latest #oncology research that underscores our mission to transform the future of #cancer treatment. Learn more about our upcoming data presentations: ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
According to Martine van Vugt, Head of Corporate Strategy and Planning, Genmab’s #companyculture is simple: it’s doing the right thing.
-
Genmab
@Genmab
Translational research can arm researchers with insights to tailor treatments to specific patients, which can potentially allow for a more personalized approach to delivering #cancer care. Learn more in this article on @statnews: www.statnews.com/sponsor/2022/04/22/four-innovations-that….
-
Genmab
@Genmab
Congratulations to Genmab CEO Jan van de Winkel on making it into the @medicine_maker’s 2022 Power List!
-
Genmab
@Genmab
We understand the power of partnerships within the life sciences ecosystem. With over 20 #collaborations, #partnerships have been foundational to our approach since the beginning. Learn more in this recent article on @statnews: www.statnews.com/sponsor/2022/04/22/four-innovations-that….
-
Genmab
@Genmab
We look forward to presenting the latest #oncology research alongside our partners @abbvie and @JanssenGlobal at #eha22. Learn more about our new data and ongoing commitment to our goal of improving the lives of people with #cancer: ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
Investor update: Genmab has announced #financialresults for Q1 2022. Read more here: ir.genmab.com/news-releases/news-release-details/genmab-a….
-
Genmab
@Genmab
When did we begin honing our focus on antibody therapeutics?
Genmab
@Genmab
The answer is A – We’ve been antibody therapeutic-focused since our founding in 1999. That’s how we’ve achieved our strong pipeline of proprietary products and next-generation antibody technologies. Antibody therapy has always been and continues to remain at our core.
-
Genmab
@Genmab
We’re excited to be part of this year’s @oncologynursing #onscongress. This National Minority Cancer Awareness Month #nmhm2022 and all year long, nurses play an integral role in #cancercare by boosting their patients and communities.
Learn more: www.ons.org/congress/2022. -
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2022
ir.genmab.com/news-releases/news-release-details/genmab-a… -
Genmab
@Genmab
Learn more about the Phase 1/2 topline results for our investigational #bispecific antibody in relapsed/refractory large B-cell #lymphoma. ir.genmab.com/news-releases/news-release-details/genmab-a… @abbvie
-
Genmab
@Genmab
Genmab and our partner @abbvie announced topline results from a phase 1/2 study for our investigational #bispecific antibody in relapsed/refractory large B-cell #lymphoma. Read the latest here: ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
We’re proud to be a sponsor for the @CancerCare Spring Gala in support of CancerCare’s mission to provide free, professional support services to those navigating #cancer.
Learn more here: secure.everyaction.com/SM1uJgIbpk6jMzqiGMFJeA2. -
Genmab
@Genmab
Our in-depth knowledge of antibody biology helps us discover novel #cancer therapies for patients.
Want to learn more? Visit our booth at @AACR’s #aacr22 to for further information: www.aacr.org/meeting/aacr-annual-meeting-2022/. -
Genmab
@Genmab
Every team member plays a key role in our efforts to make a difference for patients. Hear from Martine J. van Vugt, PhD, Senior Vice President, Corporate Strategy and Planning, on our 2022 #leadership.
-
Genmab
@Genmab
We’re excited to be part of @AACR’s #aacr22 and share the latest in our best-in-class #oncology research.
Visit our booth to learn more about how we’re engineering a transformative tomorrow: www.aacr.org/meeting/aacr-annual-meeting-2022/. -
Genmab
@Genmab
Interested in learning about our beginnings as a Denmark based #biotech start-up and our recent tremendous growth? Hear from EVP and CFO Anthony Pagano at @ICDK_CPH’s DKBIO 2022.
Learn more: www.dkbio.org. -
Genmab
@Genmab
What sets us apart from other companies? We’re creators, original thinkers, and we challenge the status quo. We strive to create and get new #medicines to patients instead of making incremental changes to existing ones.
Learn more about us: www.genmab.com. -
Genmab
@Genmab
Congrats to the Genmab colleagues who have recently been elected to our #boardofdirectors! We’re honored to have you play a key role in setting Genmab’s goals and future success.
Learn more at www.genmab.com/who-we-are/board-of-directors/. -
Genmab
@Genmab
Investor Update: Genmab held its 2022 Annual General Meeting earlier today. Learn more at ir.genmab.com/news-releases/news-release-details/passing-….
-
Genmab
@Genmab
Genmab and @SeagenGlobal are committed to supporting the #cervicalcancer community. Learn more about this disease and its impact with @SHAREing: www.sharecancersupport.org/cervical-cancer/
-
Genmab
@Genmab
#dyk For the past 12 years, Genmab employees have held 3 seats on our Board of Directors to strengthen employee involvement in decision-making? Hear from current employee-elected board members and stay tuned to know the newly elected members on March 28. www.genmab.com/who-we-are/board-of-directors/
-
Genmab
@Genmab
We ensure that patients come first every step of the way as we work towards harnessing the power of antibodies to develop cancer treatments. To learn more about our science and amazing teams, visit us at @SGO_org’s upcoming #sgomtg: www.sgo.org/events/annual-meeting/.
-
Genmab
@Genmab
We’re committed to reducing our #environmental impact by selecting low energy office and lab equipment and implementing office climate control systems and fixtures.
Learn more about our #csr efforts in our recently published report here: ir.genmab.com/static-files/3a18c1bc-d3ee-401f-a721-c01704…. -
Genmab
@Genmab
At Genmab, our translational research and precision medicine teams integrates insights about patients, diseases, therapies, and antibody modalities to drive which of the following?
Genmab
@Genmab
D: All of the above, and much more. At Genmab, we work towards the goal of tailoring medicines by leveraging the power of translational research and precision medicine teams every single day. Learn more about our translational research here: www.genmab.com/research-innovation/translational-research/.
-
Genmab
@Genmab
2021 was a transformational year in achieving Genmab’s 2025 vision. Hear from EVP and COO Anthony Mancini to learn more about our achievements in 2021. Read our Annual Report at: ir.genmab.com/static-files/ac715ea0-08ab-4ad7-9b76-24016c….
-
Genmab
@Genmab
For @SchuurmanJ01, education and mentorship extend beyond the lab. She will be presenting the opening keynote speech at the #festivalofbiologics today and having a conversation with early career scientists at the upcoming @GordonConf on Antibody Biology and Engineering.
-
Genmab
@Genmab
The @US_FDA granted #orphan_drug_designation to an investigational bispecific antibody in our pipeline for the treatment of #follicular #lymphoma. Read the details: ir.genmab.com/news-releases/news-release-details/genmab-a… @abbvie
-
Genmab
@Genmab
In honor of #internationalwomensday, Genmab has made a donation to @equalitynow to support their cause of creating a just world for women and girls.
At Genmab we prioritize gender #diversity with 58% female representation on our teams. Learn more here: ir.genmab.com/static-files/3a18c1bc-d3ee-401f-a721-c01704…. -
Genmab
@Genmab
It’s important to understand the impact of #cervicalcancer in order to better support the community. Learn more critical facts about this disease. @SeagenGlobal
-
Genmab
@Genmab
Genmab is excited to announce the appointments of Birgitte Stephensen to Chief Legal Officer and @ChrisCozic to Chief People Officer as we continue to grow and become a fully integrated #biotech. Read the announcement here: ir.genmab.com/news-releases/news-release-details/genmab-a….
-
Genmab
@Genmab
We are offering 2 #postdocpositions in our #translationalresearch, #datascience and #pathology teams to further scientific discoveries and treatments with a goal to impact #cancer patients.
Download the brochure and apply at www.genmab.com/wp-content/uploads/2022/02/Genmab_Postdoct…. -
Genmab
@Genmab
We’re excited to share that the first-ever data on our antibody-drug conjugate in patients with head and neck squamous cell carcinoma will be presented with @SeagenGlobal at #hncs22.
Learn more here: ir.genmab.com/news-releases/news-release-details/genmab-a… @ASTRO_org -
Genmab
@Genmab
Shareholder update: Genmab Annual General Meeting will be held on Tuesday, March 29 at 2 PM CEST in Copenhagen, Denmark. Learn more at www.genmab.com/annual-general-meeting-2022/.
-
Genmab
@Genmab
At Genmab, we are dedicated to bettering the lives of those living with #cancer. Learn more about our work: www.genmab.com/pipeline/.
-
Genmab
@Genmab
We’re excited to announce that our 2021 #corporateresponsiblity report is now available.
Watch a video summary and download the full report on our #cr efforts here: www.genmab.com/our-responsibility/. -
Genmab
@Genmab
#investor Update: We have published our 2021 Annual Report! Learn more about our journey to become a fully integrated biotech and our work towards our goal of improving the lives of people living with #cancer.
Read the report here: www.genmab.com/annual-report-2021/. -
Genmab
@Genmab
At Genmab, we practice #equalityinscience.
by ensuring we have equal gender representation at every level throughout our organization. This @WomenScienceDay, Chalana shares her thoughts on working towards our goal of transforming the future of #cancer treatment. -
Genmab
@Genmab
A reminder for Genmab Shareholders: Register your email to receive shareholder communications including Genmab’s upcoming Annual General Meeting. Log on to our Investor Portal at investor.vp.dk/ip/ctrl/portal/Frontpage.do?command=&aside… and add your email under “My profile”
-
Genmab
@Genmab
Listen to our podcast about the development of our DuoBody® Bispecific #antibodytechnology platform.
-
Genmab
@Genmab
On #worldcancerday, we’re proud to support @AmericanCancer, @UICC & @EGM_Cancer in recognizing the inequities in cancer care globally. Thank you to all our speakers for helping us better understand the care gap experienced by cancer patients and HCPs.
Genmab
@Genmab
Thank you to our speakers, @TawanaTJohnson, @GlopesMd, @JacqDalyEGM and Gemma Henderson!
-
Genmab
@Genmab
Curious about our work in gynecological #cancer? Visit our booth at @SGO_org’s Winter Meeting to learn more: www.sgo.org/events/winter-meeting/.
#gcsm -
Genmab
@Genmab
Genmab and @SeagenGlobal are working with @TamikaFelder to spotlight #cervicalcancer stories beyond the month of January with our #ceme program. Stay tuned for more.
-
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021
ir.genmab.com/news-releases/news-release-details/genmab-a… -
Genmab
@Genmab
. @TamikaFelder, founder of @IAmCervivor is putting a face to #cervicalcancer and joining us on our #ceme campaign to elevate the stories that need to be heard. Join us as we listen and learn from this community. #cervicalcancerawarenessmonth @SeagenGlobal
-
Genmab
@Genmab
We are proud to announce that Genmab is once again featured in the @EWOB_ European Women on Boards Gender Equality Index Report. We have been acknowledged as Best Practice Leader and ranked 3rd in Denmark among those covered by the report. #genderdiversity #womeninleadership
-
Genmab
@Genmab
Each of us is inspired by our commitment to patients. Hear from our #oncology Account Manager @FinelliGinger.
-
Genmab
@Genmab
#icmyi: Genmab’s CEO, Jan van de Winkel, recently spoke at @jpmorgan’s #jpm2022 on our company progress and key updates.
Check out the replay: ir.genmab.com/events-and-presentations. -
Genmab
@Genmab
Join us tomorrow as CEO Jan van de Winkel shares important updates on our #pipeline and what’s next at @jpmorgan’s #jpm2022.
Don’t miss the live webcast here: ir.genmab.com/events-and-presentations. -
Genmab
@Genmab
January is #cervicalcancerawarenessmonth and we’re focused on listening and learning from the #cancer community by lifting the voices of those living with #cervicalcancer @SeagenGlobal @GYNCancer
-
Genmab
@Genmab
We’re proud to announce that Janine Schuurman, Senior Vice President, Head of Antibody Research & Technology, was elected Vice President of @TheAbSociety. Learn more about the recent announcement: www.antibodysociety.org/the-antibody-society/the-antibody….
-
Genmab
@Genmab
Check out the latest in our company’s growth and #pipeline development as shared at #jpm2022: ir.genmab.com/news-releases/news-release-details/genmab-p….
-
Genmab
@Genmab
News Update: Genmab and @Synaffix entered into license agreement providing Genmab access to Synaffix ADC technologies. Read more at ir.genmab.com/news-releases/news-release-details/genmab-a….
-
Genmab
@Genmab
#happyholidays! From all of us at Genmab, we hope you have a happy and healthy holiday and new year.
-
Genmab
@Genmab
The DuoBody® technology platform is the basis of many #bispecificantibodies in our #pipeline. Learn more about the background of this platform in this podcast episode: vimeo.com/636105275/ba065aeec3.
-
Genmab
@Genmab
Thank you for attending our presentations at #ash21. Learn more about our #oncology pipeline and process for turning science into medicine: www.genmab.com/pipeline/.
-
Genmab
@Genmab
Join us today for our virtual R&D update and #ash21 data review. Our Executive Management team will highlight progress in our product #pipeline and recent data findings. Register here: ir.genmab.com/events/event-details/2021-virtual-rd-update….
-
Genmab
@Genmab
In honor of #internationalvolunteerday, Genmab employees in the U.S. joined together with @Cr4Hope @IamCervivor and @accorg to create seasonal greeting cards for adults and children living with cancer. Join us: www.genmab.com/careers/.
-
Genmab
@Genmab
At Genmab, social responsibility is key to who we are, which is why we're proud to have supported several organizations across #stem education, sustainability, better health outcomes & local communities. Learn more about our efforts at www.genmab.com/our-responsibility/.
-
Genmab
@Genmab
To get the latest on clinical research on hematological malignancies, visit our booth at #ash21: www.hematology.org/meetings/annual-meeting.
-
Genmab
@Genmab
Interested in learning more about our innovative pipeline and key data presentations at #ash21? Join our CEO Jan van de Winkel and our executive management team for a virtual R&D update and data review:
ir.genmab.com/events/event-details/2021-virtual-rd-update…. -
Genmab
@Genmab
Investor Update: We recently published our financial calendar for the year 2022! For more information, please visit ir.genmab.com/financial-calendar.
-
Genmab
@Genmab
Each day, we work towards challenging conventions in pursuit of the next big breakthrough in cancer treatment. See how we’re pioneering new frontiers with our #bispecificantibodies: www.genmab.com/who-we-are/history/.
-
Genmab
@Genmab
We’re well on our way to achieving our 2025 vision of transforming the future of #cancer treatment and establishing our pipeline of differentiated antibodies.
See how we are evolving into a fully integrated #biotech powerhouse: www.genmab.com/who-we-are/history/. -
Genmab
@Genmab
#happythanksgiving! This year, we’re proud to be donating turkeys and sides to @nj_rise to feed 50 families in Mercer County, New Jersey.
-
Genmab
@Genmab
As Gemma says, “no one fights alone” in their journey living with cancer. This #caregiversmonth, we want to thank the friends, family, doctors and caregivers who are there every step of the way.
-
Genmab
@Genmab
We’re excited to support @umu_museum in their transformation to becoming the leading research museum in the Netherlands. We look forward to seeing the results of their renovations including new exhibitions to showcase the importance of research and scientific literacy.
-
Genmab
@Genmab
Investor update: Genmab has announced #financialresults for Q3 2021. Read more here: ir.genmab.com/news-releases/news-release-details/genmab-a….
-
Genmab
@Genmab
We’re excited to be presenting data with @BioNTech_Group at #sitc2021 Congress, beginning today!
-
Genmab
@Genmab
We are pleased to present important data on our #bispecificantibodies with our partner @abbvie at #ash21 Read the latest here: bwnews.pr/31p4vgR
-
Genmab
@Genmab
We’re delighted to share multiple data presentations for solid tumors including a mini oral presentation on the safety and initial clinical data of an investigational therapy in patients with advanced solid tumors at #sitc21 from Nov 10-14: www.sitcancer.org/2021/program/annual-meeting-schedule-2021
-
Genmab
@Genmab
News Update: Genmab Improves its 2021 Financial Guidance ir.genmab.com/news-releases/news-release-details/genmab-i…
-
Genmab
@Genmab
At #ash2021, we will present important data with our partner evaluating our portfolio of #bispecificantibodies. Learn more: bwnews.pr/31p4vgR @abbvie
-
Genmab
@Genmab
Genmab Announces Multiple Abstracts to be Presented at the 63rd Annual Meeting and Exposition of the American Society of Hematology ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
We’re excited to announce that we have been shortlisted for @EuroMed_Awards Company of the Year, and our CEO, Jan van de Winkel, has been shortlisted for CEO of the Year at the #mediscienceawards!
-
Genmab
@Genmab
Genmab to Present at Jefferies Virtual London Healthcare Conference ir.genmab.com/news-releases/news-release-details/genmab-p…
-
Genmab
@Genmab
Janine Schuurman, Senior Vice President of Antibody Research & Technology, and Esther Breij, Senior Director of Translational Research, will share presentations on #bispecificantibodies, IgG hexamerization and dual epitope targeting at @CHI_Healthtech’s #pegseurope.
-
Genmab
@Genmab
We’re proud to support @FNIH_Org’s 2021 Biomarkers Consortium Cancer Steering Committee Scientific Symposium, uniting #cancerresearch experts to propel the future of #biomarker discovery and development in #oncology.
Learn more: fnih.org/our-programs/biomarkers-consortium/csc-scientifi… -
Genmab
@Genmab
Genmab is proud to support the Danish Cancer Society, @cancer_dk, this Breaking Cancer Week. We’re honored to donate and contribute to the fight against #cancer.
-
Genmab
@Genmab
We’re honored to have been voted one of the #mostattractiveemployersdenmark2021 by the @UniversumGlobal Talent Survey. To learn about our company culture and job opportunities, visit: www.genmab.com/careers/
#topemployer2021 -
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2021
ir.genmab.com/news-releases/news-release-details/genmab-a… -
Genmab
@Genmab
We’re excited to congratulate @PrincetonChem’s @dmac68, our #collaborator on the @Princeton Catalysis Initiative (PCI) and a 2021 #nobel laureate!
Learn more about our partnership here: pci.princeton.edu/2020/10/21/pci-signs-agreement-with-gen…. -
Genmab
@Genmab
Genmab Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT® (amivantamab) for Patients with Advanced Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations, After Failure of Platinum-based Therapy ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
We’re excited to announce that our #bispecificantibody #collaboration with @abbvie has landed a spot on the shortlist for Best Partnership Alliance at the 2021 @PharmaScrip #scripawards!
See the 2021 shortlist here:
pharmaintelligence.informa.com/events/awards/scrip-awards… -
Genmab
@Genmab
We’re discussing our #bispecificantibodies, DuoBody® and HexaBody®, at the @SGO_org’s Allied Health Professionals Meeting. Learn more about how our proprietary technologies are working with the aim of transforming treatment in the #oncology space.
www.sgo.org/events/allied-health-professionals-meeting/ -
Genmab
@Genmab
Nicole Heaps, Senior Medical Science Liaison, plays an instrumental role in helping bring our #medicines directly to patients, especially as we evolve to a fully integrated #biotech powerhouse.
To learn what it is like to work at Genmab, visit www.genmab.com/careers/ -
Genmab
@Genmab
Last year, our researchers joined @_Hubrecht and Dutch molecular biologists to develop “The Beast,” a start-to-end streamlined and automated procedure for COVID-19 testing. This innovation won the Prix Galien Excellence COVID-19 Award earlier in the year.
-
Genmab
@Genmab
We are pleased to present important data on our solid tumor portfolio of #bispecificantibodies with our partners @BioNTech_Group at #sitc21. Read the latest here: ir.genmab.com/news-releases/news-release-details/genmab-a… @sitcancer
-
Genmab
@Genmab
At #sitc21, we are presenting important data with our partners @BioNTech_Group that evaluates our solid tumor portfolio, including #bispecificantibodies: ir.genmab.com/news-releases/news-release-details/genmab-a… @sitcancer
-
Genmab
@Genmab
While we’ve spent the last 30 days recognizing blood and gynecologic cancers, it doesn’t stop here. We’re still on the road to discovering innovative approaches to improve outcomes for people living with these cancers. #bloodcancerawarenessmonth #gynecologiccancerawarenessmonth
-
Genmab
@Genmab
As September and #gcam come to a close, we, in partnership with @SeagenGlobal pledge to continue the education around #gynecologiccancer and support women impacted by the disease.
-
Genmab
@Genmab
Genmab is proud to have accomplished the goals outlined in our 2020 Corporate Social Responsibility Report and enthusiastic that we remain on target toward our objectives in 2021. Read more about our #csr efforts at ir.genmab.com/static-files/da4642b0-1e0f-47b0-9087-800544….
-
Genmab
@Genmab
Genmab is thrilled to partner with @SeagenGlobal this Sunday in sponsoring #move4her, a live one-hour virtual and interactive walk raising awareness for education, outreach and research of #gynecologiccancers @GYNCancer
-
Genmab
@Genmab
Our Vice President and Head of Global Drug Safety and Pharmacovigilance, @AtallaGigi, shared her thoughts around merging adverse events throughout clinical trials and post-marketing surveillance at the 25th Pharmacovigillance2021 conference.
-
Genmab
@Genmab
Genmab and @SeagenGlobal are proud to develop therapeutic options with the aim of helping improve the lives of people with #cancer. Hear from @IamCervivor on what a new treatment option means for the #cervicalcancer community.
-
Genmab
@Genmab
Genmab and @SeagenGlobal proudly share our new U.S. FDA-approved therapy for people living with recurrent or metastatic #cervicalcancer with limited treatment options once the disease progresses after #chemotherapy.
-
Genmab
@Genmab
We are proud to announce our first U.S. FDA approved therapy for people with recurrent or metastatic #cervicalcancer with disease progression after chemotherapy! @SeagenGlobal.
-
Genmab
@Genmab
Today is #worldgo day. We and @SeagenGlobal are joining the effort to encourage women to talk to their doctor about #gynecologiccancers and schedule regular check-ups. Share what you #gofor this #gcam. @WorldGOday
-
Genmab
@Genmab
Genmab has created a number of proprietary technologies. Do you know how many we have developed?
Genmab
@Genmab
The answer is D: 4 — DuoBody®, HexaBody®, DuoHexaBody® and HexElect®.
Learn more about these technologies at
www.genmab.com/research-innovation/antibody-technology-pl… -
Genmab
@Genmab
We recently shared our latest research on an investigational combination therapy in recurrent or metastatic #cervicalcancer. See our science at work at #esmo21.
-
Genmab
@Genmab
Genmab and partner @SeagenGlobal are bringing our latest research in recurrent or metastatic #cervicalcancer to #esmo21. Learn how we’re innovating in #cancercare.
-
Genmab
@Genmab
Genmab is thrilled to partner with @SeagenGlobal this Sunday in sponsoring #move4her, a live one-hour virtual and interactive walk raising awareness for education, outreach and research of #gynecologiccancers @GYNCancer
-
Genmab
@Genmab
Test your knowledge – How many new cases of #cervicalcancer are estimated in US in 2021?
Genmab
@Genmab
National Cancer Institute estimates as many as 14,480 new cases of cervical cancer this year in the U.S.
Source: National Cancer Institute SEER -
Genmab
@Genmab
Today marks the official kickoff of #esmo21 where we’re discussing our leading antibody science in resources like our data presentations. Visit our virtual booth to learn about our innovative antibody technologies, latest #clinicalresearch and pipeline: www.esmo.org/meetings/esmo-congress-2021
-
Genmab reposted
Blood Cancer United
@BloodCancerUtd
Let’s GO! This Blood Cancer Awareness Month, get in on the #3minutechallengells! 🤟 Visit us on Instagram to help us make an impact this month to #cancelbloodcancer 👉 www.instagram.com/llsusa/
-
Genmab
@Genmab
Tahamtan Ahmadi, Executive Vice President and Chief Medical Officer, Head of Experimental Medicines focuses each day on harnessing diverse possibilities within Genmab’s research #pipeline.
Learn more at #soho21. www.sohoonline.org/site_page.cfm?pk_association_webpage_m… -
Genmab
@Genmab
Many women with a #gynecologiccancer experience little to no symptoms making it important to see your #obgyn regularly for screening and communicate with your doctor about potential symptoms. Learn more from @GynCancer. #gcam
-
Genmab
@Genmab
As the fourth most deadly cancer in women worldwide, #cervicalcancer remains a significant medical challenge. We proudly partner with @SeagenGlobal to advance research for patients with recurrent or metastatic cervical cancer #esmo21.
-
Genmab
@Genmab
Oncology nurses play a vital role in advancing patient care. We’re excited to hear their insights about current frontline challenges at the #onsbridge conference to continue innovating our current pipeline with the goal of creating treatment for people living with #cancer.
-
Genmab
@Genmab
September is #gynecologiccancerawarenessmonth and we are committed to advancing education, support and research on behalf of those affected by #gynecologiccancers. Follow along this month to learn more! #gcam
-
Genmab
@Genmab
We're excited to share that recent research featuring our investigational #bispecific antibody has been published in @TheLancetOncol. Read more here: ir.genmab.com/news-releases/news-release-details/clinical… @abbvie
-
Genmab
@Genmab
We are very excited to present the latest data on our investigational combination therapy in recurrent or metastatic #cervicalcancer at #igcs2021 and #esmo21. Follow along at genmab.com to learn more!
-
Genmab
@Genmab
Today we’re proud to present new data from our clinical trial in recurrent or metastatic #cervicalcancer at #igcs2021. @SeagenGlobal and Genmab are committed to our goal to make an impact on the lives of people with #cancer.
-
Genmab
@Genmab
Developing oncologic therapies is challenging but rewarding. We have been fortunate to have many groundbreaking accomplishments. #dyk how many Genmab created products are currently in clinical development?
Genmab
@Genmab
The answer is C: 23; we leverage antibodies’ versatility. We are proud to invest in and advance a robust pipeline of differentiated product candidates that are at the forefront of the industry. Learn more at www.genmab.com/pipeline/.
-
Genmab
@Genmab
At the @IGCSociety Annual Global meeting, we are proud to share our latest research in #cervicalcancer and join #oncology researchers around the world in the fight against #gynecologiccancer. #igcs2021 @SeagenGlobal
-
Genmab
@Genmab
Genmab to Present at Morgan Stanley 19th Annual Global Healthcare
Conference ir.genmab.com/news-releases/news-release-details/genmab-p… -
Genmab
@Genmab
Genmab’s DuoBody technology leverages the power of bispecific antibodies with a potential to create therapies for which diseases?
Genmab
@Genmab
The answer is D – All of the above; our DuoBody® platform serves as the basis of many bispecific antibodies in Genmab’s product pipeline as well as products of our partners. Learn more at www.genmab.com/research-innovation/antibody-technology-pl…
-
Genmab
@Genmab
Our DuoBody technology played a role in creating a bispecific antibody used in a study investigating the use of this antibody in #hemophiliaa, and preclinical data from this study was published in @BloodJournal by partner @novonordisk.
-
Genmab
@Genmab
Jan van de Winkel, Ph.D., President and CEO of Genmab, joined a recent @PharmExec panel alongside 4 #biopharma executives to discuss collaboration and the importance of partnering with peer organizations to speed up innovation.
-
Genmab
@Genmab
Investor Update: Genmab has published #q2fy21 financial results. Read the full announcement here: ir.genmab.com/news-releases/news-release-details/genmab-a… #q2results #financialresults
-
Genmab
@Genmab
Our work at Genmab is contributing to major advancements in #oncology. Currently, there are 4 approved therapies that have incorporated Genmab #innovation, and more in the pipeline. Learn more about our #bispecific antibody technology platforms: www.genmab.com/research-innovation/antibody-technology-pl…
-
Genmab
@Genmab
Genmab’s booth at the 2021 Pan Pacific Lymphoma Conference hosted by @UNMC will be available for all in-person attendees who are looking to learn more about our #cancerresearch. Please visit us at booth #118.
-
Genmab
@Genmab
Genmab is focused on the creation and development of innovative and differentiated antibody products, with the aim of improving the lives of #cancer patients. Learn more about our #research and #innovation: www.genmab.com/antibody-science/antibody-technology-platf…
-
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2021 ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
Thank you @NJBmagazine and @NJBIA for recognizing Genmab as a winner of the New Good Neighbor Award winner for the Genmab US #headquarters in #newjersey. Learn more here: njbia.org/njbia-nj-business-magazine-announce-2021-new-go…
-
Genmab
@Genmab
Genmab is now 1,000 employees strong! As we evolve into an international biotech powerhouse we’re growing our team with new diverse talent who want to make an impact for people living with #cancer. Join us: www.genmab.com
-
Genmab
@Genmab
At Genmab, we spend our days researching new ways to advance #cancer research so we can help patients fight for a future that is #immune2cancer.
#cancerimmunotherapymonth -
Genmab
@Genmab
Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation, Including for the Treatment of Patients with Newly Diagnosed Light-chain (AL) Amyloidosis ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
Genmab is dedicated to maintaining an environment that is #inclusive for all employees. Lab Application Engineer Marion Janschitz shares their experience around identity at Genmab during #pridemonth.
-
Genmab
@Genmab
Our virtual booth at @icmlugano is now live. Visit to learn about our #antibody technology platforms and investigational therapies for the treatment of #cancer: www.icml.ch/icml/home.html
-
Genmab
@Genmab
We’re presenting data on our investigational therapies at #eha2021. See our presentations for more information ehaweb.org/congress/eha-congress-2021/key-information/
-
Genmab
@Genmab
Actors win Oscars, #innovators win the Prix Galien. Congratulations to Genmab’s Martijn Bosch & Rob Ruijtenbeek in partnership with the @_Hubrecht Institute & other collaborators on winning the Prix Galien Award in the Netherlands for their work on a #covid19 testing robot.
-
Genmab
@Genmab
At #asco21 we are looking forward to our data presentation on investigational medicines in our pipeline utilizing the DuoBody® bispecific #antibody platform. Learn more about our technology: www.youtube.com/watch?v=__rE120SkTw&t=38s
-
Genmab
@Genmab
We’re inspired and motivated by the #cancer community, especially by all the survivors who fought tirelessly for their remission. We work hard with a goal to develop innovations in treatment to help more people celebrate #nationalcancersurvivorsday.
-
Genmab
@Genmab
Genmab is committed to being a sustainability biotech company on #worldenvironmentday and every day. We’re #leed-certified by @USGBC for the highest standards in #greenbuilding leadership at the New Jersey location & BREEAM certified at our global R&D center at Utrecht, the NE!
-
Genmab
@Genmab
Connect with Genmab at the 2021 @ASCO Annual Meeting. Visit our #virtualbooth to learn about our innovative pipeline, next-generation antibody platforms and data presentations: conferences.asco.org/am/attend
-
Genmab
@Genmab
#asco21 is an exciting opportunity to come together with the #oncology research community and share the latest data on our investigational medicines in clinical trials. Learn more at 2021 ASCO: meetinglibrary.asco.org/browse-meetings/2021 ASCO Annual …
-
Genmab
@Genmab
We are excited to participate in a fireside chat at the @GoldmanSachs 42nd Annual Global Healthcare Conference. Join us on June 8 and check out the webcast at: ir.genmab.com/events-and-presentations
-
Genmab
@Genmab
We are very proud of the Genmab scientists who were a part of this collaboration @_Hubrecht
Koninklijk Huis
@koninklijkhuis
De Koning spreekt online over de impact van de coronacrisis op de wetenschap met @_knaw, @Meertens_knaw, @_Hubrecht. Veel wetenschappers hebben hun onderzoek moeten stilleggen, tegelijkertijd ontstaan nieuwe samenwerkingskansen, zoals met robot The Beast. www.koninklijkhuis.nl/actueel/nieuws/2021/06/01/koning-sp…
-
Genmab
@Genmab
#icymi – We recently announced regulatory approval for @JanssenGlobal’s therapy that was created using our DuoBody® #bispecific technology platform. Visit www.genmab.com/antibody-science/antibody-technology-platf… to learn more about our next-gen antibody technology platforms.
-
Genmab
@Genmab
At Genmab, collaborations and partnerships have always been part of our DNA. Thank you @PharmaVOICE and @tgrom for featuring our collaboration with @abbvie. Check out the article to learn more www.pharmavoice.com/news/2021-06-collaborations-across-th…
PharmaVoice
@PharmaVoice
In this month's cover story, @tgrom shines a light on a number of industry collaborations designed to accelerate progress to solve R&D and patient challenges. www.pharmavoice.com/digital-edition/june-2021/
-
Genmab
@Genmab
News Update: Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration ir.genmab.com/news-releases/news-release-details/genmab-a… @BoltBio
-
Genmab
@Genmab
We are pleased to present important data on our portfolio of #bispecificantibodies and #antibodydrugconjugates with our partners at #asco21 and #eha2021. Learn more: ir.genmab.com/news-releases/news-release-details/genmab-a… @abbvie @SeagenGlobal @JanssenGlobal
-
Genmab
@Genmab
Thanks for the shout out on our bispecific technology @pharmaphorum!
www.genmab.com/research-innovation/antibody-technology-pl…
pharmaphorum
@pharmaphorum
Straight after claiming its first approval for a cancer bispecific antibody, @JNJnews highlights positive results for two more, both for multiple myeloma, at this year's #asco congress #oncology #pharma pharmaphorum.com/news/straight-after-its-first-cancer-bis…
-
Genmab
@Genmab
Watch our EVP and COO Anthony Mancini accept the Corporate Achievement 2021 Award from Patricia J. Goldsmith @CancerCare during the virtual Festival of Hope Gala. #cancerinnovation
-
Genmab
@Genmab
Our DuoBody® #bispecific antibody technology was showcased in @jbiolchem’s publication. Read the article to learn about the discovery of a potential treatment option for patients with non-small cell lung cancer currently being developed by @JanssenGlobal: www.jbc.org/article/S0021-9258(21)00427-0/fulltext
-
Genmab
@Genmab
Thank you @CancerCare for making us a part of the Festival of Hope and presenting us with the 2021 Corporate Achievement Award. We remain dedicated to developing novel therapies with the goal of improving the lives of people with #cancer. www.cancercare.org/press/releases/214-2021_05_19
-
Genmab
@Genmab
We’re proud to announce our SARS-CoV-2 testing robot, STRIP-1, developed in partnership with @_Hubrecht Institute won the esteemed Prix Galien Excellence #covid19 Award in the Netherlands! We’re honored to be the recipients of this award, also known as the ‘Oscars of Innovation.’
-
Genmab
@Genmab
Genmab Announces that Janssen has been Granted U.S. FDA Approval for RYBREVANT™ (amivantamab-vmjw) for Patients with Metastatic Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) SC Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
Congratulations to our President and CEO Jan van de Winkel on his recognition in @endpts “60 over 60.” Under his leadership, Genmab has continue to grow and develop innovative #antibody medicines that have the potential to transform the future of #cancer treatment.
Endpoints News
@endpts
There’s a whole generation of pioneers who have been breaking new paths in R&D for decades. This is our tip of the hat for what they’ve done. And what they promise to do.
endpts.com/legacies-60-biopharma-pioneers-over-60-who-hel… -
Genmab
@Genmab
Genmab is a proud sponsor of @JAofNJ’s Junior Achievement Inspire Virtual Career Expo in New Jersey, which aims to promote the importance of #education and highlight potential #career opportunities to students as they begin to plan their futures. janj.ja.org/events/ja-inspire-virtual-career-expo-2021
-
Genmab
@Genmab
Together with our partners, we are presenting important data evaluating our portfolio of #bispecificantibodies and #antibodydrugconjugates at #asco21 and #eha2021. Learn more: ir.genmab.com/news-releases/news-release-details/genmab-a…, @abbvie @SeagenGlobal @JanssenGlobal
-
Genmab
@Genmab
Our EVP and COO Anthony Mancini spoke with @CancerCare and reflected on Genmab’s achievements and purpose-driven culture. Watch his remarks here.
-
Genmab
@Genmab
Thank you @BioCentury @StephenPHansen for the mention in your recent article. We’re honored to be considered a success story for growth and innovation. www.biocentury.com/article/636235/the-nordic-track-for-fi…
-
Genmab
@Genmab
May is National Cancer Research Month. We are proud of our scientists and their work every day toward the goal of improving the lives of those affected by cancer. #ncrm21 #researchsaveslives
-
Genmab
@Genmab
Congratulations to our President and CEO Jan van de Winkel on topping the annual CEO performance list from Danish #financial magazine, Økonomisk Ugebrev. Under his leadership, Genmab has continued to grow & focus on developing innovative #cancer therapies ugebrev.dk/ledelse/genmab-wins-our-ceo-performance-rankin…
-
Genmab
@Genmab
Our virtual #asco21 booth is now live. Visit to learn about our innovative pipeline, next-generation antibody platforms and data presentations at the 2021 @ASCO Annual Meeting: conferences.asco.org/am/attend
-
Genmab
@Genmab
Today, May 13 at 3:55 PM EST, watch Kate Sasser, Senior VP, Head of Translation Research speaking on the Frontiers in Cancer Immunotherapy at a virtual symposium by @NYASciences www.nyas.org/events/2021/webinar-frontiers-in-cancer-immu…
#immunotherapy2021 -
Genmab
@Genmab
We continue to focus on reducing our environmental impact and are happy to share that our U.S. headquarters is now Gold #leed certified for its #sustainabledesign features.
-
Genmab
@Genmab
Genmab recognizes the importance of promoting #diversity and we are proud to share that women compose more than 50% of employees throughout the entire organization in 2020. Learn about our Diversity Policy: ir.genmab.com/corporate-social-responsibility/ #femaleleadership
-
Genmab
@Genmab
A team of @JanssenGlobal and Genmab scientists co-authored an article published in @jbiolchem on the discovery of a novel bispecific antibody, which is being developed by Janssen for non-small cell #lungcancer.
-
Genmab
@Genmab
Thank you @onetreeplanted for educating our employees and their children on the importance of taking care of the #environment!
-
Genmab
@Genmab
A big thank you to oncology #nurses everywhere, including those who now work at Genmab! We appreciate your hard work and dedication to helping patients every day. #oncologynursingmonth
-
Genmab
@Genmab
Investor update: Genmab is announcing the financial results for Q1 2021. Read more here: ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
We are honored to be recognized by @CancerCare for our commitment to our goal of transforming cancer treatments for people with cancer. www.cancercare.org/press/releases/211-2021_04_28
-
Genmab
@Genmab
At Genmab, we believe we have the potential to transform cancer treatment. Our strong pipeline includes a number of potentially best-in-class or first-in-class antibody candidates based on our proprietary technology platforms. Photo Credit: Tuala Hjarnø
-
Genmab
@Genmab
We are proud to be named the recipient of the 2021 Corporate Achievement Award from @CancerCare and be a part of the virtual Festival of Hope Gala. www.cancercare.org/press/releases/211-2021_04_21
-
Genmab
@Genmab
Thank you to oncology nursing professionals for all they do for patients with cancer. If you are registered for #onscongress, be sure to check out our virtual booth at @oncologynursing’s Annual Congress on April 20,22,27 and 29. genmab-at-ons-2021.com
-
Genmab
@Genmab
We recognize #nationalminoritycancerawareness Month in the U.S. and encourage you to visit @CancerCare website which has resources for minority patient groups affected by cancer.
www.cancercare.org/blog/resources-for-national-minority-c… -
Genmab
@Genmab
We are celebrating Medical Laboratory Professionals Week and are proud to recognize the medical laboratory professionals at Genmab playing a vital role in our research aimed at improving the lives of patients with cancer. Thank you for all that you do! Photo Credit: Tuala Hjarnø
-
Genmab
@Genmab
Genmab hired over 220 employees in 2020. If you are looking to join a growing biotech organization where everyone takes pride in being the best at what they do, take a look at our open positions. www.genmab.com/careers/
-
Genmab
@Genmab
We are honored to be recognized by @CancerCare for our commitment to our goal of transforming cancer treatments for people with cancer.
CancerCare
@CancerCare
CancerCare's 33rd annual Festival of Hope Gala will be held virtually on Wednesday, May 12, 2021. @Genmab will be honored along with others who have made substantial contributions that help CancerCare improve the lives of people affected by cancer. secure.everyaction.com/089b8YWrdUm21yTdSDMCTA2
-
Genmab
@Genmab
We are proud to be taking part in @OncologyNursing’s 46th Annual Congress. Please visit our virtual booth during #onscongress on April 20, 22, 27 and 29 to learn about our antibody technology platforms and innovative pipeline.
-
Genmab
@Genmab
#icymi: The results of the pivotal phase 2 innovaTV 204 clinical trial evaluating tisotumab vedotin as monotherapy in recurrent or metastatic #cervicalcancer was recently published in @TheLancetOncol www.thelancet.com/journals/lanonc/article/PIIS1470-2045(2…
@SeagenGlobal @rcoledude -
Genmab
@Genmab
Congratulations to our President and CEO Jan van de Winkel on being named to @medicine_maker’s 2021 Power List. With his leadership, Genmab has continued to grow and focus on our vision of transforming cancer treatment. Check out his profile: themedicinemaker.com/power-list/2021/biopharmaceuticals/j…
-
Genmab
@Genmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
ir.genmab.com/news-releases/news-release-details/genmab-a… -
Genmab
@Genmab
What if the world saw cancer differently? Understanding cancer better so that we can overcome it has been our focus for more than 20 years. We’re working everyday toward our goal of fundamentally transforming the treatment of cancer. #wearegenmab
This media couldn't be displayed. See it on the original post. -
Genmab
@Genmab
At #aacr, we are looking forward to data presentation on 2 key investigational medicines in our pipeline utilizing the DuoBody bispecific antibody platform. Access to the posters can be found at www.abstractsonline.com/pp8/.
-
Genmab
@Genmab
Passing of Genmab A/S’ Annual General Meeting
ir.genmab.com/news-releases/news-release-details/passing-… -
Genmab
@Genmab
We are pleased to announce the results of the pivotal phase 2 innovaTV 204 clinical trial evaluating tisotumab vedotin as monotherapy in recurrent or metastatic #cervicalcancer is published in @TheLancetOncol @SeagenGlobal
-
Genmab
@Genmab
The BLA filing for our investigational therapy for recurrent or metastatic #cervicalcancer was recently accepted by the @US_FDA. We’d like to thank the patients, physicians, nurses and all our collaborators including @SeagenGlobal for their support during our #clinicaltrials.
-
Genmab
@Genmab
The @US_FDA has accepted our Biologics License Application, bringing us and our partner @SeagenGlobal closer to potentially addressing an unmet medical need for women with recurrent or metastatic #cervicalcancer, with disease progression on or after #chemotherapy. #gyncsm
-
Genmab
@Genmab
Join Genmab at @AACR's Virtual Annual Meeting April 10-15 and May 17-21 to learn about our innovative pipeline and next-generation antibody platforms, as well as information about our data presentations. #aacr21
Visit our booth to learn more: genmab-at-aacr-2021.com -
Genmab
@Genmab
The @US_FDA has accepted our Biologics License Application with Priority Review designation for tisotumab vedotin, an investigational #antibodydrugconjugate being co-developed with @SeagenGlobal, intended to treat women with recurrent or metastatic #cervicalcancer.
-
Genmab
@Genmab
Genmab was recently highlighted in @IRMagazine and our Vice President & Head of Investor Relations Andrew Carlsen discussed the motivation behind Genmab’s successful secondary IPO on @Nasdaq in 2019. Read more here: www.irmagazine.com/sell-side/inside-genmabs-blockbuster-ipo
-
Genmab
@Genmab
At Genmab, we’re committed to our goal of improving the lives of all cancer patients. Today on World Health Day, we’re proud to support the @WHO’s campaign to build a fairer, healthier world for everyone. #worldhealthday
-
Genmab
@Genmab
Don’t miss Genmab at #aacr21. This is an exciting opportunity to hear from our antibody technology leaders about how we’re harnessing the power of the immune system to develop innovative products for patients. www.abstractsonline.com/pp8/
-
Genmab
@Genmab
Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis ir.genmab.com/news-releases/news-release-details/genmab-a…
-
Genmab
@Genmab
A big thank you to all the doctors and healthcare professionals in the US and around the world fighting cancer, #covid19 and many other diseases. We appreciate your hard work and dedication to helping patients each and every day. #nationaldoctorsday
-
Genmab
@Genmab
At Genmab, we’re dedicated to our goal of improving the lives of patients with cancer. If you are looking for a job where you’ll make a difference, check out our open positions. www.genmab.com/careers/
-
Genmab
@Genmab
Join our President and CEO Jan van de Winkel for a panel discussion on Funding & Partnering Strategies @I4Hevent in April. Register at: www.hyphenprojects.nl/i4h/i4h2020-attendee-registration/S…
Innovation for Health
@I4Hevent
Learn from successful innovators in the Panel Discussion Funding & Partnering Strategies @I4Hevent, with Ivan Burkov (@INKEFCapital), Jan van de Winkel (@Genmab), Arjen Lemmen (@argenxglobal) & Kasper Roet (QurAlis). Register today & join this session: www.hyphenprojects.nl/i4h/i4h2020-attendee-registration/S….
-
Genmab
@Genmab
Genmab is proud to sponsor the @BioNJ_Org Inaugural Diversity, Equity & Inclusion…Because It Matters Conference. At Genmab, we seek diverse perspectives and insights that challenge the way we approach problems and find solutions. #bionjdei2021
-
Genmab
@Genmab
In the future of #bispecific #antibodies, “Details matter” says Genmab Chief Medical Officer Tahamtan Ahmadi in a new article from Nature Biotechnology. Read the latest on how bispecific antibodies are propelling new cancer therapies. www.nature.com/articles/s41587-021-00850-6 @nresearchnews
-
Genmab
@Genmab
We are deeply saddened by the violence in the U.S. against the Asian American Pacific Islander community and stand firmly against racism, violence, and discrimination in any form.
-
Genmab
@Genmab
Did you know that #multiplemyeloma is the second most common blood cancer worldwide? We’re focused on advancing science that may improve the lives of patients with #multiplemyeloma. #myelomaactionmonth
-
Genmab
@Genmab
The DuoBody® platform builds on insights from the natural biology of antibodies for discovery and development of #bispecific antibodies. To learn more, visit our booth at #nccn2021
-
Genmab
@Genmab
Genmab is proud to be a sponsor of @SGO_org’s virtual annual meeting on Women’s Cancer. Visit our virtual booth at genmab-at-sgo-2021.com #sgomtg
registration.experientevent.com/showsgo211 -
Genmab
@Genmab
Genmab is proud to be exhibiting at @NCCN’s Virtual Annual Conference. Visit our virtual booth to learn more about our antibody technology platforms and pipeline at
www.nccn.org/professionals/meetings/annual_conference.aspx #nccn2021 -
Genmab
@Genmab
We’re excited to share updates from Genmab’s pipeline at the virtual #sitc2020, including first-in-human data on a bispecific #antibody in joint development with @BioNTech_Group. Read more: ir.genmab.com/news-releases/news-release-details/genmab-a…








































































































































































































































































































































































































































































































































































